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Abstract 
 Plants defend themselves against pathogens by activating responses 
that can also cause unintended collateral damage to the plant itself. Improved 
understanding of the evolutionary constraints and molecular mechanisms 
affecting these responses can provide means to minimize the tradeoff 
between disease-related losses and hyperimmunity-related yield drag in 
crops. As a model to investigate this problem, I have exploited natural 
variation at the ACCELERATED CELL DEATH 6 (ACD6) gene, which controls 
a major trade-off between growth and disease resistance among natural 
accessions of Arabidopsis thaliana. The hyperactive allele ACD6-Est-1 is 
known to confer broad-spectrum immunity, but at the same time to also 
negatively affect growth in many A. thaliana accessions.  
 Here, I first surveyed a large collection of A. thaliana genomes for the 
presence of Est-like ACD6 alleles. I confirmed that not all accessions with this 
allele express overt hyperimmunity. I then demonstrated that Est-like ACD6 
alleles from accessions that do not show the typical autoimmune phenotype 
normally associated with this allele could confer hyperimmunity when 
transformed into a different genetic background, indicating that the attenuation 
of the Est-like ACD6 phenotype was likely due to extragenic modifiers. I then 
investigated pathogen responses of several of these accessions more closely. 
My experiments revealed that reduced growth and immune responses were 
partially uncoupled in some of these accessions. These findings dovetailed 
with genetic results suggesting that different accessions contain genetically 
distinct modifiers of the typical Est-like ACD6 phenotype. Finally, I 
demonstrated by quantitative trait loci (QTL) mapping that these modifiers are 
located in different regions of the genome, with one of the modifiers potentially 
being a gene in cluster of genes encoding nucleotide-binding domain and 
leucine-rich repeat (NLR) immune receptors. This is an important finding, as 
ACD6 had previously been linked only to PAMP-triggered immunity (PTI), but 
not to effector-triggered immunity (ETI), which predominantly relies on NLR 
immune receptors. My study thus provides new insights into the complex 
genetic interactions that affect disease resistance and growth. 
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Zusammenfassung 
 Pflanzen verteidigen sich gegen Krankheitserreger, indem sie 
Verteidigungsmechanismen abrufen, mit denen sie sich auch selbst 
unbeabsichtigt Schaden zufügen können. Ein verbessertes Verständnis 
evolutionärer Beschränkungen und molekularer Mechanismen, die die 
Ausprägung der Verteidigungsmechanismen beeinflussen, kann dazu 
beitragen, das Gleichgewicht zwischen krankheitsbedingten Verlusten und 
durch Hyperimmunität verursachten Ertragsminderungen zu steuern. Zur 
näheren Untersuchung dieses Problems habe ich die natürliche Variation des 
ACCELERATED CELL DEATH 6 (ACD6) Genes genutzt, welches in 
natürlichen Akzessionen von Arabidopsis thaliana die Balance zwischen 
Wachstum und Krankheitsresistenz kontrolliert. Das hyperaktive Allel ACD6-
Est-1 ist bekannt dafür, breitgefächert Immunität zu verleihen und gleichzeitig 
das Wachstum in vielen A. thaliana Akzessionen zu beeinträchtigen.  
 Hier untersuchte ich zunächst eine große Sammlung von A. thaliana 
Genomen auf das Vorhandensein von Est-ähnlichen ACD6-Allelen. Ich 
bestätigte, dass nicht alle Akzessionen mit diesem Allel offensichtliche 
Anzeichen von Hyperimmunität besitzen. Dann zeigte ich, dass Est-ähnliche 
ACD6-Allele aus solchen Akzessionen trotzdem Hyperimmunität vermitteln 
können, wenn sie in einen anderen genetischen Hintergrund transformiert 
werden. Das weist darauf hin, dass die Abschwächung des Est-ähnlichen 
ACD6-Phänotyps wahrscheinlich extragenischen Modifikatoren 
zuzuschreiben ist. Anschließend untersuchte ich die molekularen Antworten 
auf Pathogenbefall in einigen dieser Akzessionen genauer. Meine 
Experimente zeigten, dass verringertes Wachstum und Immunantwort in 
manchen dieser Akzessionen teilweise entkoppelt sind. Diese Erkenntnisse 
ergänzen meine genetische Experimente, die andeuteten, dass verschiedene 
Akzessionen unterschiedliche Modifikatoren des typischen Est-ähnlichen 
ACD6-Phänotyps enthalten. Schließlich zeigte ich mit Hilfe von QTL (= 
quantitative trait loci) Kartierung, dass diese Modifikatoren in verschiedenen 
Regionen des Genoms angesiedelt sind, und dass einer der Modifikatoren 
eventuell ein Gen in einem Cluster von nucleotide-binding leucine-rich repeat 
		 xviii 
(NLR) Genen ist. Dies ist eine wichtige Erkenntnis, da ACD6 bisher nur mit 
PAMP-ausgelöster Immunität (PAMP-triggered immunity, PTI) in Verbindung 
gebracht wurde, nicht aber mit Effektor ausgelöster Immunität (effector-
triggered immunity, ETI), welche hauptsächlich auf NLR Immunrezeptoren 
basiert. Meine Studie gibt daher neue Einblicke in die komplexen genetischen 
Interaktionen, die Krankheitsresistenz und Wachstum beeinflussen.  
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1 Introduction 
 Organisms are continuously besieged by pathogens of various phyla 
(e.g. bacteria, fungi, oomycetes, and viruses) and have to defend themselves 
to survive infection by these pathogens. Plants, being immobile, cannot 
actively escape from these often more mobile and more numerous pathogens. 
However, disease in natural populations is the exception, such that most of 
the individuals are usually healthy (Allen, Bittner-Eddy et al. 2004, Partida-
Martinez and Heil 2011). For protection, plant cells have developed a diverse 
system of defense mechanisms. Unlike vertebrates, plants lack the circulatory 
system with specialized defense cells or an adaptive immune machinery to 
fight pathogen invasion (Dangl and Jones 2001). Instead, plant cells rely on 
an array of predetermined or induced structural, chemical and protein-based 
defenses that culminate in a highly effective immune response against most 
potential pathogens.  
1.1 Plant pathogens 
 In pursuance of understanding how plants protect themselves we must 
first know the pathogens that assail them. There are three broad groups of 
plant pathogens based on their different substrate requirements, biotrophs, 
necrotrophs and hemibiotrophs (Laluk and Mengiste 2010). Biotrophs are 
pathogens that penetrate or establish close contacts with the host for growth 
and reproduction in their life cycle. These types of pathogens are obligate 
parasites that obtain nutrients from living cells (Glazebrook 2005). Their 
continued development on the host relies on deception, such that the host’s 
defense response is evaded. This fragile relationship between the biotroph 
and the plant host is biochemically and structurally complex to a degree that 
biotrophs have established specialized structures to obtain the sugars, amino 
acid and other nutrients that they need. There are several biotrophs that 
depend upon highly specialized feeding structures that penetrate the host cell 
wall, colonizing the intercellular space without disrupting the plasma 
membrane, called haustoria (Schulze-Lefert and Panstruga 2003, Garnica, 
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Nemri et al. 2014). An example of a biotrophic pathogen that employs 
haustoria is the barley powdery mildew fungus Blumeria graminis. 
Alternatively, there are biotrophic pathogens that do not form haustoria but 
remain in the apoplast such as the tomato pathogen Cladosporium fulvum 
(Vleeshouwers and Oliver 2014). Furthermore, there are biotrophic vesicular-
arbuscular mycorrhizal fungi that form mutualistic relationships with the roots 
of their plant hosts, in which the fungus obtains sugars from the plant and 
provides phosphates and other minerals in return (Szabo and Bushnell 2001). 
Necrotrophs, as the name implies, employ a mode of infection by which 
death of the host plant cells precedes or follows colonization by the pathogen. 
Phytotoxic compounds, cell wall-degrading enzymes and other extracellular 
enzymes are released into the host tissue prior and during colonization to 
destroy plant cell walls and release nutrients (Alfano and Collmer 1996, 
Mengiste 2012). Examples of necrotrophic pathogens include the bacterial 
soft-rot Erwinia carotovora and the mold fungus Botrytis cinerea. A third group 
of pathogens, hemibiotrophs, first establishes a biotrophic interaction with 
the host and then switches to a necrotrophic lifestyle (Vargas, Martin et al. 
2012). The duration of the biotrophic versus the necrotrophic phase varies 
significantly among hemibiotrophs (Mengiste 2012). During the early stages of 
infection, hemibiotrophs actively suppress the host’s immune responses. In 
the later stages of infection, hemibiotrophs undergo a physiological transition 
from an asymptomatic growth to a destructive necrotrophic stage (Lee and 
Rose 2010). The oomycete that caused the potato famine in the 19th century, 
Phytophthora infestans, is one well-known example of a hemibiotroph. 
Another representative hemibiotroph is the bacterium Pseudomonas syringae. 
The divergent strategies of these pathogens further underpin the necessity for 
multiplicity and adaptability of plant immune responses.  
1.2 Plant defense mechanisms 
 Depending on its lifestyle, an invading pathogen must grapple with a 
variety of detection mechanisms and physical or metabolic defenses deployed 
by the plant host (Spoel, Johnson et al. 2007, Bari and Jones 2009). Defense 
responses involve inducible networks of complex, tightly regulated molecular 
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pathways. These pathways often overlap and influence each other. At the 
same time, these pathways are integrated into the plant’s developmental and 
life cycle strategy (Katagiri, Thilmony et al. 2002, de Wit 2007, Rodriguez, 
Petersen et al. 2010). After pathogen assault, defense ultimately culminates in 
characteristic downstream response such as reinforcement of the cell wall, 
reactive oxygen species (ROS) production, activation of defense genes and 
synthesis of secondary metabolites and defense hormones, and a form of 
programmed cell death called hypersensitive response (HR) (Pontier, Balague 
et al. 1998, Lam, Kato et al. 2001, Greenberg and Yao 2004, War, Paulraj et 
al. 2012, Ponce de Leon and Montesano 2013). 
 Precedent to these triggered immune responses are physical 
adaptations at common entry points that limit the access of pathogens and 
deter herbivore or insect feeding (Thaler 2002). Plants are equipped with 
(constitutively) produced plant defense chemicals. The multitude of these 
chemicals produced by plants during defense has often been called 
“secondary plant metabolites” owing to the fact that they are products of 
specialized biosynthetic pathways (Ryan and Jagendorf 1995). The plant 
inducible defense system has been rationalized to be predominantly via two 
main pathways that build upon recognition of compounds not typically 
produced by the plant’s own tissues. The first, which relies on receptors at the 
cell membrane, is known as pathogen/microbe associated molecular pattern 
(P/MAMP) triggered immunity (PTI/MTI). The second and more specialized 
induced response is based on recognition of specific, often race-specific 
pathogenic ligands usually delivered into the plant; it is termed effector-
triggered immunity (ETI) (Dangl and Jones 2001). Plant hormones as part of 
PTI and ETI play a substantial role in defense responses and have been 
shown to be involved in fine-tuning of defense and growth (Spoel and Dong 
2008, Verhage, van Wees et al. 2010, Lozano-Duran, Macho et al. 2013)  
 The major mechanisms will be summarized in the subsequent sections 
separately.  
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1.2.1 Physical and preformed defenses 
 Plant organs are equipped with structural barriers that can be 
considered constitutive (continuous) defenses, which aid in limiting pathogen 
attachment, invasion and infection. Predominantly comprised of mechanical 
barriers embedded in plant morphology, these physical structures at the plant 
surface include thickened cell walls, waxy epidermal cuticles, spines, thorns 
(spinescence), trichomes (pubescence), toughened or hardened leaves 
(sclerophylly) and barks (Taiz and Zeiger 2010). Specifically these defensive 
preformed barriers are based on a lignin and cellulose-rich cell wall, thick 
waxy acyl lipid cuticle on the epidermal cells, and stomatal morphology and 
physiology that lessen pathogen connection with viable host cells. Highlighting 
these physical defenses, we focus on the cell wall as an important line of 
defense against bacterial and fungal invaders. Not just a structural 
impediment, the cell wall is equipped with chemical compounds that can be 
rapidly activated when a cell detects the presence of pathogens (Malinovsky, 
Fangel et al. 2014). Proteins and enzymes such as pectin methylesterases 
can reshape the cell wall during growth and strengthen the cell wall as a 
defense response. Recognition of invading pathogens, discussed further 
below, leads to activation of enzymes that result in bursts of superoxide (O2-) 
or hydrogen peroxide (H2O2), collectively known as reactive oxygen species 
(ROS) (Hammond-Kosack and Jones 1996). This ROS burst can damage the 
cells of invading organisms, but they also protect the plant from invasion by 
giving the plant strength and rigidity, strengthening the cell wall by catalyzing 
cross-linkages between cell wall polymers (Asselbergh, Curvers et al. 2007). 
Furthermore, ROS serves as a signal to neighboring cells that an attack is 
underway. Specific to a microbial attack, callose between the cell wall and cell 
membrane adjacent to the invading pathogen is rapidly synthesized and 
deposited (Luna, Pastor et al. 2011). Plant induced defense responses have 
been shown to include cell polarization, focal redistribution of the actin 
cytoskeleton, guided migration of organelles, targeted secretion, and callose 
deposition at the site of pathogen contact (Kwon, Neu et al. 2008). These 
callose deposits, called papillae, are polysaccharide polymers consisting of 
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(1-3)-β-D-glucan subunits that impede penetration at the site of infection. 
(Bestwick, Bennett et al. 1995, Maor and Shirasu 2005)  
 Proteinase inhibitors, proteolytic enzymes, phytoanticipins and plant 
defensins are natural chemical barriers generated by plants as part of their 
constitutive defenses (Morrissey and Osbourn 1999). These compounds are 
produced as part of normal growth and development. They are frequently kept 
in specialized organs or tissues such as trichomes, oil glands, or epidermal 
cell layers (Bednarek and Osbourn 2009). There is evidence seen in crucifers, 
that glucosinolates and thioglucosides, which are normally synthesized in 
healthy cells, may be mobilized to the pathogen challenged site (Bednarek 
and Osbourn 2009, Clay, Adio et al. 2009). Unsurprisingly, polar vesicle 
trafficking of natural products, proteins and other cargo is an important 
component of disease resistance (Robatzek 2007, Leborgne-Castel and 
Bouhidel 2014). 
1.2.2 PAMP-triggered immunity 
 PTI begins with detection of pathogens at the plant cell surface. At the 
cell membrane are pattern recognition receptors (PRRs). These receptors 
contain extracellular domains that detect PAMPs, also called elicitors, which 
are conserved motifs/ligands found in pathogens that trigger defense 
signaling downstream (Boller and Felix 2009, Hamdoun, Liu et al. 2013). 
Another indicator of pathogen presence similar to PAMPs may also arise from 
the plant itself because of subsequent damage from pathogens. These 
endogenous elicitors are described as damage-associated molecular patterns 
(DAMPs) (Boller and Felix 2009). Most known PRRs in plants are leucine-rich 
repeat receptor like kinases (LRR-RLKs) with extracellular leucine rich 
repeats (LRR) and an intracellular kinase domain. Upon recognition of their 
corresponding ligand, the intracellular kinase domain initiates activation of 
proximal interactors and trigger a signaling cascade. FLAGELLIN SENSING 2 
(FLS2), the first identified receptor for a general elicitor in A. thaliana 
(Chinchilla, Bauer et al. 2006), is an analog of human TOLL LIKE 
RECEPTOR (TLR)5, which also recognizes flagellin, a principal component of 
bacterial flagella (Hayashi, Smith et al. 2001). FLS2 homologues have been 
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found in all higher plants for which genome information is available (Boller and 
Felix 2009), and at least the rice homologue has been shown to also function 
as a flagellin receptor (Takai, Isogai et al. 2008). Perception by FLS2 is 
through recognition of a highly conserved N-terminal epitope of flagellin, flg22. 
Upon flg22 binding, FLS2 heterodimerizes with another PRR, 
BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED KINASE 1 (BAK1), 
activating downstream factors and plant immunity. Since the identification of 
FLS2, other PAMPs and their receptors have been found. ELONGATION 
FACTOR THERMO UNSTABLE (EF-TU), a protein responsible for delivering 
aminoacyl-tRNA to the ribosome during bacterial translation is another 
bacterial PAMP, which is recognized by the EF-TU RECEPTOR (EFR) LRK in 
A. thaliana (Zipfel, Kunze et al. 2006). Another protein, LYSIN MOTIF 
RECEPTOR KINASE (LYK) or CHITIN ELICITOR RECEPTOR KINASE 
(CERK1), is the major receptor for the fungal PAMP chitin in O. sativa and A. 
thaliana (Kaku, Nishizawa et al. 2006, Miya, Albert et al. 2007, Cao, Liang et 
al. 2014). Unlike FLS2 and EFR, instead of an LRR domain, CERK1 contain 
two extracellular LysM motifs (Miya, Albert et al. 2007). Chitin is a fungal β-1,4 
linked N-acetyl-glucosamine oligomer (GlcNAc) found as a building block in 
fungal cell walls. A list of currently known Arabidopsis, rice and tomato PRRs 
and their corresponding ligands are shown in Table 1.1.  
 Challenge with flg22 and EF-Tu leads to up-regulation of similar sets of 
genes, suggesting that recognition of different PAMPs triggers a similar set of 
defense responses within the host cell (Zipfel, Kunze et al. 2006) Common 
processes initiated during PTI response are activation of MAP kinase 
cascades and oxidative burst (Nitta, Ding et al. 2014), followed by callose 
deposition (Luna, Pastor et al. 2011) and the release of ROS and flux of Ca2+ 
molecules (Bolwell 1995, Stael, Kmiecik et al. 2015). 
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Table 1.1 A. thaliana, tomato and rice PRRs 
PRR  Subfamily* Ligand† Species References 
FLS2 LRR RLK flg22 A. thaliana 
(Gomez-Gomez and Boller 2000) 
(Chinchilla, Bauer et al. 2006) 
EFR LRR RLK elf18 A. thaliana 
(Kunze, Zipfel et al. 2004) 
(Zipfel, Kunze et al. 2006) 
PEPR1/2 LRR RLK PEPs A. thaliana (Yamaguchi, Pearce et al. 2006) 
bCERK1 
(OsCERK1) 
LysM RLK chitin 
A. thaliana 
Rice 
(Miya, Albert et al. 2007) 
(Petutschnig, Jones et al. 2010)  
(Shimizu, Nakano et al. 2010)  
CEBiP LysM RLP chitin Rice (Kaku, Nishizawa et al. 2006) 
LYM1/LYM3 LysM RLP PGNs A. thaliana (Willmann, Lajunen et al. 2011) 
LYP4/6 LysM RLP PGNs/chitin Rice (Liu, Li et al. 2012) 
LeEix2 LRR RLP Eix Tomato (Ron and Avni 2004) 
ReMax LRR RLP eMax A. thaliana (Jehle, Lipschis et al. 2013) 
Ve1 LRR RLP Ave1 Tomato (de Jonge, van Esse et al. 2012) 
WAK1 WAK4 OGs A. thaliana (Brutus, Sicilia et al. 2010) 
*LRR RLK – Leucine-rice repeat receptor-like protein kinase; LysM RLK – Lysin motif receptor-like kinase; LysM RLP 
– Lysin motif receptor-like protein; WAK – cell wall-associated kinase 
† flg22 – 22 amino acid flagellin peptide; elf18 -  18 amino acid elongation factor Tu peptide; PEP – 23 amino acid 
peptide that enhances resistance to root pathogen, Phythium irregulare; PGN – peptidoglycan; Eix – ethylene-
inducing xylanase; eMax - Enigmatic MAMP of Xanthomonas; Ave1 – avirulence on Ve1; OGs - Oligogalacturonides 
 
1.2.3 Effector-triggered immunity 
 The effectiveness of PAMP signaling in controlling pathogens is 
reflected by the many ways that pathogens try to overcome PTI by injecting a 
repertoire of effectors into the host cell to inhibit PTI (Dangl and Jones 2001). 
Effectors are defined as pathogen-produced molecules that have a specific 
effect on one or more genotypes of a host (Vleeshouwers and Oliver 2014). 
These effectors (virulence factors) are typically injected by bacteria, fungi, 
oomycetes or even nematodes into the host through specialized secretion 
systems (Cambronne and Roy 2006) and Roy, 2006; Ellis et al., 2009). About 
several hundred oomycete effectors (Tyler, Tripathy et al. 2006) and more 
than 30 bacterial effectors have been identified (Lindeberg, Cartinhour et al. 
2006). Many more are yet to be discovered given the fluidity of pathogen 
genomes, i.e. rust (McDowell 2011) and complexity of pathogen genomes, i.e. 
Phytophthora infestans (Haas, Kamoun et al. 2009).  
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There are at least three major strategies for effectors to subvert host 
defenses: 1) alter turnover of proteins, 2) alter RNA metabolism or 3) inhibit 
signaling during immune response, employed by these effectors to shift host 
responses (Block, Li et al. 2008). Plant counter measures against these 
effectors rely on the products of resistance (R) genes that recognize the 
effectors either directly, or indirectly through host targets modified by 
effectors. Upon recognition, activate R proteins trigger ETI (Van der Biezen 
and Jones 1998, Dangl and Jones 2001). Successful pathogen colonization of 
plant tissue is described as a compatible interaction with a virulent pathogen. 
Alternately, a condition when the plant is able to perceive and stimulate a 
defense reaction indicates that the pathogen is avirulent, and this is referred 
to as an incompatible interaction (Katagiri, Thilmony et al. 2002). A compatible 
plant-pathogen interaction conforms to the Mendelian “gene-for-gene” model, 
a precept of which is that resistance only occurs when an R gene is able to 
recognize the corresponding effector encoded by a pathogen avirulence gene 
(Flor 1955, Ma, Dong et al. 2006). A number of diverse Avr/R gene pairs have 
been identified (Table 1.2). Most R genes encode proteins with a nucleotide-
binding domain and leucine-rich repeat domain known as NB-LRRs/NLRs. 
The A. thaliana reference genome encodes about 150 (Meyers, Kozik et al. 
2003, Guo, Fitz et al. 2011) NB-LRR proteins. Most R proteins act via indirect 
recognition of effectors, as guards of important host proteins that are 
recurrently targeted by diverse effectors (Van der Biezen and Jones 1998).  
 Several downstream events are shared between ETI and PTI, including 
protein phosphorylation, calcium fluxes, ROS, phytohormones, induction of 
defense related genes and synthesis of antimicrobial compounds (Grennan 
2006, Thomma, Nurnberger et al. 2011). ETI-PTI crosstalk is further 
evidenced by how pathogens deliver effectors target and induce a complex 
interplay of transcriptional networks to modify and suppress PTI (basal) 
responses during pathogenesis (Hauck, Thilmony et al. 2003, Li, Lin et al. 
2005, de Torres, Mansfield et al. 2006, Truman, de Zabala et al. 2006). 
Compared to PTI, ETI has been posited to evoke a more prolonged and 
robust immune response (Hamdoun, Liu et al. 2013). ETI is also more often 
associated with localized cell death called hypersensitive response (HR) that 
inhibits pathogen growth (Katagiri and  
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Table 1.2. Avr/R gene pairs  
Effector  Pathogen species Resistance (R) gene Plant host  Reference 
Avr1 Phytophthora infestans R1 Potato (Houterman, Cornelissen et al. 2008, Vleeshouwers, Raffaele et al. 2011) 
Avr2 Phytophthora infestans R2 Potato (Vleeshouwers, Raffaele et al. 2011, Saunders, Breen et al. 2012) 
Avr3a Phytophthora infestans R3a Potato (Bos, Armstrong et al. 2010) 
Avr3b Phytophthora infestans R3b Potato (Rietman, Bijsterbosch et al. 2012) 
Avr4 Phytophthora infestans R4 Potato (Rietman, Bijsterbosch et al. 2012) 
Avrblb1 Phytophthora infestans Rpi-blb1 Potato (Vleeshouwers, Raffaele et al. 2011) 
Avrblb2 Phytophthora infestans Rpi-blb2 Potato (Vleeshouwers, Raffaele et al. 2011) 
Avrvnt1 Phytophthora infestans Rpi-vnt1 Potato (Vleeshouwers, Raffaele et al. 2011) 
AvrSmira1 Phytophthora infestans Rpi-Smira1 Potato (Rietman, Bijsterbosch et al. 2012) 
AvrSmira2 Phytophthora infestans Rpi-Smira1 Potato (Rietman, Bijsterbosch et al. 2012) 
AvrB P. syringae pv. glycinea race 0 RPM1 (RIN4/RIPK/RAR1//MPK4) Tomato (Russell, Ashfield et al. 2015) 
AvrBs3 X. campestris pv. vesicatoria race 1 Bs3 Tomato and peppers (Romer, Hahn et al. 2007, Boch and Bonas 2010) 
AvrPphB P. syringae pv. phaseolicola race 3 RPS5 (PBS1/BIK1/PBL1) Bean (Qi, Dubiella et al. 2014) 
AvrPto P. syringae pv. tomato JL1065 Pto and Prf (FLS2/EFR/BAK1/RIN4) Tomato (Xing, Zou et al. 2007, Zong, Xiang et al. 2008) 
AvrPtoB P. syringae pv. tomato DC3000 Pto and Prf (Fen/FLS2/BAK1/CERK1/RIN4) Tomato (Xiang, Zong et al. 2008) 
AvrRpm1 P. syringae pv. glycinea race 0 RPM1 and RPS2 (RIN4) Tomato (Kim, Geng et al. 2009) 
AvrRps4 P. syringae pv. pisi 151 RPS4 (EDS1) Tomato (Sohn, Zhang et al. 2009) 
AvrRpt2 P. syringae pv. tomato T1 RPS2 (RIN4) Tomato (Day, Dahlbeck et al. 2005) 
HopA1 P. syringae pv. syringae 61 RPS6 (EDS1) Tomato (Kim, Kwon et al. 2009) 
HopI1 P. syringae pv. maculicula ES4326 Hsp70 Tomato (Jelenska, van Hal et al. 2010) 
HopF2 P. syringae pv. tomato DC3000 RIN4/MKK5, BAK1 Tomato (Zhou, Wu et al. 2014) 
HopM1 P. syringae pv. tomato DC3000 AtMIN7 Tomato (Lozano-Duran, Macho et al. 2013) 
HopN1 P. syringae pv. tomato DC3000 PsbQ Tomato (Rodriguez-Herva, Gonzalez-Melendi et al. 2012) 
HopU1 P. syringae pv. tomato DC3000 GRP7/GRP8 Tomato (Fu, Guo et al. 2007) 
PopP2 R. solanacearum GMI1000 RRS1 (RD19) Solanum (Deslandes, Olivier et al. 2003) 
XopD X. campestris AtMYB30 Brassica (Canonne, Marino et al. 2011) 
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(Katagiri and Tsuda 2010). The two responses could mainly be distinguished 
by their timing and location in the host, with the early extracellular response 
due to PTI and the later intracellular responses chiefly coming from ETI 
(Abramovitch, Anderson et al. 2006). 
1.2.4 Hormonal signaling and pathogen defense 
 Plant defense response is additionally modulated by phytohormones 
that work in a composite network that also regulates growth, development, 
reproduction and general response to environmental cues (Pieterse, Leon-
Reyes et al. 2009). Specifically phytohormones such as SA, jasmonic acid 
(JA), ethylene (ET), gibberellins (GA), brassinosteroids (BR), auxins, abscisic 
acid (ABA), and even cytokinins (CK) act as signaling molecules during an 
induced immune response (Robert-Seilaniantz, Navarro et al. 2007, Bari and 
Jones 2009). Subsequent to a pathogen attack, the quantity, composition and 
the timing of the phytohormonal blend produced by the plant varies among 
species and depends greatly on the lifestyle and infection strategy of the 
invading attacker (Pieterse, Leon-Reyes et al. 2009). For example, SA-
dependent defenses are effective primarily against biotrophic pathogens, 
while ET/JA dependent defenses confer resistance primarily to necrotrophic 
fungi (Bari and Jones 2009). Medleys of particular defense-related genes are 
triggered by ‘signal signatures’, which are induced by particular pathogens 
(De Vos, Van Oosten et al. 2005). Crosstalk between hormonal signaling 
pathways provides the plant with a powerful regulatory potential and allows 
the plant to tailor its defense response to the invaders encountered (Verhage, 
van Wees et al. 2010, Robert-Seilaniantz, Grant et al. 2011). Not to be left 
behind, some pathogens also manipulate hormone-regulated signaling 
pathways to evade host immune responses (Pieterse, Leon-Reyes et al. 
2009). A well-studied example is the bacterium Pseudomonas syringae 
(Nomura, Melotto et al. 2005).  
 As a regulator of plant resistance to biotrophic and hemibiotrophic 
pathogens, such as Hyaloperonospora arabidopsidis and P. syringae (Robert-
Seilaniantz, Navarro et al. 2007), SA is one of the most studied 
phytohormones (Vlot, Dempsey et al. 2009). Although affecting many plant 
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processes including growth and development, SA is primarily recognized for 
its role in local defense response and in the establishment of systemic 
acquired resistance (SAR) (Loake and Grant 2007, Rivas-San Vicente and 
Plasencia 2011). SA accumulation occurs upon either PTI or ETI activation 
(Dempsey, Vlot et al. 2011). Increased endogenous amounts of SA and its 
conjugates during pathogen infection concur with activation of disease 
resistance inclusive of elevated expression of defense genes (Shah 2003). 
This phenomenon is further reinforced by the fact that exogenous application 
of SA or synthetic functional analogs, such as 2,6,-dichloroisonicotinic (INA) 
or benzo(1,2,3) thiadiazole-7-carbothioic acid S-methyl ester (BTH), produces 
the same result (Gorlach, Volrath et al. 1996, Dong 2001). Along with this, 
blocking SA synthesis or preventing SA accumulation hinders activation of 
several defense responses (Gaffney, Friedrich et al. 1993, Delaney 1994, 
Wildermuth, Dewdney et al. 2001). 
1.3 Fine-tuning and evolution of plant defense responses 
 Summarizing the aforementioned plant defense mechanisms, there are 
several key certitudes that hold during plant-microbe interactions. First, 
pathogens are detected through PAMPs, DAMPs and effectors by host cell 
receptors. During plant-microbe interaction, a number of these receptor-ligand 
interactions may be taking place simultaneously. The plant-microbe detection-
evasion interrelation has pushed plants and pathogens into an evolutionary 
arms race (Ingle, Carstens et al. 2006, Jones and Dangl 2006, Burdon and 
Thrall 2009). The outcome is that plants have evolved multiple defense 
mechanisms with diverse arrays of receptors and disease resistance genes 
(Michelmore and Meyers 1998, Nagy and Bennetzen 2008, Horger, Ilyas et al. 
2012, Huard-Chauveau, Perchepied et al. 2013, Yang, Li et al. 2013, 
Karasov, Kniskern et al. 2014). At the same time pathogens are evolving to a) 
avoid detection by loss, sequence diversification, or post-translational 
modification of the pathogen molecules detected by the host, or b) through 
direct corruption of host immunity with new effectors (Ma, Dong et al. 2006, 
Baltrus, Nishimura et al. 2011, Lovell, Jackson et al. 2011, Cook, Mesarich et 
al. 2015). And most importantly, the aforementioned immune responses must 
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require fine-tuning and coordination such that proper allocation and use of 
metabolites in plant resistance should not be at the expense of other 
physiological processes like growth and reproduction (Rasmann, Chassin et 
al. 2015). This section will be on the arguments for the forces governing plant-
pathogen co-evolution with more focus on how plants cope with the dilemma 
of effectively sustaining simultaneous growth and defense.  
 Co-evolution is an evolutionary process that brings about reciprocal 
genetic change in interacting species owing to natural selection imposed by 
each one on the other (Turcotte, Corrin et al. 2012). It can occur between any 
interacting populations, but it is specifically appropriate for host-pathogen 
systems because of the close nature of the interaction and the selective 
pressure that each can exert on each other (Woolhouse, Webster et al. 2002). 
Two models have been put forward to describe the co-evolutionary process 
affecting plant-microbe interactions, “Red Queen hypothesis (RQH)” and 
“arms race”. The RQH describes cyclic dynamics of allele frequencies while 
the arms race portrays fixation of advantageous mutations (selective sweeps) 
(Raberg, Alacid et al. 2014). Arms race accounts for rapid evolution of the 
genes involved in plant-pathogen interactions albeit at generally low levels of 
standing genetic variation. The arms race hypothesis further postulates that at 
the center of the plant-pathogen interaction are the R-avr gene interactions. 
This is the interface that has been pinpointed to drive the plant-pathogen co-
evolutionary system, comprising the characters that determine the outcome of 
confrontation between the host and the pathogen. Once an adaptation by one 
player (i.e. R-gene) has been attained, this adaptation leads to selection on 
and an evolutionary response in the second player (i.e. effector) (Bittner-Eddy 
and Beynon 2001, Allen, Bittner-Eddy et al. 2004, Lewis, Wu et al. 2010). In 
an arms race, the antagonist is propelled in a certain direction. On the 
contrary, Red Queen dynamics result in balanced polymorphisms with deep 
coalescence times. The name comes from what the Red Queen in Lewis 
Carroll’s “Through the Looking Glass” says to Alice, “Now, here, you see, it 
takes all the running you can do, to keep in the same place”. To explain this, 
let us look at a population of host plants and obligate host-specific pathogens. 
In this situation, obligate pathogens are pressured to constantly infect hosts of 
the same species. The hypothesis assumes that the pathogen after some 
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time becomes specialized on the most common host genotypes in the 
population. Rare genotypes then gain a fitness advantage that declines as 
they become more common. An oscillation between susceptible common 
genotypes and differentially virulent pathogens ensues governed by 
frequency-dependent selection (Clay and Kover 1996).  
 Having to face the dilemma of partitioning limited resources among 
growth, reproduction and defense also motivates the mechanism and 
evolution of plant defenses. There are several conjectures formulated that 
attempt to explain the dynamics of plant defense in relation to the partitioning 
dilemma, including: 1) Optimal Defense Theory (ODT), 2) Growth Rate 
Hypothesis (GRH), 3) Carbon:Nutrient Balance Hypothesis (CNBH) and 4) 
Growth-Differentiation Balance Hypothesis (GDBH). The ODT puts forward a 
framework for investigation of genotypic expression of plant defense, with 
emphasis on allocation cost of defense based on fitness value of different 
tissues and probability of attack (Barto and Cipollini 2005, Alba, Bowers et al. 
2012, Meldau, Erb et al. 2012). The GRH relates the evolution of plant 
defense to resource availability and predicts that plants that have evolved in 
abiotically stressful environments grow more slowly although more 
constitutively resistant than plants in more productive habitats (Van Zandt 
2007, Endara and Coley 2011). The CNB hypothesis, also called the 
Environmental Constraint Hypothesis, is a model structured to explain 
phenotypic expression of defense by plants based on the supply of carbon 
and nutrients in the environment (Hamilton, Zangerl et al. 2001, Massad, Dyer 
et al. 2012). The GDB hypothesis states that there is a physiological trade-off 
between growth and secondary metabolism; balance must be maintained 
between resources used for growth and differentiation which includes 
chemical defense production (Barto and Cipollini 2005, Glynn, 2007 #1509). 
Despite using different frameworks, these hypothesis are built on similar 
central assumptions: 1) defenses can incur cost to physiology and 
metabolism; 2) efficiency of defense response depends on certain selective 
pressures (i.e. competition, environmental condition, resource availability, 
genetic potential) (Coley, Bryant et al. 1985, Strauss, Rudgers et al. 2002, 
Siemens, Lischke et al. 2003, Fine, Miller et al. 2006, Boots 2011, Kempel, 
Schadler et al. 2011). Which of these theories describes the actual situation in 
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nature is still unclear. Studies such as the one from Barto and Cipollini (Barto 
and Cipollini 2005), testing ODT and the GDBH in Arabidopsis thaliana, show 
that expected patterns of responses followed neither ODT not GBDH 
consistently, while others, such as meta-analyses carried out by Endara and 
Coley (Endara and Coley 2011), claim that GRH has substantial explanatory 
power. These hypotheses have contributed to our current understanding of 
plant defense responses but each has its limitations.  
1.4 Plant autoimmunity, natural variation and ACD6 
 Genetics has been used in two ways to further our understanding of 
immunity: first by identifying mutants in which responses to pathogens are 
compromised, such as knockouts of PPR and R genes as well as positive 
downstream signaling factors. An alternative approach is to look for mutants 
that mount an immune response in the absence of pathogens. A number of 
gain-of-function (GOF)/loss-of-function (LOF) mutants, collectively known as 
lesion-mimic mutants, have been linked to immunity and repeatedly described 
as positive/negative regulators of cell death (Bruggeman, Raynaud et al. 
2015). Those mutants point to de-repression or activation of genes involved in 
immunity, especially some R-genes (generally NLRs) (Table 1.3). 
 Some of the genes identified through lesion-mimic mutants are 
themselves suppressed by LOF of important components for defense 
response (e.g. ENHANCED DISEASE SUSCEPTIBILITY 1 (EDS1) and 
PHYTOAELXIN DEFICIENT 4 (PAD4)) or by suppression or removal of SA 
accumulation (Bruggeman, Raynaud et al. 2015). An example of such lesion-
mimic mutant is the dominant GOF mutant in Col-0 -- ACCELERATED CELL 
DEATH 6 (ACD6) acd6-1. acd6-1 shows spontaneous cell death, small 
stature and constitutively elevated defenses (Rate, Cuenca et al. 1999). 
ACD6 is described as a positive regulator of cell death and defenses in 
Arabidopsis thaliana acting in part via the major SA transducer 
NONEXPRESSER OF PR GENES 1 (NPR1) (Rate, Cuenca et al. 1999). 
Operating in a positive feedback loop with SA, ACD6 localizes at the plasma 
membrane and the endoplasmic reticulum (Zhang, Shrestha et al. 2014).  
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Table 1.3 A. thaliana lesion mimic mutants  
Mutant Lesion phenotype Resistance  Hypersensitive response* Putative function References 
acd5 Disease-like lesions Decreased Normal  Lipid kinase (Greenberg 2000) 
acd6 HR-like lesions Increased  Reduced ND (Rate, Cuenca et al. 1999) 
agd2 Few necrotic lesions Increased  Reduced ND (Rate and Greenberg 2001) 
cpn1 Necrotic lesions Increased r Accelerated  Copine protein (Jambunathan, Siani et al. 2001) 
cpr5 Chlorotic lesions Increased  Normal  Type IIIa transmembrane protein 
(Bowling, Guo et al. 1994, Stokes, 
Kunkel et al. 2002, Boch and Bonas 
2010) 
dnd1 Rare necrotic lesions Increased r Reduced AtCNGC2, cyclic nucleotide gated channel 
(Yu, Parker et al. 1998, Clough, 
Fengler et al. 2000) 
Y23 Disease-like lesions Similar / Increased  Reduced ND (Yu, Parker et al. 1998) 
hlm1 Necrotic lesions and chlorosis on leaves Increased  Reduced AtCNGC4, cyclic nucleotide gated channel (Balague, Lin et al. 2003) 
hrl1 HR-like lesions Increased  Reduced ND (Devadas, Enyedi et al. 2002, Devadas and Raina 2002) 
lsd2-lsd5 lsd2, lsd4: chlorotic lesions lsd3, lsd5: necrotic lesions Increased  ND ND (Dietrich, Delaney et al. 1994) 
lsd6-lsd7 Necrotic lesions Increased  ND ND (Weymann, Hunt et al. 1995) 
ssi1 HR-like lesions Increased  ND ND (Greenberg 2000, Shah, Kachroo et al. 2001, Shah 2003) 
ssi2 HR-like lesions Increased  ND Stearoyl-ACP desaturase (Kachroo, Schopfer et al. 2001, Shah 2003) 
ssi4 Chlorotic lesions Increased  ND TIR-NB-LRR protein (Shirano, Kachroo et al. 2002) 
*ND, not determined 
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Together with SA, ACD6 is part of a positive feedback loop that regulates the 
levels of several PAMP receptors including FLS2, EFR and CERK1 (Tateda, 
Zhang et al. 2015). Notably, a study capitalizing on natural variation identified 
a hyperactive allele of ACD6, ACD6-Est-1, which changes the balance 
between growth and defense in A. thaliana accessions (Todesco, 
Balasubramanian et al. 2010). While NLRs confer race-specific resistance, 
the hyperactive ACD6 allele protects against a wide range of unrelated 
pathogens, including insects. This unusually large benefit of hyperactive 
ACD6 allele equivalent to a constitutively active defense response, 
accordingly incurs a substantial handicap to the growth of the plant.  
 Natural ACD6 variants offer an opportunity to study different plant 
survival and adaptation strategies, ranging from being small but well protected 
to being larger but less prepared to combat pathogens. Natural variation, 
broadly defined as the phenotypic variation caused by genetic variation 
brought about by mutations maintained in nature by any evolutionary process 
like genetic drift, artificial and natural selection (Alonso-Blanco, Aarts et al. 
2009), is one of the most important basic resources for biology. This resource 
has been relevant to discover which specific allelic variants are present in 
nature, where they might either be neutral or have a selective advantage 
under specific conditions (Shindo, Bernasconi et al. 2007). Natural variation 
has been utilized for finding new genes involved in specific aspects of plant 
physiology or development (Koornneef, Alonso-Blanco et al. 2004, Weigel 
and Nordborg 2005). Natural variation in disease resistance is among the 
earliest examples of a Mendelian trait to be genetically described in plants 
(Holub 2001). As early as 1905, Biffen described a single locus responsible 
for the resistance of some wheat cultivars to yellow rust caused by Puccinia 
striiformis. Since then many more genes have been identified to confer 
resistance to an assortment of pathogens known to infect various plant 
species, as previously enumerated in Table 1.2.  
1.5 Aims and objectives of this thesis 
 Much research has been focused on NLR conferred disease resistance 
(Martin, Bogdanove et al. 2003 2007). On the other hand, little is known about 
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variation in the more generalist PAMP perception system, whose components 
are often shared across distant genera (Boller and Felix 2009, Vetter, 
Kronholm et al. 2012). While many studies focus on merely pairwise plant-
pathogen interactions, it is becoming progressively clear that a more 
comprehensive method to understand plant defense response is needed. One 
way is through inspecting specific plant defense mechanisms in their natural 
environment. At the same time, additional effort for understanding trade-offs 
during plant defense responses may uncover links for better understanding 
and production of pathogen resistant and durable crops with minimal 
physiological costs. ACD6 offers an ecologically relevant genetically traceable 
system in which these can be addressed. Unlike the use of lesion mimic 
mutants, which are generated artificially, the natural allelic variation present in 
ACD6 provides the system where differential responses are a product of 
natural selection due to the environment and pathogens present in the 
location where the accessions are originally from. Therefore, in the context of 
natural variation of the growth and defense trade-off phenotype imparted by 
having a hyperactive ACD6 allele, I attempted to: 
1) Determine the extent of ACD6 natural variation in A. thaliana 
accessions and geographical distribution of the hyperactive ACD6 
allele type to deduce the evolutionary context of this variation; 
2) Phenotypic and molecular characterization of A. thaliana accessions to 
dissect pathogen resistance pathways given the ACD6 imparted 
autoimmune phenotypes;  
3) Identify novel components of the ACD6 defense response pathway 
through genetic analysis of A. thaliana accessions having variable 
ACD6 activity. 
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2 Materials and Methods 
 General laboratory buffers, media and protocols were made and 
performed as instructed in (Sambrook and Russell 2001). Chemicals were 
mainly obtained from Sigma-Aldrich (Taufkirchen, Germany), Roth (Karlsruhe, 
Germany), and VWR/Merck (Darmstadt, Germany) unless otherwise stated. 
Buffers were prepared using double distilled water (ddH2O), except when 
other solvents were required.  
2.1 Plant material, growth conditions and phenotyping 
Seeds for A. thaliana accessions were obtained from the European 
Arabidopsis Stock Centre (The European Arabidopsis Stock Center) and the 
Arabidopsis Biological Resource Center . Information for accessions used are 
given in Appendix Table 1. Prior to stratification, seeds were sterilized by 
washing with 70% ethanol for 5 minutes followed by washing with 100% 
ethanol for 10 minutes. After decanting the last ethanol wash, seeds were air-
dried in a sterile hood until all the residual ethanol has evaporated. Seeds 
were stratified by immersion in 0.1% w/v Agar-agar for 4–7 days in the dark at 
4°C prior to planting. Plants were grown in either short-day (8 h light) or long-
day (16 h light) conditions under about 50 µmol m-2 s-1 light fluence rate in 
controlled 23°C temperature growth chambers, with 65% relative humidity. 
Plants meant for experiments testing temperature effects were concurrently 
grown in growth chambers with the same conditions but with 16°C 
temperature. For some experiments such as transgenic marker selection, 
seeds were stratified and sown in half-strength Murashige and Skoog (MS) 
medium prior to sowing in soil; 1 L of half-strength MS medium is made with: 
• 2.15g, 1X MS salts (Duchefa, Haarlem, Netherlands),  
• 0.5g MES (Duchefa, Haarlem, Netherlands),  
• 0.8% w/v Agar-agar (Merck, Darmstadt, Germany) 
• pH 5.8 with 1N KCl (Roth, Karlsruhe, Germany)  
		 20 
For most experiments, plants were sown in a completely randomized 
design with at least 4 replicates per genotype. An exception was the 
experimental design for the populations used for QTL mapping that did not 
allow for this since individual F2 plants cannot be replicated. In order to 
minimize variation, plants were watered with the same amount of water and 
the flats were rotated every two days. 
2.2 Quantification of salicylate and SA-conjugates 
Salicylate and SA-conjugates was extracted from 4-week old rosettes, 
8 biological replicates per genotype, grown in a randomized complete block 
design at 23°C short day conditions. The freeze-dried, ground plant material 
(Target: 10 mg ± 1 mg) was extracted twice with 400 µl methanol 20% 
(LCMS-grade) / 0.1% HFA (5 min ultrasonic extraction; 20 min on ice; 
centrifuge 10 min 13500 g). From the supernatant 320 µl were removed after 
each extraction step and combined in a new vial. A third extraction step with 
400 µl methanol 100% (conditions as above) was performed yielding an 
additional volume of 420 µl. The end volume of 1060 µl was split in half before 
drying overnight in the speed vacuum. For the analysis of the conjugated and 
free SA, the pellets were resolved in 30 µl methanol 50% / 0,1% HFA (mixed 
10 min; 1400 rpm; centrifuge 10 min 13500 g). Ultra Performance Liquid 
Chromatography Mass Spectrometry analysis was performed on a Waters 
Acquity UPLC system coupled to a SYNAPT G2 QTOF mass spectrometer 
equipped with a Zspray TM ESI-Source (Waters Corporation, Milford, MA, 
USA). Chromatographic conditions: Waters Acquity UPLC column (HSS T3; 
1,8µM; 21x100mm). A binary solvent was utilized at 30°C, flow rate 0.2 
ml/min, consisting of eluent A (water; 0.1% formic acid; Milli-Q-grade) and 
eluent B (Methanol; Roth – LCMS grade; 0,1% formic acid). The gradient 
starts – after a 2 min constant phase - from 99% A to 1% A in 10 min (total 
run time 15 min; injection volume 5 µL). The SYNAPT G2 was operated in 
negative mode (V-optics) to detect the compounds of interest (scan range 50-
2000 Da; scan time 0,4 sec; capillary voltage 2 kV; sampling cone voltage 20 
V; extraction cone at 3 V; source temperature 120°C; cone gas 10 l/h; 
desolvation gas 800 l/h, 450°C; nebulizer gas Nitrogen; collision gas Argon). 
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A lock mass calibration (leucine enkephalin (50 pg/mL) was automatically 
performed. The software used to control the LCMS system and to perform 
data integration was MassLynx V4.1 / TargetLynx (Waters Corporation, 
Manchester, UK). The quantifier ion used for the free salicylic acid and the 
salicylic acid conjugates were m/z 137.057 and 299.102, respectively. 
2.3 Trypan blue staining 
Cell death resulting from the hypersensitive response associated with 
increased ACD6 activity was visualized through staining by Trypan blue. 
First, lacto-phenol/Trypan blue solution (10 mL lactic acid, 10 mL 
glycerol, 10 mL phenol, 10 mg Trypan blue and 10 mL water) and 2.5g/mL 
chloral hydrate solution (25 g chloral hydrate in 10 mL water) were prepared. 
Freshly harvested leaf tissue was stained by completely immersing it in the 
lacto-phenol/Trypan blue stain and boiling the tube in a heat block set at 
100°C for 30-60 seconds. After boiling, the tubes were then kept at room 
temperature for 10 to 25 minutes. Next, the staining solution was aspirated 
out and replaced by the chloral hydrate solution to destain/clear the leaf 
tissues. Tissues were then soaked over-night (~12-16 hours) in fresh chloral 
hydrate solution for better clearing. The samples are kept in 60% glycerol for 
long-term storage or prior to documentation. 
2.4 Molecular characterization  
2.4.1 Oligonucleotide primer design 
PCR primers were usually initially designed from the Col-0 reference 
sequence using Primer3 (Untergasser, Nijveen et al. 2007). For cloning 
purposes, certain primers were also designed by hand with the aid of Gene 
Construction Kit® Version 4.0.0. A list of primers made in the conduct of 
experiments relevant to this thesis, together with other useful information 
about them, can be found in Appendix Table 2. All primers were ordered from 
MWG (Ebersberg, Germany). Dried primers were resuspended in sterile 
ddH2O to produce a stock concentration of 100 µM. Working solutions for 
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PCR reactions were diluted 10 fold in sterile ddH2O to give a working 
concentration of 10 µM. Working stocks were temporarily stored at 4°C, while 
concentrated stocks are kept at -20°C.  
2.4.2 Plasmid DNA extraction 
Small-scale routine plasmid DNA extractions for cloning experiments 
were conducted based on (Sambrook and Russell 2001). Alternatively, when 
high quality, large-scale amounts of plasmid DNA was needed the plasmid 
extraction kit from Promega® PureyieldTM Plasmid Miniprep System (Madison, 
WI, USA) was used as instructed by the manufacturer.  
2.4.3 Genomic DNA extraction 
 The DNA extraction protocol was modified after Doyle and Doyle 
(Doyle and Dickson 1987). The same protocol was adapted for both 96-well 
plate format as well as individual tube format. Leaf samples were collected on 
ice and kept at -80°C overnight. With the aid of two steel beads per tube, 
maceration was done using a grinding mill (Retsch MM300, Haan, Germany) 
set at 20 beats per second for 1 minute or until the tissues were finely ground. 
In instances when larger amount of cleaner DNA was needed, plant tissue 
was collected in either 1.5 ml or 15 ml tubes that were immediately placed in 
liquid nitrogen. Frozen plant tissue was then ground using a mortar and pestle 
that had been pre-cooled with liquid nitrogen. Ensuring that no residual 
powdered tissue was stuck at the tube caps, 500 µL of pre-heated (65°C) 
extraction buffer (2% w/v CTAB, 1.42 M NaCl, 100 mM Tris pH 8.0, 20 mM 
EDTA, 0.2% v/v β-mercaptoethanol) supplemented with 5 µL 20 mg/mL 
RNAse A (Invitrogen, Carlsbad, California) was added to each sample (~200 
mg of pulverized tissue). The mixture was then vigorously shaken and 
incubated at 65°C for 1 hour. Dissociation of proteins from nucleic acids was 
facilitated by the addition of 300 µL chloroform:isoamyl (24:1) and light 
inversion of the tubes. Subsequently, to separate the cellular components the 
samples were centrifuged at 16,000 x g for 20 minutes at room temperature. 
The resulting supernatant was transferred into a new tube. DNA precipitation 
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was then facilitated by mixing 0.7 volumes (~400 µL) of isopropanol with the 
collected supernatant. The tubes were temporarily kept at 4°C for a minimum 
of 20 minutes and then centrifuged at 16,000 x g for 30 minutes at room 
temperature. After decanting the supernatant, the resulting pellet was washed 
with 700 µL 70% v/v ethanol and centrifuged at 16,000 x g for 10 minutes. 
The resulting DNA pellet was air-dried and resuspended in double distilled 
sterile water. DNA quality and quantity was measured using a UV-Vis 
NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, 
Massachusetts, USA). Samples that had ratios of 1.8 to 2.0, for absorbance at 
260 nm and 280 nm (A260/A280), were considered as the acceptable. OD260 = 
1 is equivalent to 50 µg/ml of double-stranded DNA. 
2.4.4 Polymerase Chain Reaction (PCR)  
PCR cycling conditions were optimized for each primer pair used. 
Reactions were performed in a PTC-200 Peltier thermal cycler from MJ 
Research (Waltham, Massachusetts, USA). The generic 20 µL PCR cocktail 
for amplifying fragments (especially for cloning) was composed of:  
• Template (~ 5-10ng of plasmid DNA or 10-100 ng of genomic DNA),  
• 4 µL of 5X Phusion® HF Buffer (New England Biolabs Inc., Ipswich, 
MA),  
• 2 µL of 2mM dNTPs (10 mM each dNTP base, InvitrogenTM), 
• 2 µL of 10 µM Forward primer, 
• 2 µL of 10 µM Reverse primer, 
• 0.2 µL of Phusion® High-Fidelity DNA polymerase (5 U/µL, New 
England Biolabs Inc., Ipswich, MA), 
• Sterile ddH2O to make up the volume to 20 µL 
 
For amplification and cloning of artificial microRNA (amiRNA) 
fragments, Pfu polymerase and the corresponding buffer was used, as 
instructed by the manufacturer. The highly efficient but less expensive, 
Thermo-Start Taq DNA polymerase (Thermo Scientific Waltham, 
Massachusetts, USA) was used for routine genotyping PCR. The following 
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reaction components per reaction was scaled-up depending on the number of 
samples to be genotyped: 
• Template (~ 5-10ng of plasmid DNA or 10-100 ng of genomic DNA),  
• 2 µL of 10X PCR Buffer 
• 2 µL of 2 mM dNTPs (10 mM each dNTP base, InvitrogenTM), 
• 2 µL of Forward primer 10 µM, 
• 2 µL of Reverse primer 10 µM, 
• 0.5 µL of DNA polymerase  
• Sterile ddH2O to make up the volume to 20 µL 
 
Thermal cycling programs were set up as follows: 
 1x Cycle  Initial denaturation 30 sec (Phusion)  98°C 
      45 sec (Pfu)   94°C 
      2 min (Taq)   94°C 
 34x Cycle 1) Denaturation 5 sec (Phusion)  98°C  
      45 sec (Pfu)   94°C 
      20 sec (Taq)   94°C 
   2) Annealing  30 sec (Phusion)  50– 72°C* 
      45 sec (Pfu)   50– 65°C* 
      30 sec (Taq)   50– 65°C* 
3) Extension  30 sec/Kb (Phusion) 72°C 
    1 min/Kb (Pfu)  72°C 
    1 min/Kb (Taq)  72°C 
 1x Cycle  Final extension  5 min (Phusion)  72°C 
      10 min (Taq)   72°C 
 1x Cycle Incubation  as needed   14°C 
* Annealing temperature was based on the calculated melting 
temperature (Tm) of the specific primer used in the PCR reaction.  
 
PCR conditions and some reaction components had to be individually 
optimized for some primer pairs. 
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2.4.5 Agarose gel electrophoresis 
PCR products and restriction enzyme fragments were separated in a 
submerged agarose gel prepared with 1x TAE [2.0 M Tris Acetate, 0.05 M 
EDTA buffered by glacial acetic acid (~57.1 mL per liter) to pH 8.2 – 8.4]. The 
concentration of the gel, in % w/v, varied with the expected fragment size of 
products loaded – a higher concentration was used when smaller fragments 
were to be separated. Loading buffer (10 mM Tris-HCl, 1 mM EDTA pH 8.0, 
50% v/v glycerol, 0.05 g/mL bromophenol blue) was mixed with PCR products 
and restriction fragments, for visualization and tracking of the electrophoresis 
progression. A molecular marker was loaded on to wells adjacent to the 
samples being resolved. The gels were usually run at 10-20 V/cm for as long 
as needed to obtain the desired separation. The resulting separated 
fragments were visualized with UV light (302 nm) and documented using 
AlphaImager (Alpha Innotech, Genetic Technologies, Inc., Florida, USA). 
2.4.6 RNA extraction  
RNA was extracted using a modified TRIzol (InvitrogenTM) method. Plant 
tissues, collected in 1.5 ml tubes containing two steel beads, were ground to 
powder using pre-frozen (cooled at -80°C) tube adaptors for the grinding mill 
(Retsch MM300). Carefully making sure that the plant tissue did not thaw, 1 
mL of TRIzol was added per sample (~100 – 200 mg). The mixture was 
homogenized and incubated at room temperature for 5 minutes. Next, 500 µL 
chloroform was added and the tube was subsequently inverted around 24 
times and centrifuged at 14,000 x g for 10 minutes at 4°C. The supernatant 
was transferred to a new 1.5 ml tube, after which 500 µL isopropanol was 
added and mixed by gentle inversion. This mixture was incubated on ice for 
10 minutes and then centrifuged at 14,000 x g for 20 minutes at 4°C. After 
centrifugation, the resulting pellet was washed with 70% ethanol and re-
precipitated again by centrifugation at 14,000 x g for 10 minutes at 4°C. 
Precipitated RNA was air-dried and dissolved in 30 – 50 µL of DEPC-treated 
ddH2O. Quantity was measured using a UV-Vis NanoDrop 2000 
spectrophotometer (Thermo Scientific) set to measure absorbance at 260 nm 
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and 280 nm. The presence of intact ribosomal RNA and comparative 
absorbance ratios A260/A280 of ~2.0 was used to assess the quality of the RNA 
extracted. RNA samples were stored at -80°C. 
2.4.7 DNAse I treatment  
RNA samples were routinely treated with DNAse I to ensure that there 
was no contaminating DNA in the samples. Treatment was done using the 
RQ1 RNase-Free DNAse from Promega® kit, employed as per the 
manufacturer’s instructions. RNA quality and quantity were re-checked after 
DNAse treatment and normalized by dilution to ~ 50 - 100 ng/µL.  
2.4.8 First-strand complementary DNA (cDNA) synthesis  
As soon as the RNA was cleaned-up and diluted to the desired 
concentration, first-strand complementary DNA (cDNA) was synthesized. The 
SuperScript® First-Strand Synthesis System for RT-PCR kit (InvitrogenTM), 
was utilized for this purpose. Random hexamers and oligo(dT) primers were 
the oligonucleotides of choice for cDNA amplification. The protocol as 
suggested by the manufacturer was adapted. To unfold the RNA the 24 µL 
reaction, incubated at 65°C for 5 minutes, consisted of the following: 
• 20 µL Template (~ 10 µg of normalized DNAse-treated RNA),  
• 2 µL oligo(dT)18 primer, 
• 2 µL random hexamer primer 
The reactions were immediately flash-cooled at on ice to preserve the 
unfolded RNA structure, and the following reaction components are added: 
• 8 µL Reaction buffer,  
• 2 µL Ribolock RNAse Inhibitor, 
• 4 µL 10 mM dNTP mix, 
• 2 µL RevertAid M-MuLV Reverse Transcriptase 
The total 40 µL reaction was incubated at 42°C for 60 minutes. The reaction 
was halted by incubation at 70°C for 5 minutes. The final single-stranded 
cDNA was then diluted 1:10 and used for succeeding PCR reactions. 
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2.4.9 Quantitative RT-PCR (qRT-PCR) 
Gene expression changes were determined using reverse transcription 
followed by quantitative real-time RT-PCR (qRT-PCR) using gene specific 
primers (Appendix Table 2). The reaction was performed with Fast SYBR® 
Green Master Mix (InvitrogenTM). The progression of the reaction cycles for 
real-time quantification of template amplification was monitored with CFX384 
TouchTM Real-Time PCR Detection System (Biorad, Hercules, CA, USA). A 
minimum of three biological replicates was tested for most experiments 
except for routine checks of unstable transgenic lines (primary transformants) 
when replication is not possible. Two technical replicates of each genotype as 
well as the corresponding housekeeping gene for normalization were 
measured.  
The relative expression ratio to the control, usually the accession Col-0, 
was quantified based on a formula from Pfaffl (Pfaffl 2001):  
2 - [(Ct test sample – Cthousekeeping gene) - (Ctnormalization sample - Cthousekeeping gene)]
  
A typical 20 µL qPCR reaction consisted of the following: 
• 5 µL Fast SYBR® Green Master Mix,  
• 2 µL of 10 µM Forward primer, 
• 2 µL of 10 µM Reverse primer, 
• 4 µL single-stranded cDNA, diluted 1:10 
• 7 µL water 
2.4.10 Artificial microRNA (amiRNA), domain swaps, rescue and genomic 
complementation constructs  
Constructs expressing amiRNAs under the control of the constitutive 
Cauliflower Mosaic Virus (CaMV) 35S promoter were designed and prepared 
as described (Schwab, Ossowski et al. 2006). First, the target cDNA 
sequence was submitted to the WMD online tool (Weigelworld , Ossowski, 
Schwab et al. 2008) to design the amiRNA primers. Sequence verified 
amiRNA constructs were then inserted into the MIR319a backbone and 
transferred behind the CaMV 35S promoter in a modified transformation 
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vector (pFK210) derived from pGREEN (Hellens, Edwards et al. 2000). A list 
of the amiRNA constructs used in this work can be found in Appendix Table 3. 
Genomic constructs were prepared with restriction enzymes or Gateway 
cloning. ACD6 alleles from Pro-0 and Rmx-A180 were isolated using specific 
primers (Appendix Table 2). In addition, domain swap constructs were made 
between Est-1 and Pro-0 ACD6 allele types (Appendix Table 3). As with the 
amiRNA constructs, all binary vectors were based on the pGREEN system. 
Constructs were introduced into Col-0 and other genotypes (Appendix Table 
3) using Agrobacterium tumefaciens mediated transformation (Weigel and 
Glazebrook 2006).  
2.5 Pathogen-Associated-Molecular-Pattern (PAMP) assays and 
Pathogen response assays 
2.5.1 PAMP-induced Reactive-oxygen species (ROS) assays 
A two-day experimental set-up, excluding the growth of the plants used 
for the assay, was needed to perform PAMP-induced ROS assays. The 
scheme and the details are provided in Figure 2.1. Each assay for a particular 
genotype was repeated at least three times to ensure that the pattern shown 
by the assay was consistent. The Elicitation Solution (for composition refer to 
Figure 1) was always kept protected from direct light and was only added to 
the recovered leaf discs a few seconds prior to reading of ROS burst by the 
luminometer (TECAN Infinite ® 200 Pro). A multichannel pipette was used to 
aliquot the solution to each well to guarantee that sets of samples are treated 
with the solution at the same time. 
The flg22 peptide was ordered from and synthesized by EZBiolab Inc. 
(Westfield IN, USA) at >85% purity with the following sequence: QRL STG 
SRI NSA KDD AAG LQI A.  
2.5.2 Pseudomonas syringae storage and growth 
Pseudomonas syringae pv. maculicola ES4326 (Psm) and 
Pseudomonas syringae HrcC- (Pst HrcC-) strains were provided by A.G. 
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Staphnill (JIC, UK). Long-term pathogen stocks were kept in 50% glycerol at -
80°C before transfer to agar stock plates on LB medium supplemented with 
50 µg/ml each of rifampicin and kanamycin kept at 28°C overnight (~12 to 16 
hours). Those plates were stored for up to 2 weeks at 4°C. Single colony 
bacteria grown for actual assays were also taken from and re-inoculated to LB 
medium with the appropriate antibiotics. Approximately 250 µL of the growth 
culture was then lawn plated unto a fresh LB plate, again with the appropriate 
antibiotics, and grown at 28°C overnight (~12 to 16 hours). 
2.5.3 Bacterial (Pseudomonas syringae) inoculation and counting 
A typical experimental set-up and flow of the inoculation is shown in 
Figure 2.2. For each genotype tested, at least three individual plants 
(biological replicates) for infection and a corresponding set for mock 
inoculation were grown in a 23°C short-day growth chamber for four weeks. 
Three days before leaf disc collection, bacterial inoculum used for infiltration 
was prepared by re-suspending scrapings from fresh lawn-plated bacteria in 
10mM MgCl2. Bacterial density was measured using an Eppendorf Bio-
photometer (Hamburg, Germany) and adjusted to OD600 0.002 (equivalent to 
~106 cfu/mL). Pressure infiltrations were made using 1 mL needleless syringe 
on the abaxial side of each leaf, until the whole leaf appeared to be water-
soaked. At least 4 leaves were infiltrated per plant. Leaf discs (5 mm 
diameter) taken from two leaves of three plants amounted to a minimum of 6 
data points per genotype per treatment. To assess bacterial content in 
comparative trials, dilution plating and colony counting were performed after 
macerating the collected leaf disc in 200 µL 10 mM MgCl2 with two steel 
beads per tube using a grinding mill (Retsch MM300). 
Serial dilutions of between 100 to 10-7 were dot-plated (~10 µL per spot) 
on LB plates (Figure 2.3) with the necessary antibiotics and incubated for two 
days at 28°C. At the same time, each dilution series was dot-plated twice as  
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Figure 2.1 PAMP-induced Reactive-oxygen species (ROS) assay experimental set-up and 
scheme 
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Figure 2.2 Plant experimental set-up for bacterial inoculation and sample collection for colony 
counting assay 
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technical replicate. The number of colonies that formed was counted at the 
highest possible dilution and the average between the two technical replicates 
was recorded for each specific dilution. Finally, the number of colony forming 
units per leaf area taken was calculated with the final unit of measure in (log) 
cfu.cm2. 
 
2.6 Screening of accessions and generation of mapping populations 
The collection of Arabidopsis thaliana accessions (Appendix Table 1) 
available in the laboratory was screened for the presence of ACD6-Est-1 
allele. A fragment of the more variable 3’- end region of ACD6 (At1g14400) 
was amplified by PCR using oligonucleotides G-12247 
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Figure 2.3 Agar plate set-up for bacterial dilution and colony counting from macerated leaf 
extracts of infected and non-infected leaves. 
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(AGCCGTAGACGCTGGAAATA) and G-18613 
(AGAAGAAACATATCCTTGAA). Next, PCR fragments were Sanger 
sequenced and the presence of the causal amino acid change typical of 
ACD6-Est-1 allele was assessed. All accessions containing the causal SNPs 
for said amino acid changes were grown in 23°C SD and phenotyped for the 
presence of late-onset leaf necrosis. From that subset, six accessions 
showing none to mild late-onset leaf necrosis/ cell death patches were kept 
and tested further. Testcrosses and mapping populations were created 
simultaneously, as illustrated in Figure 2.4. Those plants were genotyped with 
markers (Appendix Table 2) distinguishing the ACD6-Est-1 allele from ACD6-
Col-0 allele to determine if the late-onset phenotype co-segregated with the 
ACD6 allele type.  
2.6.1 Identification of Est-like ACD6 alleles using Illumina short reads of 
accessions from the 1001 Genomes Project 
2.6.1.1 Mapping and SNPs calling 
To map and find accession-specific SNPs, a home-made pipeline written 
in Nextflow language (group) was used to do the following: 
• Mapping with BWA mem (Li and Durbin 2009) 
• Sorting SAM file using Picard (Institute) SortSam  
• Removing PCR duplicates using Picard MarkDuplicates 
• Indexing BAM files using Picard BuildBamIndex 
• Local realignment around indels using Genome Analysis Toolkit 
(GATK) (McKenna, Hanna et al. 2010) RealignerTargetCreator and 
IndelRealigner 
• Calling variants (SNPs and indels) using GATK Haplotype Caller 
After mapping and SNP calling, all individual vcf files were merged 
through GATK GenotypeGVCFs. A subset of the genome containing ADC6 
was extracted using vcftools (coordinates of ACD6 -- chr Chr4 --from 
8298043bp to 8298249bp). This fragment covers the two crucial triplets,  
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causal for Est-1 ACD6 hyperactivity, and 243 bp between them. The critical 
CTT/TTT substitution occurs in position Chr4 8298247. Indels were removed 
using GATK SelectVariants. Finally, fasta sequences were produced for each 
accession, using GATK FastaAlternateReferenceMaker. If there was no 
coverage for a particular position, Col-0 reference SNP was taken instead. 
Confirmation for a subset of accessions, having at least one of the 
crucial triplets as being Est-like, was done by Sanger sequencing of the 
transmembrane fragment amplified using oligonucleotides G-12247 and G-
18613. 
 
 
 
Figure 2.4 Schematics of A) crossing of testcross between candidate accessions with ACD6 
modifiers and B) generation of populations used for genetic/QTL mapping. 
		 35 
2.6.1.2 Plotting geographic distribution of accessions  
Accessions were plotted on the world map based on the triplet sequence 
for the two causal amino acid changes using ggplot (Wickham 2009) package 
in R . For better resolution, a separate plot was made for the subset of 
accessions with confirmed Sanger sequencing SNPs and lesion phenotypes.  
2.6.2 Restriction-site Associated DNA Sequencing (RAD-Seq) 
Library preparation: Restriction-site Associated DNA Sequencing, a 
genotyping-by-sequencing method, was employed to genotype F2 populations 
for QTL mapping. The method uses restriction enzyme digestion to create 
fragments of genomic DNA with a specific overhang. These overhangs are 
then exploited for adapter ligation. For our purpose, RAD-Seq library 
preparation and adapter sequences were adapted from the methods 
developed by (Poland, Brown et al. 2012). A set of 192 adapters based on 
Pst-1 and Mse1, designed according to Poland et al. (Appendix Table 4), was 
used for pooled sequencing of a maximum of 192 individual samples per 
library.  
 
Restriction Digest: Normalized genomic DNA (200 ng) for each individual 
sample was digested in 20 µl reaction volume of NEB Buffer 4 with 8 U of PstI 
HF (High- Fidelity, New England BioLabs Inc.) and 8 U of MseI (New England 
BioLabs Inc.). Samples were incubated at 37°C for 2 hours and then at 80°C 
for 20 minutes to inactivate the enzymes. 
 
Ligation: Immediately after digestion, the adapters were ligated to the DNA 
fragments. In the same reaction tube, extra NEB Buffer 4 (#B7004S) and 
1mM ATP (Thermo Scientific, #R0441) were added together with 200 U T4 
DNA Ligase (ThermoFisher Scientific, Waltham, Massachusetts, USA), 0.1 
pmol Adapter 1 and 15 pmol of the common Y-adapter (Appendix Table 2). 
Samples were incubated at 22°C for 2 hours and then at 65°C for 20 minutes 
to inactivate the ligase. 
 
		 36 
Multiplexing and Amplification: For each designated library, ligated samples 
were multiplexed in a single tube by pooling equal amounts from each 
sample. Prior to PCR amplification the multiplexed mixture was purified using 
a QIAquick PCR Purification Kit (Qiagen, Venlo, Limburg, Netherlands). A 200 
µl total of pooled ligated DNA was combined with 1000 µl buffer PB in a fresh 
2.0 mL tube. One spin column was used for each 600 µl of the mixture. Each 
column was spun at 16, 000 x g, and sequentially washed and air-dried. The 
ligated DNA fragments were eluted using 60 µl of buffer EB. PCR 
amplification of the cleaned up fragments was done in a single tube. Each 
library was amplified for 12 cycles of 95°C (10 seconds), 62°C (30 seconds), 
72°C (30 seconds) and a final 5-minute extension at 72°C. After PCR 
amplification, the reactions were purified again purified using a QIAquick PCR 
Purification Kit. For different mapping populations, a single library consisted of 
either 96 or 192 samples, which was sequenced on a single lane of Illumina 
HiSeq2000.  
 
Processing of Illumina Raw Data: Raw Illumina 100 bp reads was processed 
using custom Perl scripts supplemented with the mapping and analysis 
pipeline SHORE (2013). The (unfiltered QSeq) Illumina data were assigned to 
individual samples using the designated barcode sequence. Only sequences 
that had maximum of 2 mismatch in the barcode followed by the expected 
PstI cut-site were kept. A 10% leeway as the maximum amount of ambiguous 
base calls per read was set with the minimum trimmed read length as 30 bp. 
Low complexity filters as well as SHORE custom filters were also used. 
Trimmed and quality-filtered reads (from all the F2 individuals as well as the 
parental genotypes) were then mapped to the preprocessed Col-0 reference 
sequence genome. Consensus analysis based on the SHORE homology 
scoring matrix resulted in a list of quality variant and quality reference SNPs 
with the corresponding quality scores and read support counts. The last 10 
bases of each alignment were offset as more “suspicious” than the rest of the 
read. High quality co-dominant SNP markers were compiled from the quality 
reference and quality variant SNPs of each F2 parental genotype. A matrix 
containing the genotypes at specific marker positions for all the F2 individuals 
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genotyped for the mapping population was then created using a customized 
script.  
2.6.3 QTL mapping and analysis 
F2 individuals from crosses between Pro-0 x Est-1, RmxA180 x Est-1, 
Br-0 x Est-1 and Bs-5 x Est-1 were phenotyped for the severity of late-onset 
necrosis. Phenotypic scores were supplied from the qualitative scoring of the 
phenotypes based on the severity of lesions formed on the plants. 
Phenotypes were entered as “0” when the individual did not develop lesions at 
the phenotyping time point and “1” otherwise. QTL mapping and testing for 
QTL effects and interactions were performed using the R/qtl package. The 
R/qtl software package is implemented as an add-on package for the 
command-line-based, open-source statistical software R. Lod scores were 
initially calculated with single-QTL model using the function ‘‘scanone’’. 
Subsequent results indicating more than one loci prompted re-computation of 
lod scores and testing interactions (epistatic, additive and dominant) using the 
functions “scantwo” and “fitqtl”. The lod score significance threshold was 
established using 1,000 permutations. In all the functions utilized the standard 
expectation-maximization algorithm was used for ‘‘method.’’  
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3 ACD6 natural variation in Arabidopsis thaliana 
populations 
 
“Biology is a science of three dimensions. The first is the study of each 
species across all levels of biological organization, molecule to cell to 
organism to population to ecosystem. The second dimension is the diversity 
of all the species in the biosphere. The third is the history of each species in 
turn, comprising both its genetic evolution and the environmental change that 
drove the evolution. Biology, by growing in all three dimensions, is 
progressing toward unification and will continue to do so.” 
              - Edward O. Wilson, 2005 
 
 
The total number of characteristics in the genetic makeup of a species 
(genetic diversity) and the tendency of these genetic characteristics to vary 
(variation) remains core to the study of all living organisms (Koornneef, 
Alonso-Blanco et al. 2004, Arber 2011, Weigel and Nordborg 2015). An 
attestation to this, natural variation (genetic diversity in the wild) in different 
plant species has been increasingly utilized to identify the molecular basis of 
important agronomic traits (Alonso-Blanco, Aarts et al. 2009). Finding the 
molecular nature of important phenotypes starts by identifying genetic 
variation controlling the trait. Conjointly, the origin and the phenotypic effects 
of these genetic variations are central to obtaining knowledge on how species 
adapt to the environment. Molecular characterization of the allelic differences 
is a fundamental building block of plant molecular breeding. 
As much as biodiversity is vast, genetic programs for several complex 
traits have been shown to be shared across groups of organisms (Weigel 
2012). Accordingly, a few species have arisen as models for the study of traits 
typically found in a larger group of species. Some model plants have been 
selected based on their own value in biotechnology or agronomy. Examples of 
such are corn, rice and wheat. There are also newly emerging models such 
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as Panicum virgatum (switchgrass) and Brachypodium distachyon (purple 
false brome) that have become increasingly popular, either because of 
favorable properties for genetic research or their direct usefulness for biomass 
production.  
The traditional genetic models were selected due to ease of investigating 
particular biological phenomena or just plain ease of handling of the species 
itself. Arabidopsis thaliana (“Arabidopsis”), selected initially as such, has now 
been adopted as a major model or reference plant especially suitable for 
genetic and molecular research. Although native to Europe and central Asia it 
is now naturalized in many places across the world, in a wide range of 
habitats (Koornneef, Alonso-Blanco et al. 2004). Natural accessions of 
Arabidopsis have often been called “ecotypes”, a term that implies that 
individuals are type specimens for a particular ecological environment. The 
neutral term “accession” is more preferable (Alonso-Blanco and Koornneef 
2000, Weigel 2012).  
There are many studies of the effects of specific natural alleles found in 
Arabidopsis populations. Traits that have been investigated include 
resistances to biotic (Schiff, Wilson et al. 2001, Wilson, Schiff et al. 2001) and 
abiotic factors (Zhang and Lechowicz 1995), control of developmental 
processes and physiological traits (van Der Schaar, Alonso-Blanco et al. 
1997, Perez-Perez, Serrano-Cartagena et al. 2002) and even production of 
biochemical compounds (Kliebenstein, Kroymann et al. 2001). Most of these 
studies focus on clear defined phenotypes responsible for specific traits. 
Recently, additional attention has been given to study trade-offs in 
Arabidopsis and in other plants that exemplify the adaptation consequences 
of acquiring advantage over one phenotype/trait at the expense of another 
(Kiani, Trontin et al. 2012, Oakley, Agren et al. 2014, Zhang, Shrestha et al. 
2014, Rasmann, Chassin et al. 2015, Shyu and Brutnell 2015). 
One example is alleles in the Arabidopsis gene ACD6 that underlie a 
trade-off effect between growth and defense (Todesco, Balasubramanian et 
al. 2010). It has been shown that reduced size and autoimmune symptoms 
are correlated across Arabidopsis accessions. A conventional QTL mapping 
strategy identified the Est-1 allele type as causal for both late-onset necrosis 
(in the absence of pathogens), and slower leaf production and reduced 
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biomass. It has also been found that this hyperactive ACD6 allele, compared 
to the reference allele, strongly enhances resistance to a broad range of 
pathogens from different phyla (e.g. Golovinomyces orontii, 
Hyaloperonospora arabidopsidis, and Pseudomonas syringae). Furthermore, 
the authors reported that approximately 20% of the 96 accessions they 
sequenced for ACD6 had an allele similar to that of Est-1 (Figure 3.1). 
The late-onset necrosis phenotype is reminiscent of the hypersensitive 
response induced by pathogen resistance. By this reason, and not just in the 
aforementioned study, the lesion response has been used as a proxy for 
autoimmunity or hyperactivation of plant defense response (Moeder and 
Yoshioka 2008). ACD6 Est-1 like alleles have been assumed to generally 
associate with the proxy phenotype for ACD6 hyperactivity late-onset necrosis 
(interchanged often with the simpler description appearance of “lesions” in the 
succeeding sections and Chapters). Notably, not all accessions (e.g., Pro-0 
and Rmx-A180) that had the Est-like allele of ACD6 showed strong lesions 
(Todesco, Balasubramanian et al. 2010). The genetic or evolutionary reasons 
for this variation were, however, not investigated further. 
In this chapter, I focus on efforts to identify the extent of variation, 
distribution and maintenance of Est-like ACD6 alleles in natural Arabidopsis 
accessions. Specifically, I began with identification of a quick but robust 
method to assay ACD6 allele type. Next, I used that information to 
substantiate the claim that the late-onset necrosis/lesion phenotype is a 
consequence of having an Est-like ACD6 allele. Finally, after I had obtained 
ACD6 genotype and phenotype information, I surveyed geographic patterns of 
variation, distribution and maintenance of Est-like ACD6 alleles in Arabidopsis 
accessions.  
3.1 Causal amino acids for ACD6 hyperactivity 
My first step into dissecting the possibility of natural modulation of the 
trade-off effect of ACD6 on growth and defense potential was finding more 
cases of Est-1 like allele without lesion phenotype (like Pro-0 and Rmx-A180) 
(Todesco, Balasubramanian et al. 2010). This would not only give us  
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Figure 3.1 Known ACD6 genetic variation and associated phenotypes before I began my 
thesis work. A) Hierarchical clustering of ACD6 alleles in 96 accessions of Arabidopsis 
thaliana shows that accessions having Est-like ACD6 alleles group together. Est-like ACD6 
alleles generally associate with late-onset necrosis, the severity of which varies among the 
accessions tested. As illustrated in the tree: yellow indicates mild, orange intermediate and 
red severe necrosis. B) The trade-off effect of ACD6 on growth and defense. Severity of 
lesioning is inversely proportional to susceptibility to pathogens and biomass. Among 
accessions with Est-like ACD6 alleles, amiR-ACD6 knockdowns abolish the lesions and 
increase biomass. 
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information on how common they are but also provide more cases with which 
ACD6 variability can be studied. Concurrent to that goal, I attempted to 
confirm the previously defined ACD6-Est-1 SNPs responsible for hyperactivity 
of the Est-1 ACD6 allele. Transgenic tests have identified two causal amino 
acid changes that are together necessary and sufficient to change a Col-0 
ACD6 allele into an allele with the Est-1 activity (Figure 3.2): A566N and 
L634F (Todesco, Balasubramanian et al. 2010).  
Using the Est-type nucleotide triplets AAC (encoding N566) and TTT 
(encoding F634), I used short reads from the 1001 Genomes Project 
(http://1001genomes.org/) to find accessions with these SNPs. Short-read 
data from 858 accessions passed the quality filter I used. Table 3.1 shows the 
distribution of nucleotide triplet types for these 858 accessions. Some of the 
nucleotides called from the short read sequences were ambiguous. For amino 
acid 566, the following triplets were observed in addition to GCA (Col-0-like, 
encoding Ala): GAA (Glu), GMA (Ala/Glu), GTA (Val), GWA (Ala/Val) and 
GYA (Ala/Val). AAC, the nucleotide triplet coding for Est-1, was not recovered 
from any of the mapped reads. For amino acid 634, I found in addition to CTT 
(Col-0-like, encoding Leu) and TTT (Est-1-like, encoding Phe): GTT (Val), 
KTT (Val/Phe), STT (Val/Leu) and YTT (Leu/Phe). Heterozygous calls 
question accuracy of SNP calling from short-read data, as A. thaliana mostly 
reproduces by self-fertilization (Platt, Horton et al. 2010). The species exists in 
metapopulations, with genetically identical plants in the native range being 
generally restricted to individual stands (Cao, Schneeberger et al. 2011). With 
self-fertilization and bi-parental breeding only 95% of A. thaliana have five or 
fewer heterozygous loci (Platt, Horton et al. 2010). Given these facts, 
heterozygosity is not characteristic of A. thaliana accessions. The ambiguous 
SNPs are likely pseudo-heterozygous and are due to sequencing errors or 
paramorphism (polymorphism between paralogs) (Fu, Emrich et al. 2005). In 
Col-0 there is an ACD6 paralog (AT4G14390), located immediately upstream 
of the ACD6 locus. This or any other paralog that is not included in the 
reference genome may be causal for this paramorphism. Illumina short reads 
are 100-250 bp short DNA fragments are when they are aligned to the 
reference. Short fragments from non-reference paralogs could still be aligned  
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Figure 3.2 Representative acd6-2 transgenics with induced point mutations showing the two 
causal amino acid changes that are sufficient to confer Est-like ACD6 hyperactivity in Col-0-
like ACD6 alleles. Induced point mutations (ICMs) revert A) Col-0 type Alanine (Ala) at 
position 566 to Est-1 type Asparagine (Asn) and/or B) Col-0 type Leucine (Leu) at position 
634 to Est-1 type Phenylalanine (Phe). 
Note: Transgenics made by Dr. Marco Todesco, I did the phenotypic screening. 
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to the reference but with some mismatches that could result in ambiguous 
SNPs calls. 
 Given the nucleotide triplet type ambiguities seen, I wanted to test the 
robustness of this short read-based allele-type-designation, by deducing the 
likely genotype from Est-1-like necrosis and by parallel Sanger sequencing. I 
grew seedlings for a subset of 94 accessions with the respective nucleotide 
triplet combinations, shown in Table 3.2. Accessions with ambiguous 
nucleotide triplet combinations were prioritized. The selected accessions have 
nucleotide triplet combinations for which there was the highest probability that 
one of the pseudo heterozygous SNP results in a position 566 and 634 Est-
like ACD6 amino acid. Since there were assayed Est-1 F634 triplets, more 
focus was put into determining what position 566 triplets those were found in 
conjunction with. Serving as control, I also grew Est-1 and Col-0 together with 
these selected accessions. Genomic DNA samples were used to amplify an 
800 bp fragment in the ACD6 transmembrane domain where the causal SNPs 
for amino acid position 566 and 634 are located. This 800 bp was used for 
Sanger sequencing. In parallel, a set of 6 seedlings each was grown to 
maturity and phenotyped for appearance of spontaneous lesions.  
Sanger results identified a new nucleotide triplet, AAA (encoding Lys), for 
amino acid 566 (Figure 3.3). Also at amino acid position 566, accessions with 
GMA ambiguous nucleotide triplet could be categorized either as having Col-0 
like, GCA (Ala) or the new nucleotide triplet, AAA (Lys). Still at amino acid 
position 566, accessions with GWA ambiguous nucleotide triplet could be 
categorized either as having Est-1 like AAC (Asn) or the newly discovered 
AAA (Lys) nucleotide triplet. It seemed that the new nucleotide triplet for 
ACD6 amino position 566 caused mistyping for some accessions. 
Comparison between Illumina and Sanger sequences showed that most 
selected accessions had Est-like nucleotide triplets for F634 (Figure 3.3), 
including those initially called as having KTT(Val/Phe) and YTT (Leu/Phe). 
Most of the accessions originally typed as having TTT (Phe) for ACD6 amino 
acid 634 were indeed TTT. Contingent on Sanger sequencing results, prior 
designation of accessions as having Est-like ACD6 based on F634 alone was 
87% accurate.  
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 Accessions with more severe HR-like lesions have Est-1 triplet 
nucleotides AAC and TTT at ACD6 amino acid 566 and 634 respectively 
(Figure 3.4A). Analysis of the two ACD6 amino acid positions showed that this 
observation holds although there is a lesion severity gradient for accessions 
having both AAC and TTT triplet nucleotides (Figure 3.4B). This gradient may 
be due to other SNPs in ACD6 that result in non-synonymous amino acid 
changes which could temper the effect of the identified Est-like amino acid 
causal for hyperactivity. Other than this, extragenic factors can reduce ACD6 
hyperactivity in some of these accessions that have both Est-like causal 
amino acids. Accessions that contained the new triplet nucleotide AAA 
encoding for ACD6 amino acid position 566, can have mild HR-like lesions, 
when combined with either Col-like CTT or Est-like TTT at ACD6 amino acid 
position 634 (Figure 3.4B). There were two accessions that had Col-like triplet 
nucleotide combination, GCA/CTT and GCA/TTT respectively, which had 
severe lesions. The lesion phenotype observed in these accessions can be 
due to a gene different from ACD6, for which the allele present in the said 
accession could also result in an HR-like lesion. Otherwise, there might be 
other SNPs that are present in ACD6 alleles different from Est-1 that could be 
causal for an ACD6-dependent lesion phenotype. Cloning and transforming 
the ACD6 alleles from these accessions could be a way to check for the 
lesion phenotype causality.  
 Summarily, with the results from this section I have shown: 
• With ~20% error, raw Illumina resequencing data analyzed using the 
pipeline I adapted can be used to designate accessions as having Est-
like ACD6 alleles. The errors might have been due to Illumina 
sequencing errors or the uncertainty of assigning Illumina short reads 
between paralogs. Follow up with experiments  
• Most of the A. thaliana accessions having both Est-like ACD6 amino 
acids N566 and F634 showed strong HR-like lesions. Some had none 
or mild lesions which resembling Pro-0 and Rmx-A180 phenotypes. 
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Table 3.1 Frequency distribution of triplet types at positions coding for ACD6-Est-1 causal amino acids among A. thaliana accessions of the 1001 Genomes 
Project based on reconstituting SNPs from the raw Illumina short read sequences for ACD6 
Combination Position 5661 Similarity Accessions Position 6341 Similarity Number of accessions with amino acid combination 
1 GAA New 229 CTT Col-0 721 
2 GCA Col-0 523 GTT New 17 
3 GMA New/Col-0 92 TTT Est-1 102 
4 GTA New 3 KTT New/Est-1 3 
5 GWA New/Col-0 7 STT New/Col-0 12 
6 GYA New/Col-0 4 YTT Col-0/Est-1 3 
 total 
 
858 total  858 
1IUPAC nucleotide code: M- A or C, W- A or T, Y- C or T, K- G or T, and S- G or C.  
 
Table 3.2 Frequency distribution of accessions selected for Sanger sequencing. Triplet types at positions coding for ACD6-Est-1 causal amino acids among 
Arabidopsis thaliana accessions of the 1001 Genomes Project based on reconstituting SNPs from short read sequences for ACD6 
Combination Position 566 1 Amino acid identity Similarity Position 634 
1 Amino acid identity Similarity 
Number of accessions with 
amino acid combination 
1 GCA Ala Col-0 YTT(CTT/TTT) Leu or Phe Col-0/Est-1 2 
2 GCA Ala Col-0 KTT(GTT/TTT) Val or Phe New/Est-1 2 
3 GCA Ala Col-0 TTT Phe Est-1 51 
4 GMA(GCA/GAA) Ala or Glu New/Col-0 KTT(GTT/TTT) Val or Phe New/Est-1 1 
5 GMA(GCA/GAA) Ala or Glu New/Col-0 TTT Phe Est-1 32 
6 GWA(GAA/GTA) Ala or Val New/Col-0 CTT Leu New 6 
1IUPAC nucleotide code: M- A or C, W- A or T, Y- C or T, K- G or T, and S- G or C.  
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Figure 3.3 Illumina short-read sequencing and Sanger sequencing codon call concordance 
for ACD6 nucleotides encoding amino acids 566 and 634. 
Figure 3.4 Correlation of lesions with codon types for ACD6 residues 566 and 634. A) Taking 
each codon type at position 566 and 634 separately, accessions with Est-like codons have 
more severe lesions. B) Codon type combination AAC(Asn)/TTT(Leu) was present in most of 
the accessions with severe lesions. 
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3.2 Diversity and maintenance of ACD6 allele types  
Based on nucleotide-triplets for ACD6 amino acid 634 from the 858 A. 
thaliana accessions for classifying ACD6 allele type, I could detect 
predominantly accessions with Col-0 ACD6 alleles (Figure 3.5). Accessions 
with Est-like ACD6 alleles consisted of 12% of the population tested, another 
4% of the population had neither Col-0 nor Est-1 but other types of ACD6 
alleles. Shown in Figure 3.5 are the geographic origins of the accessions 
tested, from which it is clearly seen that these different ACD6 allele types co-
occurred with each other. As suggested by Todesco and colleagues 
(Todesco, Balasubramanian et al. 2010), co-occurrence of these functionally 
distinct ACD6 alleles in both local and global populations of A. thaliana is 
congruous with this locus being under balancing selection.  
 To make further use of the short-read data from the 1001 Genomes 
project, I adapted an alternative method, Mash. Originally described by Ondov 
and colleagues (Ondov 2015) as rapid estimation of pairwise distances 
between genomes or metagenomes based on raw reads, I adapted Mash for 
estimating similarity of gene short-read sequences to reference allele types. 
Mash, which is based on an algorithm called MinHash, divides sequence 
information into k-mers, which in turn are reduced to a representative sketch 
before comparison. Reduction occurs through transforming all k-mers using 
hash function1 and selection of a k-mer represented by minimum value. The 
reduction process is repeated thousands of times with different, arbitrary hash 
functions, in consequence of that thousands of independent minimal k-mers 
are saved into sketch. Similarity between sequences of different Arabidopsis 
accessions can be calculated by counting number of minimal k-mers that co-
occur. Consequently, the more min-hashes (reduced k-mers) two sequences 
share, the more similar they are (Ondov 2015). K-mer similarity reflects not 
only shared substitutions but also shared structural variants such as indels 
and inversions. I calculated similarity of short-read sequences from 858 
accessions of Arabidopsis to reference alleles of genes ACD6, FLS2 and 
PR1. I used Est-1 ACD6 and Col-0 ACD6 as reference sequence. For 
comparing and for contrasting, I also estimated the diversity of two other  																																																								1	function which allows transformation of character string into numeric	
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ACD6-related immune genes, using Col-0 FLS2 and Col-0 PR1 sequences as 
reference. I found more sequence diversity in ACD6 than FLS2 and PR1 
(Figure 3.6A and 3.6B). This finding reflected data from Todesco and 
colleagues (Todesco, Kim et al. 2014) in which they found several other 
diverse ACD6 allele types from accessions such as Se-0, Mir-0, Bla-1. 
These alleles had duplications and deletions at different parts, which are 
very distinct from the ACD6-Est-1 and the ACD6-Col-0 alleles. Clearly, there 
are more ACD6 allele types than what was previously known. By contrast, 
diversity of FLS2 locus is characterized by fewer non-reference alleles than in 
ACD6 alleles, as shown by the bulk of accessions sharing high number of k-
mers with Col-0 FLS2 reference sequence (Figure 3.6B and 3.6C). Similar 
pattern could be observed for PR1 alleles except that there were 16 outlier 
accessions sharing less than 1000 k-mers with Col-0 PR1 reference (Figure 
3.6D). Those accessions all originate from Sweden. 
   
Figure 3.3 Worldwide distribution of tested Arabidopsis thaliana accessions; color-coded 
based on short-read sequencing reconstituted ACD6 allele types. Accessions that are Est-like 
at amino acid position 634 are color-coded orange while accessions that are Col-like for the 
same amino acid position are color-coded as green. 
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Figure 3.4 Diversity estimation of Arabidopsis thaliana accessions based on selected genes 
in the ACD6 pathway. Mash (shared k-mers) similarity estimates were based on the following 
reference sequences: A) Est-1 ACD6, B) Col-0 ACD6 C) Col-0 FLS2, and D) Col-0 PR1.  
Accessions that were phenotyped for lesions are color-coded from light green to salmon 
based on the increasing severity of the lesion phenotype. Other accessions that have not 
been phenotyped for lesions are color-coded blue. 		
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 The bulk of A. thaliana accessions had ~5000 out of 10000 k-mers 
shared with either the Est-1 ACD6 or Col-0 ACD6 allele as reference. While 
the distribution trend for the tested accessions was similar when using either 
Est-1 ACD6 or Col-0 ACD6 allele as reference, severity of lesions in a subset 
of phenotyped A. thaliana accessions seemed to correlate with how similar 
their ACD6 alleles were to Est-1 and not Col-0 (Figure 3.6A and 3.6B). The 
accessions phenotyped as having Est-like HR lesions are bulked as sharing 
>8000 out of 10000 k-mers with Est-1. These same accessions shift lower in 
the distribution when Col-0 ACD6 allele is used as a reference, having >6000 
out of 10000 but <8000 out of 10000 k-mers shared with Col-0 ACD6. Huge 
variability in shared k-mers in ACD6 locus is likely caused by structural 
variants such as inversions and insertions described in Se-0, Bla-1 and Mir-0 
accessions (Todesco, Kim et al. 2014). Substitutions and more specifically 
causative SNPs have little impact on the number of shared k-mers, which 
explains the close similarity of Est-1 like and Col-0 like alleles. In summary, 
Est-1 like and Col-0 like alleles are distinct by numerous SNPs, however, are 
similar by structural variation. It has been posited that there is a latitudinal 
gradient in species richness within the geographic range of growth (Hillebrand 
2004). One longstanding hypothesis for the origin of the latitudinal richness 
gradient is the ‘‘biotic interactions hypothesis,’’ which posits that species 
interactions are stronger and more specialized at lower latitudes, promoting 
greater diversification rates and species richness (Schemske, Mittelbach et al. 
2009). Indeed such a latitudinal gradient seemed to be apparent when one 
hones into accessions marked as having Est-like ACD6 alleles. I plotted the 
geographical occurrence of each of these accessions with the corresponding 
lesion phenotype observed when they were grown in the lab (Figure 3.7). 
Based on this plot there were seemingly more diversified levels of ACD6 
hyperactivity in the accessions coming from the lower latitudes of A. thaliana 
geographic range. At the same time, a mild latitudinal gradient coinciding with 
increasing severity of lesions spanning from Portugal to Sweden could be 
observed.  
I constructed a simple 3D scatterplot for an initial overview of A. 
thaliana lesion phenotype dependent on latitude and k-mer based ACD6 allele 
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type. The plot also includes a plane overlay depicting the simple fitted 
relationship:  
Yi ~ Ai + Bi 
  where:  
  Yi = Lesion phenotype severity 
  Ai = Individual A. thaliana accession latitudinal coordinate  
  Bi = k-mer based allele type of tested gene 
This regression analysis showed that both ACD6 allele type (p=2.37E-06) and 
latitudinal coordinate (p=0.05) had significant correlation with the lesion 
phenotype severity (Figure 3.8). Taken together, an A. thaliana accession’s k-
mer based ACD6 allele type designation and latitudinal coordinate accounted 
for 33% (F-statistic 18.71, p-value: 2.76E-07) of the variation observed in the 
coordinate. Unlike in the ACD6 case, neither FLS2 nor PR1 allele type to 
exhibit appositeness with lesion development (Figure 3.8). Although more 
formal testing should be done, these results suggest that ACD6 alleles are 
distributed along a latitudinal gradient. 
 Substantiating these initial regression analyses, I fit all factorial 
information available, namely: ACD6 allele type, latitudinal coordinate from 
place of accession origin, longitudinal coordinate, and genetic (kinship) group 
designation (Genomes Consortium. Electronic address and Genomes 2016).  
The factorial information was modeled following this equation: 
Ai ~ Bi + Ci + Di + Ei 
where:  
  Ai = Lesion phenotype severity 
  Bi = k-mer based allele type of tested gene 
  Ci = Individual A. thaliana accession latitude coordinate  
  Di = Individual A. thaliana accession longitude coordinate 
  Ei = Individual A. thaliana accession genetic group designation 
 The sample included 72 accessions with confirmed lesion phenotypes 
(Table 3.2). The model that explained the most variance (44%) in the lesion 
phenotype observed was a linear model of lesion phenotype as a function of 
all the factorial information available (F-statistic, p-value 8.3E-07, variable p-
value 8.84E06, significance level 0.001). The model where the lesion 
phenotype was the direct consequence of ACD6 allele type accounted for 
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Figure 3.6 Distribution of Est-1 like ACD6 alleles and lesioning among A. thaliana 
accessions. A) Est-like ACD6 alleles color-coded based on the severity of the appearance of 
lesions (as shown in inset legend). B) Representative accessions for different lesion severity. 	
Figure 3.5 Interaction plot between the lesion phenotype, latitudinal coordinate and k-mer 
based gene similarity. A regression plane is plotted based on a fitted linear model where the 
lesion phenotype is the result of the linear combination between the accession’s latitudinal 
coordinate and the k-mer based gene similarity. 
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30.74% of the variation observed (Table 3.3). Furthermore, sequentially 
dropping out a factor for each linear model constructed, yielded ACD6 allele 
type as the most significant function that contributed to the lesion phenotype 
(Table 3.3). With this result, it seemed that an accessions lesion phenotype 
was significantly dependent on the ACD6 allele type. As with the regression 
analyses, I also tested the same models for lesion phenotype development in 
which ACD6 allele type was substituted for PR1 or FLS2 allele type. 
Comparable with the assumptions made from the 3D scatterplots, variance 
(10%) in lesion development given either an FLS2 or PR1 allele type could 
mostly be attributed to the latitudinal coordinate of the accessions tested 
(Table 3.4 and 3.5). The FLS2 full factorial model explained 16.2% of the 
variance observed (F-statistic, p-value 3.6E-02, variable p-value 8.4E03, 
significance level 0.01). As with FLS2, the PR1 full factorial model explained 
the most variance (17.36%) observed (F-statistic, p-value 2.6E-02, variable p-
value 0.0716, significance level 0.1). Unlike for ACD6, the lesion phenotype is 
not strongly correlated with an accession’s FLS2 or PR1 allele type.  
 Taking all these results together, it seems that lesion phenotype had a 
discernible dependence on latitudinal coordinates. However, it is clear that 
ACD6 allele type predominantly contributed to development of the lesion 
phenotype and not the other genes tested. 
3.1 Accessions with Est-like ACD6 alleles differ in lesion phenotypes 
The results from the previous sections confirmed Todesco and 
colleagues (2010) initial finding that there is variation in the expressivity of 
Est-like ACD6 alleles (Figure 3.7). Simultaneously grown and phenotyped at 
23°C LD, 10 of 102 accessions with an Est-like ACD6 allele did not show 
clear lesion (Figure 3.9). ACD6 activity in those accessions was modulated. 
Modulation could be an effect of either of intragenic, i.e. in ACD6 itself, or 
extragenic nature. Intragenic modifiers might render the protein inactive or 
perturb the normal protein function of Est-ACD6. Extragenic suppressors 
could either directly or indirectly interfere with ACD6-mediated response. The 
nature of these modulators of ACD6-dependent phenotypes present in the 
identified accessions were investigated and discussed in Chapter 4. 
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Figure 3.7 Accessions with an Est-like ACD6 allele but without obvious lesions. Insets are the 
control accessions: bordered green is Col-0 with non-hyperactive ACD6 allele; red bordered 
is Est-1 with a hyperactive ACD6 allele. 
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Table 3.3 Comparison of linear model fits for explaining lesion phenotype variation in 72 accessions using factorial information -- ACD6 allele type, 
geographical coordinates and genetic group 
Linear Model Variable having the significant effect 
% Variation 
Explained R-squared 
F-statistic, 
p-value 
Coefficients/va
riable 
Variable p-
value 
Significance 
level 
Ai = Bi + Ci + Di + Ei Allele type 44.1800 0.4418 8.3E-07 Intercept 0.034 * 
     B 8.84E-06 *** 
     C 0.089 . 
     D 0.783  
     E 0.537  
Ai = Bi + Ci + Di 
Allele type & an undefined 
factor 34.1000 0.3410 1.2E-06 Intercept 3.77E-02 * 
     B 2.57E-06 *** 
     C 1.01E-01  
     D 6.28E-01  
Ai = Bi + Ci 
Allele type, latitudinal 
vector and an undefined 
factor 
33.8800 0.3388 2.8E-07 Intercept 2.18E-02 * 
     B 2.37E-06 *** 
     C 5.04E-02 . 
Ai = Bi Allele type 30.7400 0.3074 1.7E-07 Intercept 2.04E-01  
     B 1.68E-07 *** 
Ai = Ci Latitudinal vector 10.1100 0.1011 5.1E-03 Intercept 5.81E-01  
     C 5.12E-03 ** 
Ai = Di An undefined factor 0.5698 0.0057 5.2E-01 Intercept <2e-16 *** 
     D 5.17E-01  
Ai = Ei An undefined factor 0.2555 0.0026 7.0E-01 Intercept <2e-16 *** 
     E 0.214  
Where: A – lesion phenotype, B – ACD6 allele type, C – latitudinal vector, D – longitudinal vector, and E – genetic/kinship group; Significance codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
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Table 3.4 Comparison of linear model fits for explaining lesion phenotype variation in 72 accessions using factorial information – FLS2 allele type, 
geographical coordinates and genetic group 
Linear Model Variable having the significant effect 
% Variation 
Explained R-squared 
F-statistic, 
p-value 
Coefficients/va
riable 
Variable p-
value 
Significance 
level 
Ai = Bi + Ci + Di + Ei Latitudinal vector 16.2000 0.1620 3.6E-02 Intercept 0.8959 
 
     
B 0.2684 
 
     
C 0.0084 ** 
     
D 0.8336 
 
     
E 0.2672 
 Ai = Bi + Ci + Di Latitudinal vector 12.0500 0.1205 2.5E-02 Intercept 0.703 
 
     
B 0.225 
 
     
C 0.0185 * 
     
D 0.9778 
 Ai = Bi + Ci Latitudinal vector 11.1800 0.1118 1.3E-02 Intercept 0.76869 
 
     
B 0.3511 
 
     
C 0.00633 ** 
Ai = Bi An undefined factor 3.4420 0.0344 1.1E-01 Intercept 7.82E-06 *** 
     
B 0.106 
 Ai = Ci Latitudinal vector 10.1100 0.1011 5.1E-03 Intercept 0.58141 
 
     
C 0.00512 ** 
Ai = Di An undefined factor 0.5698 0.0057 5.2E-01 Intercept <2e-16 *** 
     
D 0.517 
 Ai = Ei An undefined factor 0.2555 0.0026 7.0E-01 Intercept 5.31E-13 *** 
     
E 0.696 
 Where: A – lesion phenotype, B – FLS2 allele type, C – latitudinal vector, D – longitudinal vector, and E – genetic/kinship group; Significance codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
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Table 3.5 Comparison of linear model fits for explaining lesion phenotype variation in 72 accessions using factorial information – PR1 allele type, 
geographical coordinates and genetic group 
Linear Model Variable having the significant effect 
% Variation 
Explained R-squared 
F-statistic, p-
value 
Coefficients/vari
able 
Variable p-
value 
Significance 
level 
Ai = Bi + Ci + Di + Ei Latitudinal vector 17.3600 0.1736 2.6E-02 Intercept 0.2904 
 
     
B 0.1537 
 
     
C 0.0716 . 
     
D 0.6918 
 
     
E 0.2672 
 Ai = Bi + Ci + Di Latitudinal vector 12.4200 0.1242 2.2E-02 Intercept 0.3034 
 
     
B 0.1836 
 
     
C 0.0708 . 
     
D 0.8189 
 Ai = Bi + Ci Latitudinal vector 12.3500 0.1235 8.1E-03 Intercept 0.2757 
 
     
B 0.1759 
 
     
C 0.0653 . 
Ai = Bi None 0.8745 0.0087 4.2E-01 Intercept 0.176 
 
     
B 0.419 
 Ai = Ci Latitudinal vector 10.1100 0.1011 5.1E-03 Intercept 0.58141 
 
     
C 0.00512 ** 
Ai = Di An undefined factor 0.5698 0.0057 5.2E-01 Intercept <2e-16 *** 
     
D 0.517 
 Ai = Ei An undefined factor 0.2555 0.0026 7.0E-01 Intercept 5.31E-13 *** 
     
E 0.696 
 Where: A – lesion phenotype, B – PR1 allele type, C – latitudinal vector, D – longitudinal vector, and E – genetic/kinship group; Significance codes: 0 '***', 0.001 '**', 0.01 '*', 0.05 '.', 0.1 '.' 
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4 Responses associated with the modulation of 
ACD6 activity  
 
"Plant pathology has become a utilitarian science of vast possibilities." 
 - Joseph Charles Arthur. 
1904 
 
 
The fact that most plants appear healthy in an environment teeming with 
pathogens attests to plants’ capability and development of effective defense 
repertoires. 
Plant responses to pathogens generally progress from: 1) initial 
recognition of the pathogen, 2) a signaling cascade, often including 
hormones, to 3) broad transcriptional reprogramming for production of 
proteins to induce or repress key segments of the response pathway (Figure 
4.1). Parts of plant defense pathways can be appraised using specific assays.  
• To inspect pathogen recognition capability, a pathogen associated 
molecular pattern (PAMP) induced reactive oxygen species (ROS) 
production assay or direct pathogen-infection assays can be utilized.  
• Some surveys to gauge reactivity of the defense-signaling cascade 
include hormone level quantification, and MAPK (mitogen-activated 
protein kinase) activity assays.  
• Tests for downstream responses include: quantification of 
antimicrobial compounds, hypersensitive response severity, callose 
deposition and comprehensive growth changes (i.e. infection induced 
growth inhibition). Most importantly, differences in marker gene 
expression can be utilized to monitor each step of the reaction 
cascade. 
Mechanisms for fine-tuning the trade-off between defense and growth are yet 
to be exhaustively described. To this end, the case of the hyperactive Est-1 
ACD6 allele that strongly enhances resistance to a broad range of pathogens  
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Figure 4.1 A generalized illustration of plant defense. 	
Abbreviations: flg22 – flagellin 22; P/MAMPs – pathogen/microbe associated molecular 
patterns; PRR – pattern recognition receptor; ROS – reactive oxygen species; Avr – 
avirulence; MAP-kinase – mitogen associated protein kinase; EDS1 – ENHANCED DISEASE 
SUSCEPTIBILITY 1; PAD4 – PHYTOALEXIN DEFICIENT 1; NDR1 – NON-RACE SPECIFIC 
DISEASE RESISTANCE PROTEIN 1; SGT1b – SGT1 HOMOLOG b; HSP90 – HEAT 
SHOCK PROTEIN 90; RAR1 – REQUIRED FOR MLA1 RESISTANCE 1; NPR1 – 
NONEXPRESSER OF PR GENES 1; FRK1 – FLG22-INDUCED RECEPTOR KINASE; PR1 
– PATHOGENESIS RELATED GENE 1; ACD6 – ACCELERATED CELL DEATH 6; PTI – 
PAMP-triggered immunity; ETI – effector-triggered immunity. 
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while having a concomitant reduction in growth potential (Todesco, 
Balasubramanian et al. 2010) presents a useful case to supplement current 
knowledge. In this Chapter, I delve into the details of the ACD6-dependent 
trade-off between growth and defense with the aid of accessions that differ in 
expressivity of Est-like ACD6 alleles. The objectives for this chapter were: 
• To determine whether intragenic or extragenic modifiers are 
responsible for modulating hyperactive ACD6-dependent 
phenotypes, 
• To characterize the variation in the ACD6-dependent phenotypes 
such as rosette size differences, appearance of late-onset 
necrosis/lesions, and defense response activation (SA accumulation, 
PAMP-induced ROS production and marker gene expression).  
• To identify key pathways and candidate genes relevant for 
modulation of ACD6-dependent responses 
To accomplish these objectives I mainly tested the accessions Pro-0 
and Rmx-A180. For some assays I also included Bs-5 and Br-0, accessions 
that I identified later, which had Est-like ACD6 alleles but with modulated 
ACD6-dependent phenotypes. 
4.1 Pro-0 and Rmx-A180 have extragenic modifiers of ACD6-dependent 
phenotypes  
ACD6 hyperactivity in Est-1 is not due to gene expression differences 
(Todesco, Balasubramanian et al. 2010). Nonetheless, it is possible that some 
Est-like ACD6 alleles contain polymorphisms that will result in modifications of 
the gene expression profile of ACD6 or in a truncated protein that can 
ultimately perturb the downstream pathways. As shown in Figure 4.2, ACD6 
gene expression increased in all the genotypes (Est-1, Col-0 and Pro-0) 
tested as the plants aged. At the last stage of Est-1 development the increase 
in ACD6 level was more pronounced compared to Col-0 or Pro-0. High ACD6 
expression has been shown to activated expression of downstream gene PR1 
(Todesco, Balasubramanian et al. 2010). However, PR1 gene expression was 
concurrently induced only in Est-1(Todesco, Balasubramanian et al. 2010). 
Consistent with this, appearance of lesions was only apparent in Est-1. 
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Together, these findings show that the ACD6 allele of Pro-0 did not induce the 
defense response as in Est-1 despite encoding the causal amino acid 
changes for the hyperactivity of the ACD6-Est-1 allele. 
 
 
In order to test whether the ACD6-Pro-0 allele was suppressed due to 
an intragenic or extragenic mutation, I cloned the ACD6-Pro-0 allele and 
transferred it to either acd6-2 (an ACD6 T-DNA knockdown mutant) or Col-0 
(accession with a standard non-hyperactive ACD6 allele). The resulting 
transgenics had small rosette size, exhibited late-onset necrosis and had PR1 
levels comparable to Est-1 (Figure 4.3). Moreover, the transgenics had a 
higher PR1 gene expression compared to the wild type counterparts. I also 
cloned the ACD6-Rmx-A180 allele and had the same results as with the 
ACD6-Pro-0 allele (Figure 4.3). Both results show that when Est-like ACD6 
alleles from Pro-0 and Rmx-A180 that do not show phenotypic signs of ACD6  
Figure 4.2 ACD6 hyperactivity phenotypes are suppressed in Pro-0. A) Whole plant gene 
expression kinetics of ACD6 and PR1 from 6 to 40 days after sowing. B) Characteristic 
phenotypes of Col-0, Est-1 and Pro-0 at data collection endpoint (40 days after sowing). 
Below each plant are 6th leaf representatives corresponding to the accession shown above 
it. 
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hyperactivation are transferred into a different genetic background, the 
hyperactivity of the cloned ACD6 alleles does not seem to be blocked. 
I checked for sequence differences between ACD6-Est-1 and ACD6-Pro-0 
and found that ACD6-Pro-0 had a 957bp shorter 5’ UTR region (which 
included the promoter) than ACD6-Est-1 (Table 4.1, Figure 4.4A). To confirm 
that the differences in ACD6 activity in Est-1 and Pro-0 were not due to 
promoter differences, I made chimeras of the ACD6-Pro-0 and ACD6-Est-1 
alleles where 5’ region including the promoter were swapped. Exact details on 
the construction of the chimeras are shown in Table 4.2. The first half of the 
ACD6-chimera 1 (MZ34) included ACD6-Pro-0 genomic DNA sequence from 
1 bp - 4,073 bp (including the promoter region). The second half was 
composed of ACD6-Est-1 genomic DNA sequence 4,031 bp – 7986 bp. 
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Figure 4.3 Est-like ACD6 alleles from Pro-0 and Rmx-A180 are functional. Transformation 
into accession containing a non-hyperactive ACD6 allele (Col-0) and ACD6 T-DNA 
knockdown mutant (acd6-2) background unmasked suppression of the Pro-0 and Rmx-A180 
ACD6 alleles. A) Characteristic phenotype of the transgenics. B) Whole plant ACD6 and PR1 
relative gene expression in representative transgenics and the reference wild-type genotypes 
grown at 23°C at 40 DAS.  
Gene expression data for each genotype is from 3 biological replicates. Red asterisks 
indicate pairwise comparisons using t-tests with pooled SD, significant difference relative to 
acd6-2; p-value: **** < 0.0001 , *** < 0.001, ** < 0.005, *< 0.05.  
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ACD6-chimera 2 (MZ36) had the first part from ACD6-Est-1 genomic DNA 
truncated. The second half of ACD6-chimera 2 (MZ36) was from ACD6-Pro-0 
genomic DNA sequence 4,773 bp – 7030 bp (Figure 4.4A). Either chimera 
was functional in the T-DNA ACD6 knockdown mutant (acd6-2) and in Col-0, 
which has a standard ACD6 allele that does not cause lesions (Figure 4.4B 
and 4.4C). This showed that the despite being shorter the ACD6-Pro-0 
promoter region functioned similar to the Est-1 promoter region. The 3’ 
segment of ACD6-Pro-0 that contained the Est-like ACD6 hyperactivity causal 
amino acid changes, also worked the same as the ACD6-Est-1 3’ segment. 
 
Table 4.1 Pro-0 and Est-1 ACD6 genomic feature annotation 
Genomic DNA 
(gDNA) 
Coordinates (bp) Total  
Length 
(bp) 
5’ UTR 
(Promoter region) Gene body 3’ UTR 
ACD6-Pro-0 1-2585 2586-6271 6272-7030 7030 
ACD6-Est-1 1-3542 3543-7229 7230-7986 7986 
 
 
Table 4.2 Constructed ACD6-chimera’s genomic feature annotation  
Chimera 
1st half 2nd half 
Total 
Length 
(bp) 
Source 
genomic 
DNA 
Coordinates 
(bp) 
Source 
genomic 
DNA 
Coordinates 
(bp) 
ACD6-Chimera 1 
(MZ34) 
ACD6-
Pro-0 1-4073 
ACD6-
Est-1 4031-7986 8028 
ACD6-Chimera 2 
(MZ36) 
ACD6-
Est-1 1-5729 
ACD6-
Pro-0 4773-7030 7986 
 
 
Additional evidence supporting the functionality of ACD6-Pro-0 allele 
came from genotyping F2 individuals derived from a cross between Est-1 and 
Pro-0. At 4 weeks after sowing, the late-onset necrosis phenotype segregated 
in a 3:1 ratio in this F2 population, irrespective of the ACD6 allele type (Figure 
4.5). The extragenic nature of the ACD6 modulator could be inferred from the 
observation that some F2 individuals that had ACD6-Pro-0 allele exhibited 
marked late onset necrosis. Likewise, there were F2 individuals with a 
homozygous Est-1 ACD6 allele that did not show symptom of late-onset 
necrosis, even at 40 days after sowing. 
  
		 67 
 
5’ UTR (Promoter)
2585 bp
Gene body
3686 bp
3’ UTR
758 bp
ACD6-Pro-0
Fragment A Fragment B
5’ UTR (Promoter)
3542 bp
Gene body
3686 bp
3’ UTR
756 bp
ACD6-Est-1
Fragment C
Fragment D
Fragment A Fragment D
5’ UTR (Promoter)
2585 bp
Gene body
4687 bp
3’ UTR
756 bp
Pro-0
1-2585 bp
Pro-0
2586-4074 bp
Est-1
4031-7230 bp
Est-1
7230-7986
MZ34
ACD6-chimera 1
Fragment BFragment C
5’ UTR (Promoter)
3542 bp
Gene body
3688 bp
3’ UTR
758 bp
Est-1
1-3542 bp
Est-1
3543-5729 bp
Pro-0
4773-6271 bp
Pro-0
6272-7030 bp
MZ36
ACD6-chimera 2
Pro-0 Est-1
acd6-2 Col-0
acd6-2 + MZ34
acd6-2 + MZ36
Col-0 + MZ34
Col-0 + MZ36
0
1
2
3
4
5
6
C
ol
−0
Es
t−
1
ac
d6
-2
M
Z3
2
Pr
o−
0
ac
d6
-2
M
Z3
4
ac
d6
−2R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n ACD6
Genotype
****
****
****
****
****
C
ol
−0
Es
t−
1
Pr
o−
0
ac
d6
−2
−1
0
1
2
3
4
5
6 PR1
Genotype
ac
d6
-2
M
Z3
2
ac
d6
-2
M
Z3
4R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n ****
**** ****
A. B.
C.
Figure 4.4 The Pro-0 ACD6 allele is similar to the hyperactive Est-1 ACD6 allele with respect 
to production of ACD6-dependent phenotypes: late-onset necrosis and reduction in rosette 
size. Domain swaps between Est-1 ACD6 and Pro-0 ACD6 and transformation into ACD6 
null (Col-0) and knockdown (acd6-2) background unmasked suppression of the Pro-0 ACD6 
allele. A) Schematic representation of ACD6-Pro-0, ACD6-Est-1 and ACD6-chimera 
constructs genomic feature annotation. B) Characteristic phenotypes of Pro-0, Est-1, acd6-2 
and Col-0 compared to the ACD6-chimera transgenics. C) ACD6 and PR1 relative gene 
expression at 40 DAS in ACD6-chimera transgenics and the reference wild-type genotypes.  
Gene expression data for each genotype from 3 biological replicates. Red asterisks indicate 
pairwise comparisons using t-tests with pooled SD, significant difference relative to acd6-2; 
p.value: **** < 0.0001 , *** < 0.001, ** < 0.005, *< 0.05.  
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Furthermore, analysis of full length genomic Sanger sequencing results from 
both the Pro-0 and the Rmx-A180 ACD6 alleles did not reveal any SNPs that 
could cause the protein to be sufficient to block Est-1 ACD6 hyperactivity, 
moving Est-1 ACD6 into Pro-0 and Rmx-A180 background suggested the 
opposite (Figure 4.6). When transformed with Est-1 ACD6, primary Pro-0 and 
Rmx-A180 transformants (T1s) exhibited strong late-onset necrosis/lesions. 
Previous results by Rate et al. (1999) showed that ACD6-related phenotypes 
are dosage dependent. It is possible that transgene copy-number influenced 
the ACD6 phenotypes but this remains to be tested. It has been a recurring 
finding that expression levels of ACD6 are higher in transgenic lines, possibly 
independent from copy-number (Todesco, Balasubramanian et al. 2010). 
Taken together, these results show that Est-like ACD6 alleles in natural 
accessions are functional but do not result in Est-like late-onset necrosis due 
to the presence of extragenic modifiers.  
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Figure 4.5 Phenotypic and genotypic distribution in a subset of Pro-0 x Est-1 F2 individuals. 
ACD6 allele type and the late-onset necrosis phenotype do not co-segregate. 
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4.2 Phenotypic differences between Pro-0 and Rmx-A180 
After determining the modulators of ACD6 hyperactivity are extragenic, I 
proceeded to describe the phenotypic differences among the reference 
accession Col-0, the accessions having ACD6 suppressors (Pro-0 and Rmx-
A180) and the accessions with highly active ACD6 (Est-1 and acd6-1). As 
previously mentioned, the pronounced expression of defense responses 
conferred by a hyperactive ACD6 allele is associated with reduced growth. 
Phenotypes that were scrutinized were biomass (fresh weight), rosette 
diameter, rosette area, and the occurrence of late-onset necrosis/lesions. 
The gain-of-function acd6-1 line (Rate, Cuenca et al. 1999) was smaller 
than its background line, Col-0 (Figure 4.7). Moreover, knocking down ACD6 
in Est-1 increased plant size, as also previously shown by Todesco and 
colleagues (2010). While Pro-0 rosette size and weight were not altered when 
knocking down ACD6, amiR-ACD6 expression in Rmx-A180 increased plant 
size (Figure 4.7). These findings suggested that ACD6 activity in Pro-0 was 
differently modulated compared to Rmx-A180.  
 
 
Figure 4.6 Supplementing Rmx-A180 and Pro-0 with ACD6-Est-1 resulted in severely 
lesioned transgenic lines. A) Wildtype Rmx-A180 and Pro-0, B) T1 Rmx-A180 and Pro-0 
supplemented with ACD6-Est-1 and C) Wildtype Est-1. Plants were grown at 23°C short day 
conditions. Photograph was taken 40 days after sowing, Red arrows indicate leaves with HR-
like lesions. 
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 As late-onset necrosis/appearance of lesions has been used in 
previous studies as a phenotypic proxy for ACD6 hyperactivity, I examined the 
presence of such microscopic cell death on mature leaves of each of the lines 
exhibiting variable ACD6 hyperactivity. Trypan blue, a diazo dye that 
preferentially stains dead cells blue, was used to assess the amount of 
spontaneous cell death in Col-0, Est-1, Pro-0 and Rmx-A180, with or without 
amiR-ACD6. Other than Est-1, none of the other genotypes showed visible 
signs of lesions in their leaves (Figure 4.8). While Pro-0 and Rmx-A180 did 
not show macroscopically visible cell death patches, some leaves (usually the 
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Figure 4.7 ACD6-dependence of plant size in accessions with variable ACD6 activity. A) 
Fresh weight, rosette diameter and, rosette area in natural accessions and corresponding 
amiR-ACD6 transgenics. B) Representative 40 DAS rosette samples for each genotype 
grown at 23°C short-day conditions for the experiment.  
Data point for each genotype is from 8 biological replicates. Red asterisks indicate p-value 
from pairwise comparisons using t-tests, significant difference relative to the corresponding 
wild type; p-value: **** < 0.0001 , *** < 0.001, ** < 0.005, *< 0.05.  
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older ones) exhibited microscopical patches of stained cells. I could therefore 
confirm that knocking down ACD6 in Est-1 abolished late-onset necrosis/cell- 
death (Todesco, Balasubramanian et al. 2010), and that accessions with 
modulated ACD6 activity (Pro-0 and Rmx-A180) did not show the same leaf 
necrosis-related cell death (Figure 4.8). The Pro-0 amiR-ACD6 Trypan blue 
staining results support the inferences from macroscopic phenotyping. 
4.3 Pro-0 and Rmx-A180 differ in pathogen defense responses 
To elucidate how the balance between growth and defense is shifted in 
accessions with modulated ACD6 activity, I monitored characteristic defense 
activation features in Pro-0 and Rmx-A180. I investigated: 1) SA 
accumulation; 2) PAMP-induced (flg22) ROS response; 3) PTI and ETI as 
assayed by bacterial infection with a type-III secretion mutant Pseudomonas 
syringae pv. tomato DC3000 (Pst HrcC-) and Pseudomonas syringae p.v. 
maculicola ES4326, respectively; and 4) defense gene expression. 
4.3.1 SA accumulation in Pro-0 and Rmx-A180 
 To start-off with the assessment of the defense aspect of the trade-off 
in accessions with modulated ACD6, I quantified free salicylic acid (SA) and 
conjugated SA (measurements were done and made by University of 
Tübingen, ZMBP Analytics unit) from rosette samples of acd6-1, Col-0, Col-0 
amiR-ACD6, Est-1, Est-1 amiR-ACD6, Pro-0, Pro-0 amiR-ACD6, Rmx-A180 
and Rmx-A180 amiR-ACD6.  
 High SA-containing genotypes usually can mount a robust baseline 
defense (Yang, Ahammed et al. 2015, Chandra-Shekara, 2006 #1772). The 
total amount of SA of each of the tested genotypes differed significantly from 
each other. Similar to the Todesco et al. (2010) results, the gain-of-function 
mutant acd6-1 and hyperactive Est-1 had significantly higher levels of SA than 
the isogenic Col-0 or Est-1 amiR-ACD6. 
Compared to the other genotypes tested in this study, the hyperactive 
genotypes Est-1 and acd6-1 had the highest recorded free SA levels, which 
average at 40,000 ng SA / mg tissue (Figure 4.9A). Pro-0 had a very low 
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baseline SA content and knocking-down ACD6 did not significantly alter the 
SA content. On the other hand, total SA content increased when ACD6 was 
knocked down in Rmx-A180 (Figure 4.9).Although the SA content of amiR-
ACD6 Rmx-A180 was still only as much as Est-1 amiR-ACD6, removing 
ACD6 seemed to either alleviate suppression or activate SA production. 
Overall, these data suggest that ACD6 Est-like alleles affected SA 
accumulation differently depending on the genetic background. A strong effect 
of modulators on observed phenotypes are suggested by these results. 
Col-0 Wild-type
Est-1 Wild-type
Pro-0 Wild-type
Rmx-A180 Wild-type
80 μm
Rmx-A180 amiR-ACD6
Pro-0 amiR-ACD6
Est-1 amiR-ACD6
Col-0 amiR-ACD6
90 mm
Figure 4.8 ACD6-dependent necrotic lesions in the hyperactive ACD6 containing accession 
Est-1, but not in Pro-0 and Rmx-A180. 
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Figure 4.9 ACD6-dependence of SA content in unchallenged plants. A) Absolute and B) 
relative quantities of free SA. Relative quantities of conjugated SA C) glucoside 1 and D) 
glucoside 2.  
Data are from 10 biological replicates. Red asterisks indicate p-value from pairwise 
comparisons using t-tests, significant difference relative to the corresponding wild type; p-
value: **** < 0.0001 , *** < 0.001, ** < 0.005, *< 0.05.  
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4.3.2 flg22-induced ROS production and growth inhibition 
  ROS production is an indicator of immune responses. ROS 
accumulates when the PRR FLS2 detects the PAMP flg22 (Yi and Kwon 
2014). Relevant to my work, a recent study has shown that there is natural 
variation in ROS production in response to flg22 (Vetter, Kronholm et al. 
2012). 
I used a flg22-induced ROS assay and flg22-induced seedling growth 
inhibition to quantify each genotype’s competence for mounting an immune 
response. Supporting previous results by Vetter et al. (Vetter, Kronholm et al. 
2012), I found natural variation in flg22-induced ROS production across 
accessions. For the flg22-induced ROS production assay, I also included 
other accessions with putative ACD6 modifiers, Br-0 and Bs-5, and acd6-2. 
The speed and magnitude of the elicited response varied (Figure 4.10A). 
Clear patterns can be observed, namely acd6-2 had the least flg22-induced 
ROS produced and Rmx-A180 had a higher flg22-induced ROS response 
than Est-1 and acd6-1. Pro-0 had the lowest and slower response to flg22 
among all the accessions tested, except for the loss-of-function mutant acd6-
2.  
I tested ACD6-dependent flg22-induced ROS production by testing wild 
type and the corresponding amiR-ACD6 lines of Col-0, Est-, Pro-0 and Rmx-
A180 (Figure 4.10B, 4.10C, 4.10D, and 4.10E). These additional experiments 
confirmed that ROS production, in response to flg22, was suppressed upon 
ACD6 knockdown, except for Rmx-A180, which, similar to SA content, 
showed the opposite pattern of greater ROS production in the ACD6 
knockdown lines (Figure 4.10E). Measuring immediate ROS production after 
flg22 exposure provides a snap shot of early responses to PAMPs. I extended 
this experiment further by measuring the extent of growth inhibition upon 
prolonged flg22 exposure. For this assay, I included a flg22-insensitive mutant 
in Col-0 background, bak1-5 (Roux, Schwessinger et al. 2011, Schwessinger, 
Roux et al. 2011). This phosphorylation-impaired mutant cannot recruit 
specific phosphosites to activate flg22 recognition signaling components 
(Roux, Schwessinger et al. 2011). Growth inhibition differences between the 
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treated and un-treated samples were most obvious in the genotypes: bak1-5,  
Col-0, and Rmx-A180 (Figure 4.11). 
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Figure 4.10 Production of reactive oxygen species (ROS) in response to flg22. A) 
Differences among flg22-induced ROS production in wild type accessions and the Col-0 
mutants acd6-1 and acd6-2. ACD6-dependent production of reactive oxygen species (ROS) 
in response to flg22 in B) Col-0, C) Est-1, D) Pro-0 and Rmx-A180. 
Data are from 4 biological replicates. Error bars represent standard errors. The experiments 
were repeated 4 times with similar results. 
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4.3.3 PTI and ETI of representative genotypes with different ACD6 activities 
I used Pseudomonas syringae to determine PTI and ETI responses. 
Two virulent strains commonly used for research are Pseudomonas syringae 
pv. tomato DC3000 (Pst) and the Pseudomonas syringae pv. maculicola 
ES4326 (Psm), which will readily infect A. thaliana when infiltrated into 
intercellular space or applied to the leaf surface (Katagiri, Thilmony et al. 
2002, Staphnill 2009). The type-III secretion mutant Pseudomonas syringae 
pv. tomato DC3000 (Pst HrcC-) cannot deliver effectors, and is therefore 
useful for measuring PTI. I used Pseudomonas syringae p.v. maculicola 
ES4326 (Psm) to determine ETI. I favored using Psm over Pst since previous 
studies on ACD6 and disease resistance also used Psm (Ausubel, 
Glazebrook et al. 1993, Rate, Cuenca et al. 1999, Lu, Rate et al. 2003, Lu, 
Salimian et al. 2009, Wang, Seabolt et al. 2011). At the same time, Psm is a 
stronger inducer of the SA network sector than Pst (Wang, Mitra et al. 2008). 
A. thaliana R genes that have been shown to confer resistance to Psm 
include: RPM1, AT3G04210 and AT3G04220 (Ritter and Dangl 1995, 
Nimchuk, Marois et al. 2000, Preston 2000, Rant, Arraiano et al. 2013). 
I measured the progression of bacterial growth in genotypes inoculated 
with Psm from 12 to 72 hours after inoculation (Figure 4.12). For most of the 
genotype pairs tested, bacteria grew better on the amiR-ACD6 lines, 
confirming that ACD6 has a major role in controlling defense responses (Rate, 
Cuenca et al. 1999, Lu, Rate et al. 2003). The difference in ACD6-dependent 
bacterial growth was most significant in acd6-1, Est-1 and Pro-0. The 
difference in Pro-0 was like Est-1 and the hyperactive acd6-1 wherein 
silencing ACD6 increased pathogen growth. This shows that modulation of 
autoimmune symptoms in Pro-0 did not influence its capability to fight a 
pathogen attack.  
Psm growth in Rmx-A180, however, was only mildly affected by reduced 
ACD6 levels. This again pointed to Pro-0 and Rmx-A180 being affected by 
different modulators. The amiR-ACD6 had little effect in both Col-0 and Rmx-
A180 (Figure 4.12). This could either mean that the ACD6 pathway has 
reduced activity in both accessions, or that they can mount an incompatible  
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interaction that is not affected by the ACD6 pathway. In particular, Rmx-A180 
may have specific functional R-genes that could recognize specific effectors 
employed by Psm that are not found or do not function in the same way in the 
other genotypes I tested. 
A hypersensitive response (HR) characterized by localized cell death at 
the bacterial point of entry is another marker for the severity of infection. To 
support the bacterial colony counting results, I looked at 6th leaf HR severity 
72 hrs after infiltration in all the genotypes included in the Psm infection. I also 
utilized whole plant chlorophyll fluorescence imaging (CFI) for these plants, 
which provides a fast, precise and visual information on plant stress (Gorbe 
and Calatayud 2012). CFI at most detected patches of cells with 
compromised photosynthetic capacity (Figure 4.13). For the purpose of my  
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Figure 4.11 flg22-induced growth inhibition. 
Data are from 8 biological replicates. Error bars represent standard error. The experiment 
was repeated twice with similar results. Red asterisks indicate p-value from pairwise 
comparisons using t-tests, significant difference relative to bak1-5; black asterisks indicate 
significant difference from pairwise comparison between the wild type and the 
corresponding amiR-ACD6 transgenic line. p.value: **** <0.0001 , *** < 0.001, ** < 0.005, 
*< 0.05. 
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experiment the superior method was Trypan blue staining which, as 
mentioned earlier, differentially stains collapsed dead cells blue. Overall 
Trypan blue results show that all the infected genotypes developed HR. Col-0, 
Rmx-A180 and their transgenic amiR-ACD6 counterparts had the least 
amount of dead cell patches. Knocking-down ACD6 dampened the HR 
response to bacterial infection, as seen in the decrease of dead cell patches 
of infected amiR-ACD6 lines (Figure 4.13B). Whilst Pro-0 and Rmx-A180 
have modulated ACD6 responses, HR was still apparent after Psm infection.  
Figure 4.12 Psm pathogenicity test. A) Bacterial colony counts at 24 hrs, B) 48 hrs, C) 72 hrs 
after infiltration. 
Data are from 4 biological replicates. The experiment was repeated 2 times with similar 
results. Red asterisks indicate p-value from pairwise comparisons using t-tests, significant 
difference relative to Col-0; black asterisks indicates significant difference from pairwise 
comparison between the wild type and the corresponding amiR-ACD6 transgenic line. 
p.value: **** <0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
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This suggested that despite the modulated ACD6 responses, Pro-0 and Rmx-
A180 could maintain defense responses during bacterial infection.In addition, 
HR was more severe in Pro-0 amiR-ACD6 and Rmx-A180 amiR-ACD6 than 
Est-1 amiR-ACD6, pointing to a non-ACD6 factor present in Pro-0 and Rmx-
A180 that is causal for HR response during bacterial infection. A 
hypersensitive response (HR) characterized by localized cell death at the 
bacterial point of entry is another marker for the severity of infection. To 
support the bacterial colony counting results, I looked at 6th leaf HR severity 
72 hrs after infiltration in all the genotypes included in the Psm infection. I also 
utilized whole plant chlorophyll fluorescence imaging (CFI) for these plants, 
which provides a fast, precise and visual information on plant stress (Gorbe 
and Calatayud 2012). 
Col-0 Wild-type
Est-1 Wild-type
Pro-0 Wild-type
RmxA180 Wild-type RmxA180 amiR-ACD6
Pro-0 amiR-ACD6
Est-1 amiR-ACD6
Col-0 amiR-ACD6
Pst maculicola ES4326Mock Pst maculicola ES4326Mock
80 μm
B.
64 mm
A.
Pst maculicola ES4326Mock Pst maculicola ES4326Mock
Col-0 Wild-type
Est-1 Wild-type
Pro-0 Wild-type
RmxA180 Wild-type
Figure 4.13 Psm induces ACD6-dependent lesions. A) Chlorophyll fluorescence images of 
mock and Psm sprayed plants with varying ACD6 hyperactivity; red arrows indicate patches 
of dead cells; B) Representative Trypan blue stained 6th leaf of mock and Psm infiltrated 
plants. 
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 CFI at most detected patches of cells with compromised photosynthetic 
capacity (Figure 4.13). For the purpose of my experiment the superior method 
was Trypan blue staining which, as mentioned earlier, differentially stains 
collapsed dead cells blue. Overall Trypan blue results show that all the 
infected genotypes developed HR. Col-0, Rmx-A180 and their transgenic 
amiR-ACD6 counterparts had the least amount of dead cell patches. 
Knocking-down ACD6 dampened the HR response to bacterial infection, as 
seen in the decrease of dead cell patches of infected amiR-ACD6 lines 
(Figure 4.13B). Whilst Pro-0 and Rmx-A180 have modulated ACD6 
responses, HR was still apparent after Psm infection. This suggested that 
despite the modulated ACD6 responses, Pro-0 and Rmx-A180 could maintain 
defense responses during bacterial infection. In addition, HR was more 
severe in Pro-0 amiR-ACD6 and Rmx-A180 amiR-ACD6 than Est-1 amiR-
ACD6 pointing to a non-ACD6 factor present in Pro-0 and Rmx-A180 that is 
causal for HR response during bacterial infection. 
 I tested PTI capacity using Pst HrcC-. Compared to Psm, bacterial 
growth of Pst HrcC-, on average, stayed at a low bacterial titer of 1.5 Log cfu 
mL-1 (Figure 4.14). These lower bacterial titers suggest that all the genotypes 
tested have the necessary factors to mount Pseudomonas-associated PTI. 
Knocking-down ACD6 in Rmx-A180 resulted in a significant increase in PTI 
(Figure 4.14). This reinforces the results from the flg22-induced ROS 
production assay, and SA quantification results. Knocking down ACD6 in 
Rmx-A180 induced parts of the pathogen response pathway. Another notable 
result is the strong ACD6-dependency of PTI response in Pro-0 (Figure 4.14).  
4.3.4 ACD6-dependent marker gene expression 
 Through assaying changes in gene expression of these genes I aimed 
to determine which sections of the ACD6 pathway were blocked in Pro-0 and 
Rmx-A180. Different genes of the known immune response pathways (Feys 
and Parker 2000, Asai, Tena et al. 2002, Azevedo, Betsuyaku et al. 2006, Lu, 
Salimian et al. 2009, Ng, Seabolt et al. 2011, van Verk, Bol et al. 2011, 
Seyfferth and Tsuda 2014, Herrera-Vasquez, Salinas et al. 2015), as 
consolidated in Figure 4.15, were tested for gene expression differences  
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among the accessions and two mutants, acd6-1 (Col-0) and eds1-5 (Ws-0) 
using reverse transcription of mRNAs followed by quantitative real-time PCR 
(qRT-PCR). eds1-5 is an EDS1 (lipase-like protein positively regulating SA 
accumulation and R-gene mediated defense responses) mutant, in the 
background of the Ws-0 accession (Falk, Feys et al. 1999). This mutant is 
hypersusceptible to pathogens, has very low PR1 expression and 
accumulates low SA amounts (Falk, Feys et al. 1999). Parts of the overall 
pathway I tested can be divided in to four sets: 
• Set A included ACD6 (Todesco, Balasubramanian et al. 2010) and 
known ACD6-related marker genes, PR1 (Lu, Rate et al. 2003), 
FLG22-INDUCED RECEPTOR-LIKE KINASE 1/ SENESCENCE-
Figure 4.14 PTI response after infection with Pst HrcC-. A) Bacterial colony counts at 24 hrs, 
B) 48 hrs after infiltration.  
Data are from 4 biological replicates. The experiment was repeated 2 times with similar 
results. Red asterisks indicate p-value from pairwise comparisons using t-tests, significant 
difference relative to Col-0; black asterisks indicates significant difference from pairwise 
comparison between the wild type and the corresponding amiR-ACD6 transgenic line. 
p.value: **** <0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
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INDUCED RECEPTOR-LIKE KINASE (FRK1/SIRK1) (Zhang, 
Shrestha et al. 2014, Zheng, McLellan et al. 2014) and 
SENESCENCE-ASSOCIATED GENE 12 (Morris, Mackerness et al. 
2000, Todesco, Balasubramanian et al. 2010);  
• Set B contained signal-transduction genes: WRKY 
TRANSCRIPTION FACTOR 29 (Yi, Shirasu et al. 2014), WRKY 
TRANSCRIPTION FACTOR 46 (WRKY46) (van Verk, Bol et al. 
2011), and NONEXPRESSOR OF PR GENES 1 (NPR1) (Vanacker, 
Lu et al. 2001, Wang, Amornsiripanitch et al. 2006, Hu, Dong et al. 
2012)  
• Set C included type II SA accumulation genes ENHANCED 
DISEASE SUSCEPTIBILITY 1 PROTEIN (EDS1), PHYTOALEXIN 
DEFICIENT 4 (PAD4), (Aarts, Metz et al. 1998, Feys and Parker, 
#200, Dong 2001, Shapiro and Zhang 2001, Lu, Rate et al. 2003, 
Venugopal, Jeong et al. 2009, Ng, Seabolt et al. 2011). Type II SA 
genes encode proteins that do not act directly as SA biosynthetic 
enzymes but directly feed to the SA pathway (Ng, Seabolt et al. 
2011).  
• Set D was composed of genes contributing to resistance protein 
accumulation, namely: NONRACE-SPECIFIC FOR DISEASE 
RESISTANCE 1 (NDR1) (Aarts, Metz et al. 1998) and PROTEIN 
SGT1 HOMOLOG B/ ENHANCED DOWNY MILDEW 1 / 
ENHANCER OF TIR-1 AUXIN RESISTANCE 3 / SUPPRESSOR OF 
G2 ALELLE OF SKP1 HOMOLOG B (AtSGT1b/ EDM1/ETA3/RPR1) 
(Azevedo, Betsuyaku et al. 2006). 
 
Assayed gene expression levels for set A is shown in Figure 4.16. At 4 
weeks after sowing, ACD6 was expressed in the whole rosette of most of the 
genotypes tested at a level comparable to Est-1, except in Col-0 and eds1-5. 
The highest amount of transcript was measured in acd6-1. This experiment 
also confirmed that the transgenics I used for the experiment had ACD6 
expression knocked down as expected. ACD6 expression in eds1-5 was 
similarly low as in the ACD6 knockdown plants. PR1 expression was high only 
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in Est-1 and acd6-1. As discussed earlier, high ACD6 expression does not 
necessarily translate into high PR1 expression. SAG12 was only elevated in 
acd6-1 and Est-1. This indicated that the part of the lesion phenotype 
observed in both these genotypes could be due to age-dependent 
senescence (Gan and Amasino 1997).  
 
Figure 4.15 Interconnections of genes implicated in the ACD6 immune response pathway. 
Highlighted are selected genes that were tested for relative gene expression and can be 
classified as: [A] key marker genes (including ACD6), [B] signal transducers, and [C] type II 
SA accumulation genes. 
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Considering these known functions, the significantly higher FRK1 expression 
in the Rmx-A180 amiR-ACD6 plants suggests that down-regulation of ACD6 
in Rmx-A180 mimics flg22 activated defense responses. The opposite SAG12 
and FRK1 profiles imply that the developmental senescence signal through 
WRKY6 for FRK1 expression was likely blocked (Figure 4.16).  
 WRKY transcription factors are involved in plant defense responses to 
biotrophic and necrotrophic pathogens. The activation of MAP kinase 
Figure 4.16 Relative expression of key marker genes in accessions with varying ACD6 
activity and mutant genotypes, acd6-1 (Col-0) and eds1-5 (Ws-0), as measured by qRT-PCR.  
Data are from 4 biological replicates, normalized to the Col-0 values. For transgenics, 
biological replicates are from four different individuals of the T1 generation. Red asterisks 
indicate p-value from pairwise comparisons using t-tests, significant difference from pairwise 
comparison between the wild type and the corresponding amiR-ACD6 transgenic line. 
p.value: **** <0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
	 85 
pathways upon recognition of the PAMP flg22 by its cognate receptor FLS2 
leads to the transcription of defense-related genes through WRKY 
transcription factors like WRKY22/29 (Cheng, Gao et al. 2013). WRKY46 was 
shown to specifically induce salicylic acid and pathogen defense in such a 
way that plants over-expressing WRKY46 were more resistant to 
Pseudomonas syringae (Hu, Dong et al. 2012). NPR1 is central for SA-
dependent activation of defense response genes, encoding an SA receptor 
(Wu, Zhang et al. 2012). In all backgrounds, ACD6 knockdown led to 
increased expression of WRKY29 (Figure 4.17). In contrast, ACD6 
knockdown reduced WRKY46 expression in Col-0, Est-1 and Pro-0, but 
induced it in Rmx-A180 (Figure 4.17). NPR1 expression was low and highly 
variable, and therefore difficult to assess. A trend could be seen, with Col-0 
behaving opposite of Est-1 when ACD6 was knocked down. 
 
	
Figure 4.17 Relative expression of defense signal transduction genes in accessions with 
varying ACD6 activity and mutant genotypes acd6-1 (Col-0) and eds1-5 (Ws-0), as measured 
by qRT-PCR.  
Data are from 4 biological replicates, normalized to the Col-0 values. For transgenics, 
biological replicates are from four different individuals of the T1 generation. Red asterisks 
indicate p-value from pairwise comparisons using t-tests, significant difference from pairwise 
comparison between the wild type and the corresponding amiR-ACD6 transgenic line. 
p.value: **** <0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
 	
 The set C gene expression levels are shown in Figure 4.18. I 
separated them from the transcription factor gens owing to their more diverse 
functional roles. Both PAD4 and EDS1 function in resistance (R) gene-
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 The set C gene expression levels are shown in Figure 4.18. I 
separated them from the transcription factor gens owing to their more diverse 
functional roles. Both PAD4 and EDS1 function in resistance (R) gene-
mediated and basal plant disease resistance. Association of these two lipase-
like proteins has been shown to be necessary for SA accumulation (Rietz, 
Stamm et al. 2011). On the other hand, even though both proteins are 
required by the same set of R-genes, they fulfill distinct roles in mounting a 
defense response (Feys and Parker 2000). Between EDS1 and PAD4, only 
EDS1 is essential for amplification of the hypersensitive response. PAD4 is 
recruited later in the amplification of plant defense responses (Rietz, Stamm 
et al. 2011). 
 Opposite to what I expected, ACD6 knockdown primarily affected 
expression of PAD4 and not EDS1 (Figure 4.18). PAD4 levels were increased 
in Col-0 amiR-ACD6 and Rmx-A180 amiR-ACD6. The pattern was opposite 
for Est-1 and Pro-0. An obvious effect on EDS1 expression could only be 
seen in the controls acd6-1 and eds1-5. EDS1 expression was highly variable, 
making it harder to infer much from EDS1 expression differences.  
	
Figure 4.18 Relative expression of type II SA accumulation genes in accessions with varying 
ACD6 activity and mutant genotypes acd6-1 (Col-0) and eds1-5 (Ws-0), as measured by 
qRT-PCR.  
Data are from 4 biological replicates, normalized to the Col-0 values. For transgenics, 
biological replicates are from four different individuals of the T1 generation. Red asterisks 
indicate p-value from pairwise comparisons using t-tests, significant difference from pairwise 
comparison between the wild type and the corresponding amiR-ACD6 transgenic line. 
p.value: **** <0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
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 NDR1, shown by Shapiro and Zhang (Shapiro and Zhang 2001) to 
mediate the induction of SA through the production of reactive oxygen species 
(ROS), is responsive to a different set of R-genes than EDS1. RPS2, RPM1 
and RPS2, all R-loci that require NDR1, operate independently of EDS1 
(Aarts, Metz et al. 1998). Consistent with different upstream inputs, trends of 
NDR1 and EDS1 levels differed among the genotypes I tested. Knocking 
down ACD6 increased NDR1 expression in Col-0 and Rmx-A180 and lowered 
it in Est-1 and Pro-0 (Figure 4.19). The opposite changes in Pro-0 and Rmx-
A180 further reinforce the hypothesis that ACD6 response is differently 
modulated in these two genotypes. Moreover, given there is a strong 
distinction in the effect of ACD6 knockdown on NDR1 transcript levels makes 
it possible that CC-NBS-LRR’s could be a point of modulation in these two 
genotypes. 
	
Figure 4.19 Relative expression of genes contributing to resistance protein accumulation in 
accessions with varying ACD6 activity and mutant genotypes acd6-1 (Col-0) and eds1-5 (Ws-
0), as measured by qRT-PCR.  
Data are from 4 biological replicates, normalized to the Col-0 values. For transgenics, 
biological replicates are from four different individuals of the T1 generation. Red asterisks 
indicate p-value from pairwise comparisons using t-tests, significant difference from pairwise 
comparison between the wild type and the corresponding amiR-ACD6 transgenic line. 
p.value: **** <0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
 
Although not highly significant, there were indications, at least in Col-0 
and Est-1 that gene expression of SGT1b was upregulated upon ACD6 
knockdown (Figure 4.19). Rmx-A180 amiR-ACD6 showed a predisposition to 
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reduced SGT1b expression in Pro-0 amiR-ACD6 may have been due to the 
difference in the modulation factor that perturbed the usual ACD6 defense 
response pathway. 
In acd6-1, most of the marker genes were significantly higher expressed 
compared to any of the other genotypes analyzed (Figures 4.17, 4.18 and 
4.19). On the other hand, the hypersusceptible mutant, eds1-1, had the lowest 
transcript levels for most the genes tested except WRKY29.  
From all these results I infer some key generalizations for the reaction 
cascade contributing to ACD6 activity. Upon ACD6 knockdown, a general de-
repression of key markers for the plant immune reactions was observed in 
Col-0 and Rmx-A180. The opposite was noticeable in Est-1 and Pro-0 (except 
for WRKY29). I hypothesize that in certain situations (i.e. upon pathogen 
challenge of Rmx-A180), ACD6 can act as a sensor for immune activity, 
bringing about activation of key response pathways.  
4.4 Conclusions regarding differences between Pro-0 and Rmx-A180 
The phenotypic assays and gene expression assays showed that Pro-0 
and Rmx-A180 are equipped with different defense repertoires that result in 
varying responses to induced pathogen attacks.  
Pro-0 partly resembled Est-1-type immune response without the adverse 
negative effects of an autoimmune version of ACD6. This pushes forward the 
idea that an extragenic factor, which could be the Pro-0 modulator, is partly 
balancing the negative effect of having a hyperactive ACD6 allele. Pro-0 does 
not exhibit unregulated cell death, and dwarfism. Despite being suppressed, 
not having high basal SA levels and strong flg22-induced ROS production, 
ACD6-Pro-0 does not seem to be completely inactive as shown by Psm and 
Pst HrcC- infection results. Rmx-A180 presented unconventional defense and 
growth response changes upon ACD6 knockdown. These peculiarities 
included up-regulated SA production, elevated PAMP-induced ROS 
production and up-regulated FRK1, PAD4, WRKY46 and NDR1 gene 
expression. This further supports the idea that RmxA-180 ACD6-dependent 
responses are modulated differently compared to Pro-0. Rmx-A180 may be 
equipped for a specific induced defense response that could be activated and 
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is detected by a modification or down-regulation of ACD6. These results can 
also fit in a hypothesis that the modifier guards ACD6, in accordance with the 
guard-guardee/decoy model (van der Hoorn and Kamoun 2008); without the 
functional removal (as in knocking down) of ACD6, the modifier could be 
inactive, therefore completely suppressing hyperactive ACD6 effects. Either 
the “activated” modifier itself or another component that is activated by the 
modifier could be causal for activation of downstream Rmx-A180 defense 
responses and only activated when the modifier detects ACD6 degradation or 
modification.  
A more straightforward answer to what happens in Rmx-A180 or Pro-0 
during defense response could be obtained once the modifier has been 
identified. Efforts to identify and pinpoint the modifier gene/s present in 
accessions with modulated ACD6-dependent phenotypes are discussed in 
Chapter 5. All in all, the results of this chapter depict that hyperactivated 
defense responses can be modulated to minimize the compromise made 
towards growth. 
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5 A diverse set of genetic modifiers of ACD6 
responses 
  
“Certain students of genetics inferred that the Mendelian units responsible for 
the selected character were genes producing only a single effect. This was 
careless logic. It took a good deal of hammering to get rid of this erroneous 
idea. As facts accumulated it became evident that each gene produces not a 
single effect, but in some cases a multitude of effects on the characters of the 
individual. It is true that in most genetic work only one of these character-
effects is selected for study—the one that is most sharply defined and 
separable from its contrasted character—but in most cases minor differences 
also are recognizable that are just as much the product of the same gene as 
is the major effect.” 
-Thomas Hunt Morgan, 1935 
 
 
Plants of the same species vary in both distinct and subtle ways. This 
difference in the manifested trait (phenotype) is due to an environmental 
influence and the concomitant underlying genetic basis (genotype). Based on 
our understanding of genetics and inheritance, the complexity of these 
phenotypes can arise from a single gene variation or from the segregation of 
alleles at many interacting loci (quantitative trait loci). To identify loci and 
specific alleles that control the apparent phenotypic variation, a forward 
genetic approach like quantitative trait loci (QTL) analysis can be utilized. In 
this approach parents characterized by opposite phenotypes are crossed and 
their offspring is self-fertilized; resulting generation (mapping population; F2) is 
genotyped and phenotyped. Statistical methods are applied to uncover 
association between phenotype and genotypes of molecular markers across 
genome. 
Usually the probability of observing a particular allele in a given locus is 
independent of an allele observed at another locus. That simplifies finding an 
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association between a single genetic marker and a phenotype. There are also 
cases however, when a specific trait results from a corresponding interaction 
between alleles and the magnitude of their respective effects contributes to 
the phenotype observed. These interacting alleles can be at different regions 
of the genome or be at direct physical linkage. As long as there are reliable 
genetic markers for each locus that co-segregates with the trait being 
measured, a probable chromosomal location of the allele governing the 
phenotype can be identified. One can use either simple or more elaborate 
statistical techniques for the calculations, depending on the complexity of a 
trait being studied. It is also prudent to note that the manifestation of a trait is 
not purely based on the genetic component. Phenotypes are dependent on 
environmental condition. It is therefore important to measure the phenotype in 
mapping population in the condition conducive for exposing relevant traits and 
to keep these conditions constant.  
Once a localized chromosomal region is identified, fine mapping that 
involves genotyping recombinants of the mapping population can be used for 
the analysis to narrow down the list of candidate genes controlling the trait. 
One can directly employ reverse genetics approaches when a reasonably 
narrow mapping interval is attained. Reverse genetic approaches like 
transgenic techniques in a reciprocal background can be employed to confirm 
candidate genes. With these techniques, sufficiency and necessity tests can 
be conducted to pinpoint causality and feasible mechanisms of genes 
controlling the trait/s being studied.  
This Chapter of the thesis presents the results from the efforts to find 
genes that modify the expression of Est-like ACD6 alleles. I focused on four 
accessions, Pro-0, Rmx-A180, Bs-5 and Br-0, that have Est-like ACD6 alleles 
but do not show the ACD6-dependent lesion phenotype. 
5.1 The genetic basis of ACD6 modulation 
5.1.1 Dominance behavior of ACD6 modifier loci 
The response to various pathogen type challenges had suggested 
different causes for the modification of the ACD6-Est effect in Pro-0 and Rmx-
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A180. To determine whether this difference was genetic, I crossed Pro-0 and 
Rmx-A180 as well as Bs-5 and Br-0 and Est-1 to each other, and examined 
the F1 progeny of each cross for the presence of lesions characteristic for Est-
1 (Todesco, Balasubramanian et al. 2010). The expected outcomes in the F1 
progeny based on different dominance behavior are shown in Figure 5.1 and 
Figure 5.2. The F1 progeny from crosses of the four suppressed accessions to 
Est-1 was intermediate in phenotype, pointing to modifiers being semi-
dominant.  Intercrosses among the suppressed accessions also resulted in 
mildly lesioned F1 progeny (Figure 5.3), suggesting that most of the modifiers 
are unique to each accession.  
 
	
Figure 5.1 Expected phenotypes and underlying genotypes based on different dominance of 
modifier genes in accessions with Est-like ACD6. Shown are anticipated results from crosses 
of lesioned Est-1 and a non-lesioned accession such as Rmx-A180 when A) modifier exerts 
complete dominance; B) modifier is semi-dominant and; C) modifier is recessive. 
A.
B.
C.
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Figure 5.2 Expected phenotypes and underlying genotypes based on similarity and 
dominance of modifier genes in accessions with suppressed effects of Est-1-like ACD6, such 
as Pro-0 and Rmx-A180, when A) modifier is locus/i is either dominant or recessive and 
similar between Pro-0 and Rmx-A180; B) modifier is dominant and different between Pro-0 
and Rmx-A180; C) modifier is dominant and different between Pro-0 and Rmx-A180 and D) 
modifier is recessive and different between Pro-0 and Rmx-A180. 	
5.1.2 Phenotypic segregation of ACD6 modulation 
 I next constructed mapping populations for each suppressed 
accession, by selfing F1 progeny obtained from the crosses with Est-1. The F2 
individuals from each cross were expected to have the same Est-1 like 
“hyperactive” ACD6 allele but to segregate for modifier locus/i. Segregation 
ratios in the F2 mapping populations were utilized to assess the genetic 
architecture of modifier alleles. A total of 403 (Pro-0/Est-1), 270 (Rmx-
A180/Est-1), 255 (Bs-5/Est-1) and 243 (Br-0/Est-1) F2 individuals were 
phenotyped for the development of HR-like lesions at 5 weeks (Table 5.1).  
 The lesion phenotype was still the trait chosen for genetic mapping 
because it was more robust than other ACD6-dependent phenotypes, such as 
size and leaf initiation rate. Classification of HR in F2 individuals was as 
follows: Est-like (severely lesioned), F1-like (mildly lesioned) and modified 
(non-lesioned). Representative phenotypes from the Pro-0/Est-1 population 
A.
B.
C.
D.
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Figure 5.3 F1 individuals from intercrossing accessions with suppressed ACD6-Est activity, 
showing that modifiers are semi-dominant and not completely shared. Orange boxes indicate 
F1 progeny and red arrows late-onset necrosis symptoms.	
 
are shown in Figure 5.4. Assuming that the Est-like ACD6 alleles in the 
modulated accessions are not genetically distinct from ACD6-Est-1, the lesion 
phenotype segregation in the F2 populations analyzed should be due to 
segregation of modifier locus/i in the F2 individuals. The phenotypic 
segregation would remain the same if the modifier locus/i is linked to ACD6 
and therefore both modifier and ACD6 would segregate together. With these 
scenarios a semi-dominant lesion phenotype controlled by a single gene 
predicts a segregation ratio of 1:2:1 of lesioned, mildly lesioned and non-
Est-1
Est x Pro F1
Pro-0 RmxA180
Bs-5 Br-0
Pro x Bs F1 Rmx x Br F1
Est x Rmx F1
Est x Bs F1 Est x Br F1
Pro x Rmx F1
Pro x Br F1 Rmx x Bs F1
Bs x Br F1
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are shown in Figure 5.4. Assuming that the Est-like ACD6 alleles in the 
modulated accessions are not genetically distinct from ACD6-Est-1, the lesion 
phenotype segregation in the F2 populations analyzed should be due to 
segregation of modifier locus/i in the F2 individuals. The phenotypic 
segregation would remain the same if the modifier locus/i is linked to ACD6 
and therefore both modifier and ACD6 would segregate together. With these 
scenarios a semi-dominant lesion phenotype controlled by a single gene 
predicts a segregation ratio of 1:2:1 of lesioned, mildly lesioned and non-
lesioned individuals. This proposed segregation ratio did not fit the Pro-0/Est-
1, Rmx-A180/Est-1 or Bs-5/Est-1 F2 populations (Table 5.1). The phenotypic 
scoring adapted was only semi-quantitative and prone to bias of the person 
doing the scoring. Using a quantitative assay such as ion leakage could in 
future potentially circumvent this problem. 
                             	
Figure 5.4 Phenotypic scale adapted for grouping F2 individuals from the F2 populations used 
in the study. Shown are representative F2 individuals from the Pro-0/Est-1 population. Red 
arrows indicate leaves that showed late-onset necrosis symptoms. 
 
15 mm
Lesioned F2 individuals
Mildly lesioned F2 individuals
Non-lesioned F2 individuals
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Table 5.1 Phenotypic segregation of Est-like ACD6 modifier-loci mapping populations phenotyped at 40 days after sowing and the corresponding goodness-
of-fit to 1:2:1 segregation ratio. 
1 Number of individuals analyzed for the F2 population 
 
 
Table 5.2 Phenotypic segregation of Est-like ACD6 modifier-loci mapping populations phenotyped at 40 days after sowing and the corresponding goodness-
of-fit to 3:1 segregation ratio. 
1 Number of individuals analyzed for the F2 population 
F2 population N1 
Observed Expected ratio 
χ2 Test 
Statistic 
P-value χ2 Crit Sig 
Est-like F1-like 
Non-
lesioned 
Est-like F1-like 
Non-
lesioned 
Pro-0/Est-1  403 238 86 79 100 203 100 262.28 1.11-57 5.99 yes 
Rmx-A180/Est-1 270 71 161 38 68 137 68 17.57 1.53-4 5.99 yes 
Bs-5/Est-1  255 160 77 18 63 129 63 202.45 1.09-44 5.99 yes 
Br-0/Est-1 243 87 94 62 61 121 61 17.12 1.91-4 5.99 yes 
F2 population N1 
Observed Expected χ2 Test 
Statistic 
(df=1) 
P-value χ2 Crit Sig 
Lesioned  
Non-
lesioned 
Lesioned  
Non-
lesioned 
Pro-0/Est-1  403 324 79 303 100 5.87 1.54-02 3.84 yes 
Rmx-A180/Est-1 270 232 38 205 68 16.79 4.17-05 3.84 yes 
Bs-5/Est-1  255 237 18 192 63 42.69 6.41-11 3.84 yes 
Br-0/Est-1 243 181 62 182 61 0.02 8.82-01 3.84 no 
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There also seemed to be an age-related progression of the lesion phenotype 
such that at around week 6 after sowing previously non-lesioned F2 
individuals developed mild lesions. An example of age-related progression of 
the lesion phenotype that affected phenotypic segregation in representative F2 
individuals from the Pro-0/Est-1 F2 population is shown in Figure 5.5. With 
these discrepancies, I was not confident in the distinction between severely 
lesioned and mildly lesioned F2 individuals. I then opted to target causal locus 
responsible for lesion suppression by the 5th week of growth. I did a second 
goodness-of-fit test for a 3:1 lesioned and non-lesioned segregation ratio. For 
this I bulked the severely lesioned and mildly lesioned into one lesioned 
phenotypic class. A 3:1 segregation ratio still did not fit the Pro-0/Est-1, Rmx-
A180/Est-1 or Bs-5/Est-1 F2 populations (Table 5.2). Only Br-0/Est-1 F2 
observed segregation ratios fit the expected 3:1 segregation ratio. This implied 
that there is possibly more than one locus responsible for suppression of HR-
like lesions in the accessions with modified ACD6 activity.  
	
Figure 5.5 Age-dependent progression of the ACD6-dependent lesion phenotype in the Pro-
0/Est-1 F2 population used in the study. 
5.1.3 QTL mapping of ACD6 modifiers 
I mapped causal loci for ACD6-Est modifiers through RAD-Seq 
genotyping of F2 individuals. I used Pst-1/Mse-1 restriction enzymes to 
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5.1.3 QTL mapping of ACD6 modifiers 
I mapped causal loci for ACD6-Est modifiers through RAD-Seq 
genotyping of F2 individuals. I used Pst-1/Mse-1 restriction enzymes to 
generate fragments for a reduced representation of the genome. An in silico 
digest of the reference genome, generates 40,244 Pst-1/Mse-fragments, of 
those, 8,444 fragments were 400 bp long or shorter. My DNA libraries were 
size selected to include only fragments shorter than 400 bp. I multiplexed 96 
libraries in a single sequencing lane of Illumina HiSeq 2000 flow cell and 
expected 90X coverage. The observed coverage was uneven but on average 
I obtained 30X coverage across all the samples that were sequenced. Uneven 
coverage may have been due to uneven starting DNA qualities and 
concentrations, efficiency of restriction digest and adaptor ligation.  
 
From sequenced short reads I called ~2,000 SNPs that could be used for QTL 
mapping, however, I filtered them based on: 1) high sequence quality in  
individuals of the F2 population, 2) presence in at least 80% of the individuals 
in the F2 population, and 3) being polymorphic in F2 population. Additional 
marker and F2 individual filtering was done using R/qtl for redundant markers, 
genotyping errors, and redundant individuals. 
I ended up with a 304 (Pro-0/Est-1), 209 (Rmx-A180/Est-1), 256 (Bs-
5/Est-1) and 243 (Br-0/Est-1) individual, respectively, for QTL mapping (Table 
5.3). These individuals were genotyped with 285 (Pro-0/Est-1), 547 (Rmx-
A180/Est-1), 396 (Bs-5/Est-1) and 328 (Br-0/Est-1) reliable and high-quality 
markers, respectively (Table 5.3). The markers were evenly spaced 
throughout the genomes, with an average of 1 marker per cM (Table 5.3). For 
QTL mapping, lesion appearance at 5 weeks of growth was used as 
phenotype. At least one significant QTL was found in each population (Table 
5.4, Figure 5.6).  
Same as Pro-0, Bs-5 also had two ACD6 modifier loci. The first ACD6-
Bs-5 modifier locus was also in chromosome 1 (4.27 Mb interval) with a 
significant LOD score of 3.52 (Table 5.4, Figure 5.6). The second ACD6-Bs-5 
modifier locus was on chromosome 4 (2.33 Mb interval) with a significant LOD 
score of 5.55 (Table 5.4, Figure 5.6). Br-0 had only one significant ACD6 
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modifier locus, which had a LOD score of 5.13 at chromosome 5 (2.44 Mb 
interval) (Table 5.4, Figure 5.6). There were two distinct patterns, two 
accessions (Pro-0 and Bs-5) with two significant modifier loci and two 
accessions (Rmx-A180 and Br-0) with only one significant modifier locus. Pro-
0 and Bs-5 had QTL at close positions on chromosome 4, and in addition had 
individual QTL on chromosome 1. Rmx-A180 and Br-0 could each have more 
ACD6 modifier loci, however the LOD scores did not pass the significant 
threshold (Figure 5.6). A non-significant chromosome 3 ACD6-Br-0 modifier 
locus could be the same as the significant chromosome 3 ACD6-Rmx-A180 
modifier locus. On the other hand the significant chromosome 5 ACD6-Br-0 
modifier locus was similar to an insignificant chromosome 5 ACD6-Rmx-A180 
modifier locus. To check this possibility, screening more F2 individuals from 
the same F2 populations or from an advanced mapping population with more 
precise phenotyping be done. 
 LOD scores tell us how significant an association of the phenotype with 
genetic markers is, but it does not provide information regarding the effects of 
these QTL. For the markers nearest to the highest LOD score value at each 
QTL, I calculated effect sizes of the three different allelic configurations, both 
for individual loci (Figure 5.7 A), and for potential interaction between the two 
loci found in the mapping populations (Figure 5.7 B). The QTL showed a 
range of different behaviors in their effects.  
Pro-0 alleles at the chromosome 4 locus, near ACD6, were associated 
with weak lesioning, as expected, but in this case heterozygotes had a more 
intermediate phenotype than what was seen for Bs-5 at the chromosome 4 
locus (Figure 5.7 A2 and A4). Unexpected was an opposite effect of Pro-0 
alleles on chromosome 1, which enhanced lesioning (Figure 5.7 A1). The 
enhancement was strongly dependent, however, on the chromosome 4 locus, 
and not seen when the chromosome 4 locus was homozygous for the Pro-0 
allele, consistent with the parental Pro-0 accession not being lesioned (Figure 
5.7 B1).  
In the Bs-5 cross, the Bs-5 alleles at the chromosome 1 locus were 
almost completely recessive (Figure 5.7 A3), while alleles at the chromosome 
4 locus were semi-dominant (Figure 5.7 A4), with similar effect sizes of the 
homozygous configurations at both loci. Thus, the fewest lesions were seen in 
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plants doubly homozygous for Bs-5 alleles on chromosomes 1 and 4, and the 
most in plants doubly homozygous for Est-1 alleles at both QTL (Figure 5.7 
B2).  
The Rmx-A180 locus on chromosome 3 showed an overdominant 
behavior, with heterozygotes being much more lesioned than either Rmx-
A180 or Est-1 homozygotes (Figure 5.7 A6). Br-0 turned out to be quite 
different from the expectations based on phenotypic segregation (Table 5.1 
and Table 5.2).  
The Br-0 alleles on chromosome 5 were dominant, with Br-0 
homozygotes and heterozygotes having similarly low levels of lesioning 
(Figure 5.7 A6).  
 I also estimated the amount of phenotypic variance in each population 
explained by the QTL, both individually and in combination. A full genetic 
model (Lesion ~ Locus1 + Locus2 + Locus1:Locus2) accounting for both 
additive and epistatic interactions between the two candidate loci could 
explain between 2.3 and 23% of the variance (Table 5.5). The chromosome 4 
QTL in the Pro-0/Est-1 cross was the clearest and explained 18% of the 
variance in the lesion phenotype observed in the F2 individuals (Table 5.6). 
The other Pro-0 QTL in chromosome 1 explained 5.29% of the variation. The 
additive effect of these two QTLs explained the bulk (23.14%) of the 
variationobserved in the Pro-0/Est-1 F2 population. On the other hand, the 
QTL from the Br-0/Est-1 cross explained just a little more than 2% of the 
variation (Table 5.5 and Table 5.6). 
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Table 5.3 Summary of markers used per chromosome of each mapping population used for 
QTL analysis. 
F2 population N1 
Markers on chromosomes 
1 2 3 4 5 Total 
Pro-0/Est-1 304       
Number of markers  67 43 60 42 73 285 
Average spacing (cM)  1.1 1.1 1.0 1.1 0.9 1.0 
Max spacing (cM)  4.1 3.9 3.3 8.9 3.9 8.9 
Rmx-A180/Est-1 209       
Number of markers  157 75 80 94 141 547 
Average spacing (cM)  0.4 0.6 0.6 0.4 0.4 0.5 
Max spacing (cM)  3.7 3.2 5.4 5.1 1.8 5.4 
Bs-5/Est-1 256       
Number of markers  110 59 86 86 58 396 
Average spacing (cM)  0.6 0.7 0.6 0.5 1.0 0.7 
Max spacing (cM)  4.8 4.4 5.2 3.9 4.9 5.2 
Br-0/Est-1 243       
Number of markers  63 57 82 50 76 328 
Average spacing (cM)  1.0 0.7 0.6 0.8 0.8 0.8 
Max spacing (cM)  6.7 4.8 5.2 4.4 3.9 6.7 
1 Number of individuals analyzed for the F2 population 
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Table 5.4 Summary of mapped loci by QTL analysis for each mapping population.  
F2 population 
Locus 1 Locus 2 
Threshold (α =0.05) 
10,000 permutations Chr 
Interval (Mb) 
LOD 
Score Chr 
Interval (Mb) 
LOD 
Score Bayesint
a 
(Genome location) 
 
Size 
 
Bayesinta 
(Genome location) Size 
Pro-0/Est-1 1 13.92 – 23.62 9.69 3.59 4 7.48-9.69 2.21 13.14 3.09 
Rmx-A180/Est-1 3 10.47 – 16.67 6.2 4.12 NAb NAb NAb NAb 3.30 
Bs-5/Est-1 1 25.91 – 30.28 4.27 3.52 4 9.70 – 12.03  2.33 5.55 3.23 
Br-0/Est-1 5 21.88 – 24.32 2.44 5.43 NAb NAb NAb NAb 3.62c 
a Bayesint - approximate Bayesian credible interval for a particular chromosome; b  NA – not applicable; c Threshold α =0.10 with 10,000 permutations  
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Figure 5.6 QTL maps for lesioning. Immune genes with known major phenotypic effects that 
fall within the QTL intervals are indicated in italics. Vertical tick marks indicate RAD-seq 
markers. LOD thresholds at alpha=0.05 for each population mapped are indicated by solid 
horizontal lines. 
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Figure 5.7 A) Effect size and B) interaction plots for markers closest to the highest LOD score 
for each QTL. The x-axis depicts the three genotypes at each marker. EE stands for F2 
individuals that are homozygous for Est-1 alleles, and the other letters indicate the alternative 
alleles. 
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Table 5.5 Summary of phenotypic variance explained given a full, additive and interaction model between QTL 1 and QTL 2 of each mapping population used 
for QTL mapping. 
F2 Population 
Variance Explained by each QTL 
Full (y ~ Q1 + Q2 + Q1:Q2) or Full (y ~ Q1) Additive (y ~ Q1 + Q2 ) Interaction (y ~ Q1:Q2) 
LOD % Var X2 LOD % Var X2 LOD % Var X2 
Pro-0/Est-1  17.37 23.14 4.88-14 16.7632 22.43 6.66-16 0.695 0.71 0.59 
RmxA180/Est-1 4.12 8.68 8.69-05 NA NA NA NA NA NA 
Bs-5/Est-1  8.97 14.96 1.82-06 8.75 14.62 3.71-08 0.330 0.24 0.91 
Br-0/Est-1 1.23 2.30 0.05 NA NA NA NA NA NA 
 
 
 
 
Table 5.6 Summary of phenotypic variance explained taking individual QTLs separately for each mapping population used for QTL mapping. 
F2 Population 
(y ~ Q1) (y ~ Q2) 
Chr LOD % Var X2 Chr LOD % Var X2 
Pro-0/Est-1 1 3.58 5.29 2.59-14 4 13.1 18.01 7.85-14 
RmxA180/Est-1 3 4.12 8.68 7.59-05 NA NA NA NA 
Bs-5/Est-1 1 2.79 5.94 1.61-03 4 4.27 8.95 5.631-05 
Br-0/Est-1 5 1.38 2.59 0.04 NA NA NA NA 
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5.1.4 Identification of genes underlying modifier QTLs 
 Several of the QTLs I mapped are near regions with NLR genes 
(Nemri, Atwell et al. 2010). Overexpression of several NLR genes, their 
truncation or point mutations can all lead to autoimmune phenotypes (Bi, 
Johnson et al. 2011, Xia, Cheng et al. 2013, Chae, Bomblies et al. 2014) and 
hence I speculated that NLR genes might be causal for modification of ACD6 
activity. I therefore knocked down members of NLR clusters using artificial 
microRNAs (amiRNAs) (Schwab, Ossowski et al. 2006). AmiRNAs were 
designed based on the reference accession Col-0 NLR annotation, with 
several amiRNAs per cluster. Where possible amiRNAs that can target 
individual genes in a cluster were designed, but most amiRNAs targeted 
several genes in a cluster. A list of all the NLR candidates for which amiRNAs 
were transformed into the corresponding accessions is presented in Table 
5.7.  
 NLR genes were knocked down in Est-1, in all tested accessions 
having an Est-like ACD6 allele, but with reduced late-onset necrosis, and Col-
0 as control. Because the modifiers seemed to be dominant, semi-dominant 
or recessive, I constructed a range of scenarios for the outcome of the 
experiments (Figure 5.9). In case of a loss-of-function modifier, the Est-1 
knockdown was expected to show reduced lesions and improved growth 
resulting in a bigger plant (larger and heavier), while in case of a gain-of-
function modifier; the non-lesioned accession was expected to now show 
lesions and reduced growth. Col-0 was not expected to be affected by 
amiRNAs, for an ACD6 dependent effect of either a gain-of- function or a loss-
of-function modifier. If Col-0 also gained lesions, it would indicate that the 
knockdown in one of the non-lesioned accessions did not require ACD6-Est 
for its effect.  
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Figure 5.8 Location of ACD6 modifier QTL compared with that of NLR genes. QTL intervals 
are indicated by unfilled triangles. NLR density after Chae et al. (Chae, Bomblies et al.). 
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Table 5.7 AmiRNAs to identify ACD6 modifiers. 
Target 
Accession Target Gene(s) amiRNA name amiRNA sequence 
Transcript Library/ 
Reference 
RmxA180, Br-0 AT1G58602 NB-ARC (2) GGGCGATACGACGAACATTTA TAIR9_cdna_20090619 
Pro-0, Bs-5 AT1G58410 NB-LRR (7) TCATAAATCTGGGTAGTTCAT TAIR9_cdna_20090619 
Pro-0 AT1G62630.1, AT1G63350.1, AT1G63360.1 CC-NBS-LRR (2) TAATTCTTAGAGCAAAACCGG TAIR9_cdna_20090619 
RmxA180, Br-0 AT3G46530.1, AT3G46710.1, AT3G46730.1 RPP13 (1) CAACCCAACTTTGAAAACGTT TAIR9_cdna_20090619 
RmxA180, Br-0 AT3G46530.1, AT3G46710.1, AT3G46730.1 RPP13 (2) AAACTAGTTCGAGAGCTTAAT TAIR9_cdna_20090619 
RmxA180, Br-0 AT3G46530.1, AT3G46710.1, AT3G46730.1 RPP13 (3) GAACTGAACTTTGAAAACGTT TAIR9_cdna_20090619 
RmxA180, Br-0 AT5G58120.1 ADR2-x5 (1) TCTACGCAATATACCTTCCGA TAIR9_cdna_20090619 
RmxA180, Br-0 AT5G58120.1 ADR2-x5 (2) TCACTCCGGCTATAATCTAAT TAIR9_cdna_20090619 
RmxA180, Br-0 AT5G58120.1 ADR2-x5 (3) GAAACGTTTCGAAGAAACTAT TAIR9_cdna_20090619 
Pro-0 AT1G58602 RPP7 (19) TAAATGACCATATTCCTGCTC TAIR9_cdna_20090619 
Pro-0 AT1G58602 -- RPP7 cluster2 RPP7 (20) TTTTCCAGGTATTTCAGTCAA TAIR9_cdna_20090619 
Pro-0 AT1G58602 RPP7 (21) TCGAGGTATTTCAATCCGCTT TAIR9_cdna_20090619 
Pro-0 AT1G58602 RPP7 (22) TAAAGTTAGTTCTTGCTCCCA TAIR9_cdna_20090619 
Pro-0 AT1G58390 RPP7 (26) TTAGATCACGTTTTAGCCCAG TAIR9_cdna_20090619 
Pro-0 AT1G58400 RPP7 (27) TATGTCTAGATAGATCGGCAA TAIR9_cdna_20090619 
Pro-0 AT1G58400 RPP7 (28) TAAGTTAGTTTTGTGATGCGC TAIR9_cdna_20090619 
Pro-0 AT1G58390 RPP7 (29) TCTTAATTCATGCATCCGCAT TAIR9_cdna_20090619 
Pro-0 AT1G58410 RPP7 (30) TATATCAGACGCAAGTTCCCT TAIR9_cdna_20090619 
Pro-0, Bs-5 AT4g16860, AT4g16890, AT4g16900, AT4g16920, AT4g16940, AT4g16950, AT4g16960 RPP4/5 (EC290) TAGATGACAAGTTGACGTCGA TAIR9_cdna_20090619 
Pro-0, Bs-5 AT4g16860, AT4g16920 RPP4/5 (EC292) CTACGACGATAGGATAAATAT TAIR9_cdna_20090619 
Pro-0, Bs-5 AT4g16860, AT4g16920 RPP4/5 (EC293) TATCTATTAATAGCCCCCCCG TAIR9_cdna_20090619 
Pro-0, Bs-5 AT4g16860, AT4g16920 RPP4/5 (EC294) TGTCCGCTACAATTCGGCCGT TAIR9_cdna_20090619 
Pro-0, Bs-5 AT4g16860, AT4g16920 RPP4/5 (EC295) TGAATGGCAAACGTATTGCAC TAIR9_cdna_20090619 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (209) UGACACAUAAACUCCAUCGGU Chae et al., 2014 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (210) TAGTTGGAAAATCTCACGCAT Chae et al., 2014 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (211) UGUUGGCACAUAAACUCGGAG Chae et al., 2014 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (212) UACAUUUCAACUGCGAGCGUC Chae et al., 2014 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (217) TAATAATCGAATGACTCGAGG Chae et al., 2014 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (226) UUCUUACCGAUCCCAGGCGGU Chae et al., 2014 
RmxA180, Br-0 AT3G44400, AT3G44480, AT3G44630, AT3G44670 RPP1 (228) UAUAUCCGUAAUGAUUGCGGC Chae et al., 2014 
Br-0 AT3G26450, AT3G26460, AT3G26470, AT3G26480 RPW8 (110) TTCAAGGAAACACGTGAGACG TAIR9_cdna_20090619 
Br-0 AT3G26450, AT3G26460, AT3G26470, AT3G26480 RPW8 (140) TCAGAACGTAAATCGGATCGC TAIR9_cdna_20090619 
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Figure 5.9 Expected phenotypes upon candidate gene knockdown in Est-1, the accession 
with the modifier, and Col-0 		
Modifier is a loss-of-function allele
Est-1 Pro-0/RmxA180/Bs-5/Br-0 Col-0
Modifier is a gain-of-function allele
Est-1 Pro-0/RmxA180/Bs-5/Br-0 Col-0
A.
B.
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5.1.4.1 RPP4/5 as a candidate modifier of ACD6 hyperactivity 
Similar to knocking down ACD6 itself in Est-1, knocking down genes of 
the RPP4/5 cluster in Est-1 abolished autoimmunity-related late-onset 
necrosis (Figure 5.10, Figure 5.11). This was only seen when a black 
Moosgummi cover isolated plants from soil, presumably reducing microbial 
stimuli emanating from the soil, which otherwise could cause HR-like lesions. 
At 23°C, the amiRNA EC290, which targeted most genes in the RPP4/5 
cluster completely suppressed lesion formation until around 8 weeks after 
sowing (Figure 5.10). For comparison, knocking down ACD6 with an amiRNA 
suppressed lesions even at 10 weeks of growth, and also on soil (Figure 
5.10). Trypan blue staining confirmed the suppression of cell death (Figure 
5.11). Two other amiRNAs, EC292 and EC294, were similarly effective as 
amiRNA EC290, while EC293 and EC295 were less effective, with transgenic 
plants having collapsed dead cells at the leaf tips (Figure 5.11). No 
phenotypic lesion effects were apparent in Pro-0 and Col-0 (Figure 5.10, 
Figure 5.11).  
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Figure 5.10 Representative amiR-ACD6 (6 WAS and 10 WAS) and amiR-RPP4/5 (7 WAS and 10 WAS) Col-0, Est-1 and Pro-0 transgenics. 
 
Note: Est-1 amiR-ACD6 transgenics were generated by Dr. Marco Todesco; Est-1, Col-0 and Pro-0 amiR-RPP4/5 transgenics were generated by either 
Maricris Zaidem or Dr. Wangsheng Zhu. Growing the transgenic lines for phenotyping was spear-headed by Dr. Wangsheng Zhu. 
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Col-0 Est-1 Pro-0
Wildtype
amiR-RPP4/5 
(EC290)
amiR-RPP4/5 
(EC292)
amiR-RPP4/5 
(EC293)
amiR-RPP4/5 
(EC294)
amiR-RPP4/5 
(EC295)
amiR-ACD6
(MT79)
Figure 5.11 Trypan blue staining of representative amiR-ACD6 (42 DAS) and amiR-RPP4/5 (56 DAS) Est-1 and Pro-0 
transgenics. Black squares indicate that the corresponding transgenic lines were not available. 
Note: Est-1 amiR-ACD6 transgenics were generated by Dr. Marco Todesco; Est-1, Col-0 and Pro-0 amiR-RPP4/5 
transgenics were generated by either Maricris Zaidem or Dr. Wangsheng Zhu. Trypan blue staining of the transgenic lines 
for phenotyping was spear-headed by Maricris Zaidem. 	
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The RPP4/5 cluster is highly variable in organization and sequence between 
accessions (Guo, Fitz et al. 2011, Tsuchiya and Eulgem 2013, Chae, 
Bomblies et al. 2014), and the Pro-0 and Est-1 sequences are unknown. That 
amiRNAs predicted to target the same genes in Col-0 (EC292, EC293, EC294 
and EC295) gave different results in Est-1 points to Est-1 genes differing from 
those in Pro-0. 
The ACD6-Est allele not only induces late-onset necrosis, but also 
reduces growth and thus biomass (Todesco, Balasubramanian et al. 2010). 
There was a trend for several amiR-RPP4/5 to increase biomass specifically 
in Est-1, but not Pro-0, although a similar trend was observed also in Col-0 
(Figure 5.12).  
 In summary, these results, while preliminary, point to a potential role of 
genes in the RPP4/5 cluster of Est-1 contributing to the lesions caused by the 
hyperactive ACD6-Est allele. I note that the effects are not unexpected, since 
the QTL explained only ~18.01% of phenotypic variance (Table 5.5), and 
because I had found multiple independent QTL in the four crosses examined. 
5.1.5 General conclusions about Est-like ACD6 modulators 
The evidence presented in this chapter indicates that modifiers of the 
hyperactive ACD6-Est are surprisingly diverse. This can be concluded from 
the different genomic locations of QTL in different crosses, their dominance 
behavior, and their genetic interactions (additive versus epistatic). It will be 
interesting to construct strains in which modifiers from different accessions 
are combined, to test whether they further enhance the suppression of the 
ACD6-Est lesioning phenotype.  
The possibility that NLRs might contribute to ACD6 hyperactivity, as 
deduced from the RPP4/5 knockdowns in Est-1, is particularly exciting, since 
NLRs have so far not been linked directly to ACD6 function. 
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Figure 5.12 Biomass of representative A) Est-1, B) Pro-0 and C) Col-0 amiR-RPP4/5 
transgenics. Data are from 5 biological replicates each, with three independent lines for most 
transgenes. Pairwise comparisons using t-tests with pooled SD, significant difference relative 
to the wildtype (Est-1, Pro-0 or Col-0); p-value: **** < 0.0001 , *** < 0.001, ** < 0.005, *< 0.05. 
 
Note: Est-1 amiR-ACD6 transgenics were generated by Dr. Marco Todesco; Est-1, Col-0 and 
Pro-0 amiR-RPP4/5 transgenics were generated by either Maricris Zaidem or Dr. Wangsheng 
Zhu. Weighing of the transgenic lines for phenotyping was spear-headed by Dr. Wangsheng 
Zhu. 
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6 Discussion 
 
 Darwinian fitness is defined as the number of fertile offspring an 
individual has. Maximizing Darwinian fitness means to find the right balance 
between investments in growth, reproduction and in defense against 
pathogens and other environmental challenges. My thesis work built on the 
finding of a special allele at the A. thaliana ACD6 locus that shifted the 
balance from growth to defense (Todesco, Balasubramanian et al. 2010). 
However, not all accessions that appeared to have this special allele showed 
an obviously increased activity of the immune system (Todesco, 
Balasubramanian et al. 2010). 
Specifically, my work had three interrelated objectives. The first major 
objective was to better understand the worldwide distribution of hyperactive 
ACD6 alleles. The second objective was to extend our knowledge of the 
relationship between ACD6 activity and plant defense. The third objective was 
to identify natural modifiers of the hyperactive ACD6 allele.  
6.1 Variation in the hyperactive ACD6 allele  
6.1.1 Est-like ACD6 in A. thaliana accessions 
  Hyperactivity of the ACD6-Est-1 allele has been attributed to two 
amino acid changes in the transmembrane domain of the protein (Todesco, 
Balasubramanian et al. 2010). That just several or one amino acid change in 
a protein is enough to confer phenotypic variation is not new. Several 
examples of Arabidopsis proteins that have altered function due to a single 
amino acid change include ATMYC1, PHYB, PHYA, CRY2, APR2, HUA2, 
TFL and FT (El-Assal, Alonso-Blanco et al. 2001, Maloof, Borevitz et al. 2001, 
Hanzawa, Money et al. 2005, Loudet, Saliba-Colombani et al. 2007, Wang, 
Sajja et al. 2007, Filiault, Wessinger et al. 2008, Symonds, Hatlestad et al. 
2011). Amino acid changes in these proteins caused altered protein-protein 
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interactions, altered activity of activator or repressor, or altered protein 
stability. For ACD6, as with HUA2, the SNPs causal for these amino acid 
changes are thought to result in a hypermorphic allele (enhancing 
functionality). ACD6 have two major domains: 1) ankyrin domain which 
mediates protein-protein interactions and 2) transmembrane domain, which 
anchors ACD6 in the membrane. The fact that the two causal SNPs confering 
hypermorphism are located in region coding trans membrane domain points 
to the relevance of the transmembrane region for ACD6 function. Non-
hyperactive ACD6 anchors to the plasma membrane upon elevated SA 
concentration in the cytosol (Zhang, Shrestha et al.).  In acd6-1, with an 
activated ACD6 version similar to Est-like allele, ACD6 was found to localize 
in the plasma membrane, irrespective of SA or BTH concentration (Zhang, 
Shrestha et al. 2014). 
 Among the ACD6 alleles discovered in natural Arabidopsis accessions 
so far (Todesco, Balasubramanian et al. 2010, Todesco, Kim et al. 2014), only 
Est-like alleles confer autoimmunity. In my study, ~12% of Arabidopsis natural 
accessions contained Est-like ACD6 alleles, within those 88% exhibited the 
HR-like lesions similar to autoimmune mutants or accessions. The rest could 
either contain other SNPs that render ACD6-Est-1 non-hyperactive or have 
extragenic modulators of ACD6 similarly to studied cases of Pro-0 and Rmx-
A180.  
 GWAS on 96 Arabidopsis accessions conducted by Todesco and 
colleagues (2010) confirmed ACD6 association with necrosis. Est-like ACD6 
allele has a clear impact on the phenotype and segregates at low frequency in 
population, which suggests that either it is a relatively young allele or is only 
advantageous at specific conditions (Memon, Jia et al. 2016). Data I 
generated from my study could be used to conduct analyses to estimate allele 
age (Slatkin and Rannala 2000). Accessions that I identified to contain Est-
like ACD6 alleles could be used to determine the conditions that influence 
ACD6 hyperactivity. Moreover, I hypothesize that natural modulators are 
relevant for tempering and keeping the hyperactive ACD6 allele type in the 
population. 
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6.1.2 Maintenance of ACD6 allelic diversity  
 Genetic variation observed in ACD6 can be maintained within 
populations or species through balancing selection by mechanisms such as 
heterozygote advantage or overdominance, epistatic selection, frequency-
dependent selection, spatial or temporal selection, local adaptation to different 
environments (Charlesworth and Awadalla 1998, Tian, Araki et al. 2002, 
Charbonnel and Pemberton 2005, Kroymann and Mitchell-Olds 2005, Tellier 
and Brown 2011). Although differing in the specifics, these mechanisms are 
all built on the precondition that having a particular allele is beneficial 
(advantageous) or deleterious (detrimental) in some way depending on a 
associated condition. For instance, in a spatial-temporal selection scenario, 
balancing selection can occur when different alleles are favored in different 
environments over time or geography (Hedrick, Ginevan et al. 1976, Wardlaw 
and Agrawal 2012). Given these particulars, prerequisites for the ACD6 locus 
to be under balancing selection can be envisioned. Co-occurrence of diverse 
ACD6 allele types in local (Todesco, Kim et al. 2014) and global populations 
(this work and Todesco et al., 2010) and the pattern of diversity I observed in 
ACD6 locus (divergence between major allelic clusters) supports that this 
locus is under balancing selection.  
 Other than the fact that functionally distinct ACD6 allele types are 
found interspersed with each other across the global range of Arabidopsis 
occurrence, the expressivity of the ACD6-Est-1 allele seem to follow a 
geographic latitudinal gradient. The trend was that suppressed or non-
lesioned accessions with Est-like ACD6 alleles are more often found in lower 
latitudes of the Arabidopsis geographical range of growth. While the ACD6 
allele type explained 30% of the lesion severity variation, a further 10% could 
be explained by latitudinal location alone in the subset of accessions 
analyzed. The observed gradient might be a result of lower mean annual 
temperature with higher latitude. Lines carrying Est-like ACD6 alleles are 
expected to produce more SA and like acd6-1 be small, lesioned and have 
reduced fitness at lower temperatures (Todesco, Kim et al. 2014). Testing 
temperature or SA gradients explicitly in relation to ACD6 allele occurrence in 
the global populations should give more information. 
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There has been an attempt to test this on a local scale. In a set of four 
Iberian populations, ACD6-Est-like alleles were more common at lower 
elevations where the annual mean temperature is at 14.6°C than at higher 
elevations where annual mean temperatures are around 6.8°C (Zhang, 
Lariviere et al. 2014). In addition, Zhang and colleagues (Zhang, Tonsor et al. 
2015) found that in these Iberian populations, there was a cline in SA 
concentration with increasing elevation. This trend is contradictory to our 
expectations based on effect of temperature on acd6-1. Local adaptation 
offers a plausible explanation for the patterns surveyed from the 
aforementioned study’s Iberian Peninsula populations.  
I propose that further experiments be conducted to test for a role of 
ACD6 in local adaptation such as: identification of ACD6 allele frequencies in 
relation to local conditions (Gunther and Coop 2013); genomic comparisons of 
locally heterogenous ACD6 stands (Kubota, Iwasaki et al. 2015); and 
common garden experiments combined with reciprocal transplantation 
experiments (Rutter and Fenster 2007). 
6.2 Hyperactive ACD6 alleles, growth, late-onset necrosis and 
immunity 
 A hyperactive ACD6 allele while exhibiting HR-like lesions and stunted 
growth confers elevated immunity, which results in better pathogen response 
(Lu, Salimian et al. 2009, Todesco, Balasubramanian et al. 2010). Therefore 
an accession with a modulated hyperactive ACD6 allele exhibiting suppressed 
HR-like lesions and normal growth is expected to have lessened immunity 
and inadequate pathogen response. I tested this hypothesis using Pro-0 and 
Rmx-A180. What was assumed as a simple relationship between ACD6 allele 
type, growth, necrosis and pathogen response was more complex in reality.  
 Taking the growth and pathogen challenge results together, I conclude 
that: 1) The Pro-0 and Rmx-A180 ACD6 modifiers could positively uncouple 
ACD6-dependent growth and defense trade-off and 2) Pro-0 and Rmx-A180 
have different ACD6 modifiers. The fact that silencing ACD6-Pro-0 did not 
have an effect on growth but had an effect on defense was the first evidence 
that ACD6-Pro-0 could possibly uncouple the Est-like ACD6 effect on growth 
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and defense. The hypothesis of Pro-0 and Rmx-A180 having different ACD6 
modifiers was supported by the opposite responses exhibited by these two 
accessions upon ACD6 knockdown.   
6.2.1 SA accumulation and ROS production 
 ACD6 is a positive regulator of cell death, defense, and its down-
regulation decreases SA accumulation (Lu, Rate et al. 2003, Tateda, Zhang et 
al. 2014, Zhang, Shrestha et al. 2014). This concomitantly dampens flg22-
elicited ROS response (Yi and Kwon 2014, Yi, Shirasu et al. 2014). Pro-0 
exhibits the same pattern of SA accumulation and flg-22 induced ROS 
response as Est-1. On the other hand, Rmx-A180 responses were atypical 
compared to Est-1. For this atypical Rmx-A180 response upon ACD6 
knockdown to be explained, it would be best to first discuss the nature of the 
SA accumulation difference among the control (Est-1 and acd6-1) and the 
ACD6 modulated (Pro-0 and Rmx-A180) genotypes. The growth challenged 
genotypes, Est-1 and acd6-1, had SA concentrations almost at scale with 
each other. The accessions with modulated ACD6 function, Rmx-A180 and 
Pro-0 had 4-fold less and 10–fold less SA than Est-1, respectively.  
 My findings raise the following questions: 
• Is there a significant threshold for physiological SA concentrations that 
can set-off the defense reaction cascade and the appearance of HR-
like lesions? 
• Is there a preferred form of SA to induce downstream immune 
responses?   
• Are there known hormones or proteins that can titrate or offset the 
effect of SA (without changing the levels of SA)? 
 A study from Kliebenstein and colleagues (Kliebenstein, West et al. 
2006) included a side experiment with seven A. thaliana accessions, including 
Col-0 and Est-1, to test variation in response to SA application. Their report 
suggested that concentrations higher than 0.30 mM SA were phytotoxic in 
some of the accessions they tested, although they did not show the actual 
data in the paper. On the other hand, a study conducted 20 years ago on the 
ability of the synthetic SA analog abenzo-(1,2,3)-thiadiazole-7-carbothioic acid 
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S-methyl ester (BTH) to activate resistance transduction pathway showed that 
concentrations lower than 0.12 mM of BTH are insufficient to activate PR1 
(Lawton, Friedrich et al. 1996). Furthermore, Lu and colleagues (Lu, Rate et 
al. 2003) found that ACD6 is consistently expressed even without BTH 
induction, but both studies concur that as much as 100 µM (0.1 mM) BTH is 
needed to induce PR1 protein expression. Albeit through experiments using 
the SA analog, this indicates that there is a threshold level concentration 
needed for activating ACD6 and SA-dependent resistance. The Pro-0 and 
Rmx-A180 examples suggested that the concentration level needed to induce 
PR1 expression and HR-like lesions are non-uniform. Consistent with this, two 
other accessions, KZ1 and Got22, when treated with as much as 300 µM SA 
failed to accumulate PR1 protein (Gangadharan 2014). In parallel with results 
from my experiments, results from Gangadharan (Gangadharan 2014) not 
only show that there might be a different threshold level for SA to activate 
downstream immune responses, but also indicates that other accessions 
contain modulators that suppresses SA accumulation or titrate the effects of 
SA upon bacterial (Pseudomonas syringae pv. phaseolicola) infection. 
SA function during resistance to infection lies predominantly in its 
ability to activate defense genes (Blanco, Salinas et al. 2009).  van Leeuwen 
and colleagues (van Leeuwen, Kliebenstein et al. 2007) found that there is 
significant natural variation in transcriptional responses to exogenous SA. In 
the case of Rmx-A180, SA accumulation might bring about a concomitant 
transcriptional response that is not as intense as Est-1.  To prove ACD6-
dependency and narrow down candidate ACD6-Rmx-A180 modulators, 
transcriptome comparison between wild-type Rmx-A180 and Est-1 and the 
corresponding amiR-ACD6 lines can be conducted. 
The accumulation of SA in leaves following pathogen infection 
coincides with the appearance of salicylic acid β-glucoside (Wang, Sager et 
al. 2013) (Delaney 1994). Although free SA is considered the biologically 
active form of SA, elevated SAG concentration was also observed during 
activation of plant defenses (Enyedi, Yalpani et al. 1992). SAG function is not 
well established but several studies have proposed that it may serve to 
blunting potentially toxic effects of high SA concentrations through vacuolar 
sequestration (Enyedi and Raskin 1993, Chen, Malamy et al. 1995, Seo, 
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Ishizuka et al. 1995, Dean and Delaney 2008). In the assays I conducted, 
conjugated SA (glucoside 1) was always more abundant than free SA. The 
difference is more striking in Pro-0 and Rmx-A180 where the conjugated SA 
(glucoside 1) level was as much as 10 times higher than the free SA. It is 
conceivable that the SA signal is not being relayed efficiently because either 
SA is mostly present in its conjugated form or low expression of the SA 
transducer, NPR1. 
Although SA and JA are the main hormones implicated in disease 
resistance pathways, other hormones such as gibberellic acid may affect the 
SA-JA equilibrium (Robert-Seilaniantz, Navarro et al. 2007). Relevant to my 
study, ABA-dependent repression of BTH-induced resistance and PR1 
expression has been demonstrated (Yasuda, Ishikawa et al. 2008). This 
repression is affected by the NPR1 protein or signaling downstream of NPR1. 
Inspection of hormone concentrations, other than SA, could help clarify the 
reason for the SA block in accessions with modulated ACD6 phenotypes. 
 There are several ways by which ROS is produced by the plant. An 
ACD6-relevant mechanism is that SA or SAG build-up blocks catalase from 
converting toxic H2O2 into H2O and singlet O. (Chen, Malamy et al. 1995, 
Noctor, Lelarge-Trouverie et al. 2015). Further, FLS2 activation by flg22 
transiently elevates cytosolic calcium, production of ROS and other signaling 
particles to coordinate bacterial defenses (Li, Li et al. 2014). In numerous 
experiments, ROS production after flg22 treatment has been used as a key 
assay to assess PTI responses (Zhang, Shao et al. 2007, Chakravarthy, 
Velasquez et al. 2010, Segonzac and Zipfel 2011, Daudi, Cheng et al. 2012, 
Vetter, Kronholm et al. 2012, Smith and Heese 2014). Similar to SA, flg22-
induced ROS production varied among the accessions I tested. While I saw 
parallel trends, as expected, in Est-1 and Pro-0 (and the acd6-1 control), this 
was not the case for Rmx-A180. My inspection of FLS2 sequences did not 
reveal obvious mutations that might be responsible for the observed 
differential flg22 responses. The ACD6-Rmx-A180 extragenic modulator might 
be a component protein in the response pathway that affects: 
• Mechanisms for titrating H2O2 accumulation, i.e. peroxidase activity or,  
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• Mechanisms that directly increase H2O2 accumulation (i.e. 
photorespiration, fatty acid β-oxidation, superoxide dismutase 
accumulation ) or, 
• FLS2 co-activators and interactors and downstream reaction 
components. 
One peroxidase superfamily protein, AT3G28200, was actually included in the 
candidate genes from the Bayesian credible interval of the QTL mapping for 
ACD6-Rmx-A180 modifier.  
 While high SA accumulation has generally been pinpointed as a causal 
prerequisite for the formation of HR/cell-death lesions in plants, there are 
exceptions. For instance, SA sequestration by bacterial SA hydroxylase 
(nahG) expression did not suppress lesion formation in lsd2 and lsd4 mutants 
(Hunt, Delaney et al. 1997). Additionally, sid1 and sid2 mutants whilst unable 
to accumulate SA developed HR following inoculation with a high titer of P. 
syringae (Nawrath and Metraux 1999). Pertinent to the Rmx-A180 situation 
are cases where high SA levels coupled with elevated broad-spectrum 
resistance did not result in severe HR or at most resulted in a severely 
reduced HR. Examples of such mutants are defense, no death 1 (dnd1), and 
defense, no death 2/HR-like lesion mimic (dnd2/hlm1) (Clough, Fengler et al. 
2000, Balague, Lin et al. 2003, Jurkowski, Smith et al. 2004). Research from 
Lorrain and colleagues (Lorrain, Vailleau et al. 2003) using these mutants 
show that cell death may be SA-dependent but SA by itself is not the only 
thing needed for HR production. They assert that another signaling molecule 
is required in addition to SA to induce cell death after pathogen recognition. 
DND1 and DND2 encode cyclic nucleotide-gated ion channels (Genger, 
Jurkowski et al. 2008). These channels can mediate transport of K+ and Na+ 
that is activated by both cyclic GMP and cyclic AMP50. It is important to note 
that DND2/HLM1 was included in the candidate genes from the Bayesian 
credible interval of the QTL mapping for ACD6-Br-0 modifier.  
 The hypersensitive response like lesions 1 (hrl1) experiments by 
Devadas and Raina (Devadas and Raina 2002) showed that pre-treating 
Arabidopsis with SA or BTH suppressed HR development; such that a 
constitutively active SAR negatively regulates cell death. Further, research 
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using hrl1 show that synergistic overlapping roles for SA, JA and ethylene 
signaling fine-tune the cell death and defense response against pathogens. A 
relevant point is the finding that inhibition of JA responses resulted in 
exaggerated cell death and severe stunting of plants (Devadas, Enyedi et al. 
2002). It would therefore be of interest to monitor JA levels in wild-type and 
amiR-ACD6 Rmx-A180 plants.  
6.2.2 Gene expression differences 
In Rmx-A180, it was expected that PR1 levels would also be high, 
given the high levels of FRK1 (Robatzek and Somssich 2002), yet this was 
not what I observed. There appears to be a disconnection between the known 
strong developmentally induced expression of FRK1 during leaf senescence 
(Robatzek and Somssich 2002) and PR1 up-regulation in RmxA180 amiR-
ACD6 lines. Pinpointing the gene function for ACD6-RmxA180 modifier could 
help clarify this unexplained pattern. 
 In the ACD6-dependent pathway, PAD4-EDS1 participates in a positive 
regulatory loop that increases SA levels (Dong 2004). PAD4 (Wagner, 
Stuttmann et al. 2013) has been shown to be essential for defense against 
green peach aphid (GPA; Myzus persicae), and the pathogens Pseudomonas 
syringae and Hyaloperonospora arabidopsidis (Louis, Gobbato et al. 2012). It 
has been demonstrated to be required for multiple defense response including 
camalexin synthesis and PR1 gene expression in response to Pma but not in 
response to the avirulent bacterial pathogen Pst DC3000/avrRpt2 (Zhou, 
Tootle et al. 1998). These results show that there are exceptions and 
prerequisites for PAD4 participation in specific defense responses. In Pro-0, 
ACD6-Pro-0 knockdown resulted in reduction of PAD4 expression. Parallel 
with Rmx-A180 amiR-ACD6 responses, a pad4 mutation only partially 
suppressed SA accumulation and disease resistance in acd6-1 (Lu, Rate et 
al. 2003). Additionally, pad4 itself is not sufficient to abolish PR1 expression 
except in conjunction with eds1 for the acd6-1 mutant (Ng, Seabolt et al. 
2011). The same circumstances may apply to Rmx-A180 given that EDS1 
expression levels were the same in Rmx-A180 wild-type and Rmx-A180 
amiR-ACD6 transgenic lines. Rustérucci and colleagues (Rusterucci, Aviv et 
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al. 2001) have proposed that an EDS1-PAD4 effect on ROS/SA-dependent 
signaling is modulated by LSD1. LSD1 was included in the candidate genes 
from the Bayesian credible interval of the QTL mapping for ACD6-Pro-0 
modifier. It might also be worthwhile to investigate the role of LESION 
STIMULATING DISEASE RESISTANCE 1 (LSD1) in conjunction with PAD4 
and EDS1 function.  
A number of mutants constitutively accumulate high levels of SA. Like 
Est-1, these mutants show increased disease resistance that requires SA, 
PAD4, EDS1, and/or NDR1 (Lu, Rate et al. 2003). Therefore, another protein 
that might have implications for ACD6-dependent responses in Pro-0 and 
Rmx-A180 is the plasma membrane-localized integrin-like NDR1. Reflecting 
NDR1 effect on SA accumulation, ACD6 knockdown led to decreased NDR1 
expression in Pro-0 but increased NDR1 expression in Rmx-A180.  
Defense signaling mediated by TIR-NLR proteins seems to be largely 
dependent on EDS1 (Aarts, Metz et al. 1998, Hu, deHart et al. 2005), while 
NDR1 has an equivalent role for CC-NLRs (Century, Holub et al. 1995, Aarts, 
Metz et al. 1998, Bittner-Eddy and Beynon 2001, Venugopal, Jeong et al. 
2009). Several exceptions to this proposed dichotomy include CC-NLRs 
RPP8, RPP13-Nd, HRT, and RPP7, all of which appear to function 
independently of NDR1 (Aarts, Metz et al. 1998, McDowell, Cuzick et al. 
2000, Bittner-Eddy and Beynon 2001). My results suggest that an NDR1 
controlled pathway is perturbed upon ACD6 knockdown in Pro-0 and 
RmxA180. The higher NDR1 levels upon amiR-ACD6 knockdown in Rmx-
A180 could be responsible for titration of SA-induced effects such as ROS 
production that result in necrosis.  
 In summary, the gene expression assays further support that in Pro-0, 
a general ACD6-dependent dampening of defense responses that happens 
upon ACD6 silencing. On the other hand, silencing of ACD6-Rmx-A180 
results in a general up-regulation of defense responses that culminated with 
an increased accumulation of SA.  
		 127 
6.2.3 Uncoupled ACD6-dependent growth and defense responses 
 ACD6 mode of action in Pro-0 and Rmx-A180 accessions is different. 
ACD6-Pro-0 behaved like a suppressed ACD6-Est-1. On the other hand the 
Rmx-A180 atypical responses implied a subduing role of ACD6-RmxA180 in 
defense responses. ACD6 hyperactivity relies heavily on its maturation and 
localization in the plasma membrane as controlled by SA levels (Zhang, 
Shrestha et al. 2014). Despite having a hyperactive ACD6 allele, Pro-0 does 
not accumulate SA. Due to this blockage, ACD6-Pro-0 was rendered 
functionally analogous to a non-hyperactive ACD6 allele like Col-0. Similar to 
knocking down ACD6-Col-0 wherein no apparent biomass change was 
evident (Todesco, Balasubramanian et al. 2010), knocking down ACD6-Pro-0 
did not show any biomass/growth changes. Candidate modulators of ACD6-
Pro-0 would probably have a role in SA accumulation. The Rmx-A180 case is 
more complicated because even with relatively high SA levels, hyperactive 
ACD6-dependent phenotypes were not apparent. ACD6-Rmx-A180 seemed 
to be functioning as a hyperactive ACD6 allele but in a tempered capacity. 
Candidate modulators of ACD6-Rmx-A180 could be proteins it forms complex 
with, including PRRs such as FLS2, EFR and CERK1 (Zhang, Shrestha et al. 
2014).  ACD6 complexes increase in size during SA signaling (Zhang, 
Shrestha et al. 2014). The size of the protein complex formed in Col-0 and 
acd6-1 was the same, but acd6-1 contained more of the protein complex at 
the membrane (Zhang, Shrestha et al. 2014). When ACD6-Rmx-A180 was 
knocked down complex formation may have been altered which could 
possibly activate or liberate a protein responsible for the higher amplitude of 
defense responses. Given that ACD6-Rmx-A180 knockdown resulted in a 
bigger and heavier rosette, the “activated” protein’s function could possible 
not rely on the amplification of SA responses but instead spurs growth-
promoting hormones such as auxins, brassinosteroids, gibberellins or 
cytokinins (Huot, Yao et al. 2014). Quantification of these hormones in Rmx-
A180 and Rmx-A180 amiR-ACD6 lines could substantiate this claim.  
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6.3 Genetic basis of extragenic ACD6 modifiers  
 To ultimately understand potential uncoupling of ACD6 downstream 
responses in the accessions that have the hyperactive ACD6-Est-like allele, 
but do not show necrosis, it is necessary to learn the identity of the genes that 
suppress necrosis in these accessions. Consistent with different pathogen 
responses in the accessions, crosses between the accessions already 
pointed to different genes modifying ACD6 effects in these accessions.  
I conducted QTL analyses in four accessions. These confirmed that the 
different accessions mostly have different modifiers, as they map to different 
regions of the genome and interact in different ways with each other. From all 
previously described ACD6 suppressors identified in acd6-1 suppressor 
screens (Lu, Salimian et al. 2009, Wang, Shi et al. 2011, Wang, Zhang et al. 
2014), the mapping intervals overlap only with NPR1, SA INDUCTION 
DEFICIENT 2 (SID2), EDS1, PAD4, and FLS2 (Table 8.1). Other known 
suppressors such as PHOSPHATE TRANSPORTER 4;1 (PHT4;1), HOPW1-
1-INTERACTING3 (Wang, Seabolt et al. 2011), and an uncharacterized 
putative metalloprotease (AT5G20660) were not included in studied mapping 
intervals. Based on previous genetic studies NPR1 definitely plays a part in 
the ACD6 reaction cascade (Vanacker, Lu et al. 2001, Lu, Salimian et al. 
2009). NPR1 was just at the edge of the mapping interval for the ACD6-Pro-0 
chromosome 1 modifier. It was an appealing candidate as an ACD6-Pro-0 
modifier given its known function in SA accumulation. However, comparison 
of the reference, Est-1, and Pro-0 NPR1 amino acid sequence does not show 
any non-synonymous changes that could result in an altered NPR1 function  
(Appendix Figure 1). EDS1-PAD4, SID2 and FLS2 were included in Bayesian 
credible mapping intervals for modifier loci from Br-0, Bs-5 and Rmx-A180, 
respectively. FLS2 function in Rmx-A180 should definitely be studied further 
given the amplified flg22-induced ROS responses observed upon ACD6 
knockdown. At the same time, FLS2-Rmx-A180 contains several possibly 
non-synonymous amino acid changes that could be implicated in an altered 
FLS2 function (Appendix Figure 2).   Br-0 definitely has several possible non-
synonymous amino acid changes in EDS1 and PAD4 compared to Col-0 and 
Est-1 (Appendix Figure 3 and Appendix Figure 4) that can cause a differential 
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function. SID2-Bs-5 does not seem to have possible non-synonymous amino 
acid changes compared to Col-0 and Est-1 (Appendix Figure 5). Assays to 
determine ACD6 hyperactivity, similar to those conducted with Pro-0 and 
Rmx-A180, should be done for Bs-5 and Br-0.  Fine-mapping to narrow down 
the mapping intervals are currently underway. However some stumbling 
blocks, i.e. genomic locations of mapping intervals, insufficiency of 
quantitative phenotypic scale used for characterization of ACD6-dependent 
responses, are still being overcome.  
 Some ACD6 modifier QTLs I mapped appear to include NLR genes 
based on Bayesian credible intervals. RPP13 is close to one of the QTL 
intervals, and it is a candidate for being one of the Rmx-A180 modifier loci 
because comparable to Rmx-A180 responses, RPP13 function does not 
necessarily depend on just SA accumulation (Bittner-Eddy and Beynon 2001). 
A natural variant, RPP13-Nd, functions independently of SA and its activity is 
not changed in ndr1 and eds1 mutants (Bittner-Eddy and Beynon 2001). 
There is considerable functional variation at the RPP13 locus in A. thaliana 
accessions (Bittner-Eddy and Beynon 2001, Rose, Bittner-Eddy et al. 2004), 
consistent with a rare RPP13 allele affecting ACD6 responses in Rmx-A180.   
 
Table 6.1 Suppressors of acd6-1 and their genomic locations 
Gene Other Names TAIR10 coordinates (bp) 
 Accession for which gene 
may be included in mapping 
interval 
AT2G29650 PHT4;1 12673383 - 
12676049 
None 
AT5G13320 WIN3 4267510 - 
4271051 
None 
AT5G20660 Zn-dependent 
exopeptidase 
6986235 - 
6991043 
None 
AT1G64280 NPR1 23852748 - 
23855566 
Pro-0 
AT1G74710 SID2 28070296 - 
28074118 
Bs-5 
AT3G48090 EDS1 17755373 - 
17757780 
Br-01 
AT3G52430 PAD4 19431371 - 
19434401 
Br-01 
AT5G46330 FLS2 18791736 - 
18795546 
Rmx-A1801 
1 QTL did not cross the significance threshold but LOD score value spanning the specified interval was higher than 
other genomic regions 
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I have more direct evidence for an NLR modifying ACD6-dependent 
responses in Pro-0 from amiRNA-mediated knockdown of genes in the 
RPP4/5 cluster. RPP4/5 activity is SA and NDR1 dependent (van der Biezen, 
Freddie et al. 2002), consistent with the hypothesized ACD6-Pro-0 modifier 
function. In particular, SUPPRESSOR OF NPR1, CONSTITUTIVE 1 (SNC1), 
part of the RPP4/5 cluster, has been implicated in constitutive resistance to 
Psm and Hyaloperonospora arabidopsidis pv. Noco (Li, Clarke et al. 2001). 
Specifically, PAD4 and SA mediate enhanced SNC1-dependent resistance 
(Yang, Li et al. 2006), similar to ACD6. Moreover, feedback amplification in 
disease resistance involves SA and is linked to growth and defense trade-off 
subject to temperature conditions (Yang and Hua 2004). Deletions of an 
RPP4 NLR gene in snc1 reverted the plants to wild-type morphology and 
completely abolished constitutive PR1 expression and disease resistance 
(Zhang, Goritschnig et al. 2003). All these features make SNC1 or other gene 
in the RPP4/5 cluster a likely candidate as the ACD6-Pro-0 modifier in 
chromosome 4. Cloning of Est-1 and Pro-0 SNC1 and RPP4/5 genes and 
transformation into Col-0 and acd6-2 should further support this hypothesis. 
 A screen for SNC1 suppressors has identified MODIFIER OF SNC1, 3 
(MOS3), mutations in which suppress snc1 autoimmune phenotypes (Zhang 
and Li 2005). SNC1 could be the shared modifier loci between Pro-0 and Bs-
5. In addition, MOS3 was included in the Bayesian credible interval of the 
chromosome 1 ACD6-Bs-5 modifier. Non-synonymous amino acid changes 
could be seen when Col-0, Est-1 and Bs-1 MOS3 amino acid sequences were 
compared (Appendix Figure 6).  
 There has been speculation on NLRs having a link to ACD6 responses 
(Dong 2004). However a direct NLR-ACD6 interaction has yet to be shown. 
ACD6 is a very low abundance protein for which cell biological approaches 
(e.g. imaging of fluorescent fusion proteins) have not been possible (Zhang, 
Shrestha et al. 2014). Biochemical approaches such as co-
immunoprecipitation of complexes are very tedious since tagging ACD6 
seems to often disrupt protein function as seen from attempts from myself, Dr. 
Marco Todesco (pers. communication) and Shrestha (2010). Taking results 
from my study, it is possible that NLR and ACD6 function are linked via SA or 
genes that are involved in the SA-dependent immune response. Some of 
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these genes that could link NLRs and ACD6 include EDS1, PAD4, NPR1 and 
NDR1 (Century, Holub et al. 1995, Aarts, Metz et al. 1998, Bittner-Eddy and 
Beynon 2001, Lu, Rate et al. 2003, Hu, deHart et al. 2005, Venugopal, Jeong 
et al. 2009, Ng, Seabolt et al. 2011).  
6.4 Summary 
 Based on my results, I propose that 1) Pro-0 has suppressors of ACD6 
hyperactivity that dampen Pro-0 immune responses, but do not increase 
growth, and 2) Rmx-A180 has modulators of ACD6 hyperactivity that 
moderate hyperactive ACD6 constitutive activation of immune responses to 
be inducible instead (Figure 6.1). Rmx-A180 tempered immune responses 
seem to uncouple hyperactive ACD6 effects on growth and overt necrosis 
from those on immunity. At least in Rmx-A180, my results are consistent with 
the speculative idea that ACD6 may function like a guardee or decoy. 
Removal or modification of the guardee results in R signaling and activation of 
acd6-1 Col-0 Est-1 Est-1 amiR-ACD6
Pro-0 Pro-0 amiR-ACD6 Rmx-A180
Rmx-A180 
amiR-ACD6
Growth
Defense
Growth
Defense Growth
Defense
Growth
Defense
Figure 6.1 The hyperactive ACD6 allele trade-off effect on growth and defense can be uncoupled as 
exemplified by accessions with modifiers of the effects of Est-like ACD6 alleles.   
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resistance (Van der Biezen and Jones 1998, Dangl and Jones 2001, van der 
Hoorn and Kamoun 2008). Without the functional removal (as in knocking 
down) of ACD6, the modifier could be inactive, therefore completely 
suppressing hyperactive ACD6 effects. Either the “activated” modifier itself or 
another component that is switched on by the modifier could be causal for 
inducing downstream Rmx-A180 defense responses and only be activated 
when the modifier detects ACD6 degradation or modification. Further 
experiments are needed to support this hypothesis and are thus currently 
underway.  
6.5 Outlook 
 My work furthers our understanding of how ACD6 affects the trade-off 
between plant growth and defense. My work also brings us closer to 
understanding why a hyperactive ACD6 allele is maintained in natural 
populations. On the basis of natural variation, I have been able to showcase 
1) the diversity in ACD6 allele types, and 2) diversification of ACD6-
downstream signaling through the action of extragenic modifiers. The study of 
accessions with a hyperactive ACD6 allele showed that ACD6 has variable 
effects on the growth and defense phenotypes of specific accessions, which 
can be due to extragenic modulators of ACD6 activity.   
 Defense signaling in plants is a product of multiple, sometimes 
bifurcated and complex pathways with significant crosstalk. The proper 
activation of these responses relies on numerous defenses repertoires 
inclusive of preformed defense responses, molecular and biochemical 
cascades, hormonal regulation and the initiation of gene-for-gene resistance 
(Knepper and Day 2010). These immune responses must be modulated such 
that constitutive activation costs are minimized. The pleiotropic ACD6 trade-
off on growth and defense is not an exception. It will be important to identify 
these modifiers, and investigate whether they evolved only on the background 
of the hyperactive ACD6 allele, or segregate independently in the global A. 
thaliana population, and whether they have effects on their own on growth 
and defense. 
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8 Appendix 
 
Appendix Table 1. Arabidopsis thaliana accessions used in this study 
Ecotype ID Name Country Latitude Longitude 
88 CYR FRA 47.4 0.683333 
108 LDV-18 FRA 48.5167 -4.06667 
139 LDV-46 FRA 48.5167 -4.06667 
159 MAR2-3 FRA 47.35 3.93333 
265 PYL-6 FRA 44.65 -1.16667 
350 TOU-A1-88 FRA 46.6667 4.11667 
351 TOU-A1-89 FRA 46.6667 4.11667 
403 Zdarec3 CZE 49.3667 16.2667 
410 Doubravnik7 CZE 49.4211 16.3497 
424 Draha2 CZE 49.4112 16.2815 
428 Borky1 CZE 49.403 16.232 
430 Gr-1 AUT 47 15.5 
583 LI-YA-030 USA 40.8198 -72.9156 
630 LI-OF-065 USA 40.7777 -72.9069 
763 Kar-1 KGZ 42.3 74.3667 
765 Sus-1 KGZ 42.1833 73.4 
766 Dja-1 KGZ 42.5833 73.6333 
768 Zal-1 KGZ 42.8 76.35 
770 Kyr-1 KGZ 40.046526 72.683613 
772 Neo-6 TJK 37.35 72.4667 
801 KYC-33 USA 37.9169 -84.4639 
870 MIC-31 USA 41.8266 -86.4366 
915 LIN S-5 USA 41.8972 -71.4378 
932 CHA-41 USA 42.3634 -71.1445 
991 Ale-Stenar-41-1 SWE 55.3833 14.05 
992 Ale-Stenar-44-4 SWE 55.3833 14.05 
997 Ale-Stenar-56-14 SWE 55.3833 14.05 
1002 Ale-Stenar-64-24 SWE 55.3833 14.05 
1006 Ale-Stenar-77-31 SWE 55.3833 14.05 
1061 Brösarp-11-135 SWE 55.7167 14.1333 
1062 Brösarp-15-138 SWE 55.7167 14.1333 
1063 Brösarp-21-140 SWE 55.7167 14.1333 
1066 Brösarp-34-145 SWE 55.7167 14.1333 
1070 Brösarp-45-153 SWE 55.7167 14.1333 
Ecotype ID Name Country Latitude Longitude 
1074 Brösarp-61-162 SWE 55.7167 14.1333 
1137 Gårdby-22-213 SWE 56.6167 16.65 
1158 Aledal-6-49 SWE 56.7 16.5167 
1166 Aledal-14-73 SWE 56.7 16.5167 
1254 Tos-82-387 SWE 59.4333 17.0167 
1257 Tos-95-393 SWE 59.4333 17.0167 
1303 Ängsö-12-402 SWE 59.5667 16.8667 
1313 Ängsö-59-422 SWE 59.5667 16.8667 
1317 Ängsö-74-430 SWE 59.5667 16.8667 
1318 Ängsö-80-432 SWE 59.5667 16.8667 
1363 Ham-7-233 SWE 59.7833 17.5833 
1367 Ham-13-241 SWE 59.7833 17.5833 
1435 Röd-17-319 SWE 62.8 18.2 
1552 Sku-30 SWE 63.0833 18.3667 
1585 Hen-16-268 SWE 65.25 15.6 
1829 Mdn-1 USA 42.051 -86.509 
1853 MNF-Pot-21 USA 43.595 -86.2657 
1872 MNF-Pot-75 USA 43.595 -86.2657 
1890 MNF-Riv-21 USA 43.5139 -86.1859 
1925 MNF-Che-2 USA 43.5251 -86.1843 
1954 MNF-Jac-12 USA 43.5187 -86.1739 
2016 MNF-Pin-39 USA 43.5356 -86.1788 
2171 Paw-26 USA 42.148 -86.431 
2202 Pent-23 USA 43.7623 -86.3929 
2276 SLSP-31 USA 43.665 -86.496 
2278 SLSP-35 USA 43.665 -86.496 
2317 Ste-40 USA 42.03 -86.514 
4779 UKSW06-179 UK 50.4 -4.9 
4807 UKSW06-207 UK 50.4 -4.9 
4826 UKSW06-226 UK 50.4 -4.9 
4884 UKSW06-285 UK 50.3 -4.9 
4900 UKSW06-302 UK 50.3 -4.8 
4931 UKSW06-333 UK 50.327643 -4.6 
4958 UKSW06-360 UK 50.5 -4.5 
5023 UKSE06-118 UK 51.3 0.5 
5104 UKSE06-252 UK 51.3 0.5 
5151 UKSE06-325 UK 52.2 -1.7 
5165 UKSE06-362 UK 51.3 0.4 
5210 UKSE06-432 UK 51.2 0.3 
5236 UKSE06-470 UK 51.2 0.4 
5253 UKSE06-500 UK 51.1 0.6 
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5276 UKSE06-533 UK 51.3 1.1 
5349 UKSE06-639 UK 51.1 0.4 
5353 UKNW06-003 UK 54.5 -3 
5470 UKNW06-212 UK 54.7 -3.4 
5486 UKNW06-233 UK 54.6 -3.3 
5506 UKNW06-281 UK 54.6 -3.1 
5535 UKNW06-354 UK 54.6 -3.1 
5577 UKNW06-403 UK 54.7 -3.4 
5644 UKNW06-481 UK 54.4 -2.9 
5720 Cal-2 UK 53.3 -1.6 
5726 Cnt-1 UK 51.3 1.1 
5741 For-2 UK 56.6 -4.1 
5748 Kil-0 UK 56 -4.4 
5757 Mc-1 UK 54.6 -2.3 
5768 UKID63 UK 54.1 -1.5 
5772 Set-1 UK 54.1 -2.3 
5778 Sna-1 UK 52.2 1.5 
5779 UKID74 UK 51 -3.1 
5784 Ty-1 UK 56.4 -5.2 
5800 UKID96 UK 57.4 -5.5 
5811 UKID107 UK 52.9 -3.1 
5818 UKID114 UK 51.8 -0.6 
5822 UKID116 UK 56.7333 -5.98333 
5829 Ale1-2 SWE 55.3838 14.0612 
5830 App1-12 SWE 56.3333 15.9667 
5831 App1-14 SWE 56.3333 15.9667 
5832 App1-16 SWE 56.3333 15.9667 
5835 Bil-3 SWE 63.324 18.484 
5836 Boo2-3 SWE 55.86 13.51 
5837 Bor-1 CZE 49.4013 16.2326 
5856 Dör-10 SWE 63.0167 17.4914 
5860 Dra-3 SWE 62.6814 18.0165 
5865 Dra1-4 SWE 55.76 14.12 
5867 Dra2-1 SWE 55.76 14.12 
5874 DraII-6 CZE 49.4112 16.2815 
5890 DraIV 1-8 CZE 49.4112 16.2815 
5893 DraIV 1-11 CZE 49.4112 16.2815 
5907 DraIV 2-9 CZE 49.4112 16.2815 
5921 DraIV 3-7 CZE 49.4112 16.2815 
5950 DraIV 5-12 CZE 49.4112 16.2815 
5964 DraIV 5-28 CZE 49.4112 16.2815 
5984 DraIV 6-13 CZE 49.4112 16.2815 
Ecotype ID Name Country Latitude Longitude 
5993 DraIV 6-22 CZE 49.4112 16.2815 
6008 Duk CZE 49.1 16.2 
6009 Eden-1 SWE 62.877 18.177 
6010 Eden-5 SWE 62.877 18.177 
6011 Eden-6 SWE 62.877 18.177 
6012 Eden-7 SWE 62.877 18.177 
6013 Eden-9 SWE 62.877 18.177 
6016 Eds-1 SWE 62.9 18.4 
6017 Eds-9 SWE 62.9 18.4 
6019 Fjä1-2 SWE 56.06 14.29 
6020 Fjä1-5 SWE 56.06 14.29 
6021 Fjä2-4 SWE 56.06 14.29 
6022 Fjä2-6 SWE 56.06 14.29 
6023 Fly2-1 SWE 55.7509 13.3712 
6024 Fly2-2 SWE 55.7509 13.3712 
6025 Gro-3 SWE 62.6437 17.7339 
6030 Grön-5 SWE 62.806 18.1896 
6034 Hov1-7 SWE 56.1 13.74 
6035 Hov1-10 SWE 56.1 13.74 
6036 Hov3-2 SWE 56.1 13.74 
6038 Hov3-5 SWE 56.1 13.74 
6039 Hovdala-2 SWE 56.1 13.74 
6040 Kni-1 SWE 55.66 13.4 
6041 Lis-3 SWE 56.0328 14.775 
6042 Lom1-1 SWE 56.09 13.9 
6043 Löv-1 SWE 62.801 18.079 
6046 Löv-5 SWE 62.801 18.079 
6064 Nyl-2 SWE 62.9513 18.2763 
6069 Nyl-7 SWE 62.9513 18.2763 
6070 Omn-1 SWE 62.9308 18.3448 
6071 Omn-5 SWE 62.9308 18.3448 
6073 ÖMö1-7 SWE 56.1481 15.8155 
6074 Ör-1 SWE 56.4573 16.1408 
6076 Rev-2 SWE 55.6942 13.4504 
6077 Rev-3 SWE 55.6942 13.4504 
6085 Sparta-1 SWE 55.7097 13.2145 
6086 Sr:3 SWE 58.9 11.2 
6087 Stu-2 SWE 56.4666 16.1284 
6088 Stu1-1 SWE 56.4666 16.1284 
6090 T1000 SWE 55.6525 13.2197 
6091 T1010 SWE 55.6525 13.215 
6092 T1020 SWE 55.6514 13.2233 
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6094 T1040 SWE 55.6494 13.2147 
6095 T1050 SWE 55.6486 13.2161 
6096 T1060 SWE 55.6472 13.2225 
6097 T1070 SWE 55.6481 13.2264 
6098 T1080 SWE 55.6561 13.2178 
6099 T1090 SWE 55.6575 13.2386 
6100 T1110 SWE 55.6 13.2 
6101 T1120 SWE 55.6 13.2 
6102 T1130 SWE 55.6 13.2 
6104 T1160 SWE 55.7 13.2 
6288 Udu-12 CZE 49.2771 16.6314 
6390 UduI 3-36 CZE 49.2771 16.6314 
6396 UduI 4-9 CZE 49.2771 16.6314 
6413 Ull3-4 SWE 56.06 13.97 
6424 ZdrI 1-23 CZE 49.3853 16.2544 
6434 ZdrI 2-9 CZE 49.3853 16.2544 
6445 ZdrI 2-21 CZE 49.3853 16.2544 
6680 ANH-1 GER 51.85 6.4333 
6709 Bg-2 USA 47.6479 -122.305 
6744 CSHL-5 USA 40.8585 -73.4675 
6830 KZ13 KAZ 49.5 73.1 
6897 Ag-0 FRA 45 1.3 
6898 An-1 BEL 51.2167 4.4 
6900 Bil-5 SWE 63.324 18.484 
6901 Bil-7 SWE 63.324 18.484 
6903 Bor-4 CZE 49.4013 16.2326 
6904 Br-0 CZE 49.2 16.6166 
6906 C24 POR 40.2077 -8.42639 
6907 CIBC-17 UK 51.4083 -0.6383 
6908 CIBC-5 UK 51.4083 -0.6383 
6909 Col-0 USA 38.3 -92.3 
6911 Cvi-0 CPV 15.1111 -23.6167 
6913 Eden-2 SWE 62.877 18.177 
6915 Ei-2 GER 50.3 6.3 
6916 Est-1 RUS 58.3 25.3 
6917 Fäb-2 SWE 63.0165 18.3174 
6918 Fäb-4 SWE 63.0165 18.3174 
6919 Ga-0 GER 50.3 8 
6920 Got-22 GER 51.5338 9.9355 
6921 Got-7 GER 51.5338 9.9355 
6922 Gu-0 GER 50.3 8 
6923 HR-10 UK 51.4083 -0.6383 
Ecotype ID Name Country Latitude Longitude 
6924 HR-5 UK 51.4083 -0.6383 
6926 Kin-0 USA 44.46 -85.37 
6927 Knox-10 USA 41.2816 -86.621 
6928 Knox-18 USA 41.2816 -86.621 
6929 Kondara TJK 38.48 68.49 
6931 Kz-9 KAZ 49.5 73.1 
6932 Ler-1 GER 47.984 10.8719 
6933 LL-0 ESP 41.59 2.49 
6936 Lz-0 FRA 46 3.3 
6937 Mrk-0 GER 49 9.3 
6938 Ms-0 RUS 55.7522 37.6322 
6939 Mt-0 LIB 32.34 22.46 
6940 Mz-0 GER 50.3 8.3 
6943 NFA-10 UK 51.4083 -0.6383 
6944 NFA-8 UK 51.4083 -0.6383 
6945 Nok-3 NED 52.24 4.45 
6951 Pu2-23 CZE 49.42 16.36 
6956 Pu2-7 CZE 49.42 16.36 
6957 Pu2-8 CZE 49.42 16.36 
6958 Ra-0 FRA 46 3.3 
6959 Ren-1 FRA 48.5 -1.41 
6960 Ren-11 FRA 48.5 -1.41 
6961 Se-0 ESP 38.3333 -3.53333 
6963 Sorbo TJK 38.35 68.48 
6964 Spr1-2 SWE 56.3 16 
6965 Spr1-6 SWE 58.4173 14.1576 
6966 Sq-1 UK 51.4083 -0.6383 
6967 Sq-8 UK 51.4083 -0.6383 
6968 Tamm-2 FIN 60 23.5 
6969 Tamm-27 FIN 60 23.5 
6970 Ts-1 ESP 41.7194 2.93056 
6971 Ts-5 ESP 41.7194 2.93056 
6972 Tsu-1 JPN 34.43 136.31 
6973 Ull2-3 SWE 56.0648 13.9707 
6974 Ull2-5 SWE 56.0648 13.9707 
6975 Uod-1 AUT 48.3 14.45 
6976 Uod-7 AUT 48.3 14.45 
6979 Wei-0 SUI 47.25 8.26 
6981 Ws-2 RUS 52.3 30 
6982 Wt-5 GER 52.3 9.3 
6984 Zdr-1 CZE 49.3853 16.2544 
6985 Zdr-6 CZE 49.3853 16.2544 
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6986 Abd-0 UK 57.1539 -2.2207 
6987 Ak-1 GER 48.0683 7.62551 
6989 Alst-1 UK 54.8 -2.4333 
6990 Amel-1 NED 53.448 5.73 
6992 Ang-0 BEL 50.3 5.3 
6994 Ann-1 FRA 45.9 6.13028 
6997 Appt-1 NED 51.8333 5.5833 
7000 Aa-0 GER 50.9167 9.57073 
7002 Baa-1 NED 51.3333 6.1 
7003 Bs-1 SUI 47.5 7.5 
7008 Benk-1 NED 52 5.675 
7010 Be-0 GER 49.6803 8.6161 
7013 Bd-0 GER 52.4584 13.287 
7014 Ba-1 UK 56.5459 -4.79821 
7025 Bl-1 ITA 44.5041 11.3396 
7026 Boot-1 UK 54.4 -3.2667 
7028 Bch-1 GER 49.5166 9.3166 
7031 Bsch-0 GER 50.0167 8.6667 
7033 Buckhorn Pass USA 41.3599 -122.755 
7036 Bu-0 GER 50.5 9.5 
7058 Bur-0 IRL 54.1 -6.2 
7061 Cal-0 UK 53.2699 -1.64293 
7062 Ca-0 GER 50.2981 8.26607 
7063 Can-0 ESP 29.2144 -13.4811 
7064 Cnt-1 UK 51.3 1.1 
7067 Ct-1 ITA 37.3 15 
7068 Cerv-1 ITA 42 12.1 
7071 Chat-1 FRA 48.0717 1.33867 
7072 Chi-0 RUS 53.7502 34.7361 
7075 Cit-0 FRA 43.3779 2.54038 
7077 Co-1 POR 40.12 -8.25 
7081 Co POR 40.2077 -8.42639 
7092 Com-1 FRA 49.416 2.823 
7094 Da-0 GER 49.8724 8.65081 
7096 Di-G FRA 47.3239 5.04278 
7098 Di-1 FRA 47 5 
7102 Do-0 GER 50.7224 8.2372 
7103 Dra-0 CZE 49.4167 16.2667 
7106 Dr-0 GER 51.051 13.7336 
7107 Durh-1 UK 54.7761 -1.5733 
7109 Ema-1 UK 51.3 0.5 
7111 Edi-0 UK 55.9494 -3.16028 
Ecotype ID Name Country Latitude Longitude 
7117 El-0 GER 51.5105 9.68253 
7119 En-2 GER 50 8.5 
7120 En-D GER 50 8.5 
7123 Ep-0 GER 50.1721 8.38912 
7125 Er-0 GER 49.5955 11.0087 
7126 Es-0 FIN 60.1997 24.5682 
7127 Est GER 58.6656 24.9871 
7130 Et-0 FRA 44.6447 2.56481 
7133 Fr-2 GER 50.1102 8.6822 
7138 Fi-0 GER 50.5 8.0167 
7143 Gel-1 NED 51.0167 5.86667 
7147 Gie-0 GER 50.584 8.67825 
7148 Gifu-2 JPN 35.45 137.42 
7158 Gr-5 AUT 47 15.5 
7160 Gre-0 USA 43.178 -85.2532 
7161 Gd-1 GER 53.5 10.5 
7162 Hs-0 GER 52.24 9.44 
7163 Ha-0 GER 52.3721 9.73569 
7164 Hau-0 DEN 55.675 12.5686 
7165 Hn-0 GER 51.3472 8.28844 
7166 Hey-1 NED 51.25 5.9 
7167 Hi-0 NED 52 5 
7169 Hh-0 GER 54.4175 9.88682 
7177 Jm-0 CZE 49 15 
7181 Je-0 GER 50.927 11.587 
7182 Ka-0 AUT 47 14 
7186 Kn-0 LTU 54.8969 23.8924 
7192 Kil-0 UK 55.6395 -5.66364 
7199 Kl-5 GER 50.95 6.9666 
7202 Kb-0 GER 50.1797 8.50861 
7203 Krot-0 GER 49.631 11.5722 
7206 Kro-0 GER 50.0742 8.96617 
7207 Kyoto JPN 35.0085 135.752 
7208 Lan-0 UK 55.6739 -3.78181 
7209 La-0 POL 52.7333 15.2333 
7213 Ler-0 GER 47.984 10.8719 
7217 Lm-2 FRA 48 0.5 
7218 Le-0 NED 52.1611 4.49015 
7223 Li-2:1 GER 50.3833 8.0666 
7231 Li-7 GER 50.3833 8.0666 
7236 Litva LTU   
7244 Mnz-0 GER 50.001 8.26664 
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7248 Mv-0 USA 41.3923 -70.6652 
7250 Me-0 GER 51.9183 10.1138 
7252 Mc-0 UK 54.6167 -2.3 
7255 Mh-0 POL 50.95 7.5 
7258 Nw-0 GER 50.5 8.5 
7263 Nz-1 NZL -37.7871 175.283 
7268 Np-0 GER 52.6969 10.981 
7273 No-0 GER 51.0581 13.2995 
7276 Ob-0 GER 50.2 8.5833 
7280 Old-1 GER 53.1667 8.2 
7282 Or-0 GER 50.3827 8.01161 
7287 Ove-0 GER 53.3422 8.42255 
7288 Oy-0 NOR 60.385543 6.193019 
7296 Petergof RUS 59 29 
7298 Pi-0 AUT 47.04 10.51 
7305 Pt-0 GER 53.476 10.6065 
7306 Pog-0 CAN 49.2655 -123.206 
7307 Pn-0 FRA 48.0653 -2.96591 
7308 Po-0 GER 50.7167 7.1 
7314 Ragl-1 UK 54.3512 -3.41697 
7316 Rhen-1 NED 51.9667 5.56667 
7319 Rome-1 ITA 42 12.1 
7320 Rou-0 FRA 49.4424 1.09849 
7322 Rsch-4 RUS 56.3 34 
7323 Rubeznhoe-1 UKR 49 38.28 
7327 Sf-1 ESP 41.7833 3.03333 
7328 Sf-2 ESP 41.7833 3.03333 
7329 Santa Clara USA 37.21 -121.16 
7330 Sapporo-0 JPN 43.0553 141.346 
7332 Seattle-0 USA 47 -122.2 
7333 Sei-0 ITA 46.5438 11.5614 
7337 Si-0 GER 50.8738 8.02341 
7342 Su-0 UK 53.6473 -3.00733 
7343 Sp-0 GER 52.5339 13.181 
7344 Sg-1 GER 47.6667 9.5 
7346 Ste-0 GER 52.6058 11.8558 
7347 Stw-0 RUS 52 36 
7349 Ta-0 CZE 49.5 14.5 
7350 Tac-0 USA 47.2413 -122.459 
7351 Ty-0 UK 56.4278 -5.23439 
7353 Tha-1 NED 52.08 4.3 
7354 Ting-1 SWE 56.5 14.9 
Ecotype ID Name Country Latitude Longitude 
7355 Tiv-1 ITA 41.96 12.8 
7356 Tol-0 USA 41.6639 -83.5553 
7372 Tscha-1 AUT 47.0748 9.9042 
7373 Tsu-0 JPN 34.43 136.31 
7375 Tu-0 ITA 45 7.5 
7377 Tul-0 USA 43.2708 -85.2563 
7378 Uk-1 GER 48.0333 7.7667 
7382 Utrecht NED 52.0918 5.1145 
7383 Van-0 CAN 49.2655 -123.206 
7384 Ven-1 NED 52.0333 5.55 
7387 Vind-1 UK 54.9902 -2.3671 
7394 Wa-1 POL 52.3 21 
7396 Ws-0 RUS 52.3 30 
7404 Wc-1 GER 52.6 10.0667 
7411 Wl-0 GER 47.9299 10.8134 
7413 Wil-2 LTU 54.6833 25.3167 
7415 Wu-0 GER 49.7878 9.9361 
7416 Yo-0 USA 37.45 -119.35 
7417 Zu-0 SUI 47.3667 8.55 
7418 Zu-1 SUI 47.3667 8.55 
7419 Db-1 GER 50.3058 8.32213 
7424 Jl-3 CZE 49.2 16.6166 
7427 Ko-2 DEN   
7430 Nc-1 FRA 48.6167 6.25 
7438 N13 RUS 61.36 34.15 
7458 Ber DEN 55.675 12.5687 
7460 Da(1)-12 CZE   
7461 H55 CZE 49 15 
7471 RLD-1 UNK   
7477 WAR USA 41.7302 -71.2825 
7514 RRS-7 USA 41.5609 -86.4251 
7515 RRs-10 USA 41.5609 -86.4251 
7516 Vår2-1 SWE 55.58 14.334 
7517 Vår2-6 SWE 55.58 14.334 
7518 ÖMö2-1 SWE 56.1509 15.7735 
7519 ÖMö2-3 SWE 56.1509 15.7735 
7520 Lp2-2 CZE 49.38 16.81 
7521 Lp2-6 CZE 49.38 16.81 
7522 Mr-0 ITA 44.15 9.65 
7523 Pna-17 USA 42.0945 -86.3253 
7524 Rmx-A02 USA 42.036 -86.511 
7525 Rmx-A180 USA 42.036 -86.511 
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7526 Pna-10 USA 42.0945 -86.3253 
7717 KNO1.37 USA 41.273 -86.625 
7917 PNA3.10 USA 42.0945 -86.3253 
7947 PNA3.40 USA 42.0945 -86.3253 
8077 PT2.21 USA 41.3423 -86.7368 
8132 RMX3.22 USA 42.036 -86.511 
8213 Pro-0 ESP 43.25 -6 
8214 Gy-0 FRA 49 2 
8222 Lis-2 SWE 56.0328 14.775 
8227 THÖ 03 SWE 62.7989 17.9103 
8230 Algutsrum SWE 56.68 16.5 
8231 Brö1-6 SWE 56.3 16 
8233 Dem-4 USA 41.1876 -87.1923 
8234 Gul1-2 SWE 56.4606 15.8127 
8235 Hod CZE 48.8 17.1 
8236 HSm CZE 49.33 15.76 
8237 Kävlinge-1 SWE 55.8 13.1 
8238 Kent UK 51.15 0.4 
8239 Köln GER 51 7 
8240 Kulturen-1 SWE 55.705 13.196 
8241 Liarum SWE 55.9473 13.821 
8242 Lillö-1 SWE 56.1494 15.7884 
8243 PHW-2 ITA 43.7703 11.2547 
8244 PHW-34 FRA 48.6103 2.3086 
8246 NC-6 USA 35 -79.18 
8247 San-2 SWE 56.07 13.74 
8249 Vimmerby SWE 57.7 15.8 
8256 Bå1-2 SWE 56.4 12.9 
8258 Bå4-1 SWE 56.4 12.9 
8259 Bå5-1 SWE 56.4 12.9 
8264 Bla-1 ESP 41.6833 2.8 
8266 Boo2-1 SWE 55.86 13.51 
8275 Cen-0 FRA 49 0.5 
8283 Dra3-1 SWE 55.76 14.12 
8284 DraII-1 CZE 49.4112 16.2815 
8285 DraIII-1 CZE 49.4112 16.2815 
8290 En-1 GER 50 8.5 
8297 Ge-0 SUI 46.5 6.08 
8306 Hov4-1 SWE 56.1 13.74 
8307 Hovdala-6 SWE 56.1 13.74 
8311 In-0 AUT 47.5 11.5 
8312 Is-0 GER 50.5 7.5 
Ecotype ID Name Country Latitude Longitude 
8325 Lip-0 POL 50 19.3 
8326 Lis-1 SWE 56.0328 14.775 
8334 Lu-1 SWE 55.71 13.2 
8335 Lund SWE 55.71 13.2 
8337 Mir-0 ITA 44 12.37 
8343 Na-1 FRA 47.5 1.5 
8351 Ost-0 SWE 60.25 18.37 
8353 Pa-1 ITA 38.07 13.22 
8354 Per-1 RUS 58 56.3167 
8357 Pla-0 ESP 41.5 2.25 
8365 Rak-2 CZE 49 16 
8366 Rd-0 GER 50.5 8.5 
8369 Rev-1 SWE 55.6942 13.4504 
8376 Sanna-2 SWE 62.69 18 
8378 Sap-0 CZE 49.49 14.24 
8386 Sr:5 SWE 58.9 11.2 
8387 St-0 SWE 59 18 
8419 Wil-1 LTU 54.6833 25.3167 
8420 Kelsterbach-4 GER 50.0667 8.5333 
8422 Fjä1-1 SWE 56.06 14.29 
8423 Hov2-1 SWE 56.1 13.74 
8424 Kas-2 IND 35 77 
8424 Kas-2 IND 35 77 
8426 Ull1-1 SWE 56.06 13.97 
8427 Ull2-13 SWE 56.0648 13.9707 
8428 Uod-2 AUT 48.3 14.45 
8430 Lisse NED 52.25 4.5667 
8472 LP3413.41 USA 41.6862 -86.8513 
8584 328ME059 USA 42.093 -86.359 
9045 RMXF413.15 USA 42.039 -86.5154 
9057 Vinslöv SWE 56.1 13.9167 
9058 Västervik SWE 57.75 16.6333 
9061 Dog-5 TUR 38.3011 42.2239 
9063 Dog-7 TUR 38.3011 42.2239 
9064 Dog-8 TUR 38.3011 42.2239 
9066 Xan-2 AZE 38.6536 48.7992 
9067 Xan-3 AZE 38.6536 48.7992 
9069 Xan-5 AZE 38.6536 48.7992 
9070 Xan-6 AZE 38.6536 48.7992 
9073 Lerik1-2 AZE 38.7406 48.6131 
9075 Lerik1-4 AZE 38.7406 48.6131 
9078 Lerik1-7 AZE 38.7406 48.6131 
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9079 Lerik2-1 AZE 38.7833 48.5517 
9081 Lerik2-3 AZE 38.7833 48.5517 
9082 Lerik2-4 AZE 38.7833 48.5517 
9084 Lerik2-6 AZE 38.7833 48.5517 
9085 Lerik2-7 AZE 38.7833 48.5517 
9089 Nar-3 AZE 38.9522 48.925 
9090 Nar-4 AZE 38.9522 48.925 
9091 Nar-5 AZE 38.9522 48.925 
9094 Istisu-4 AZE 38.9786 48.5594 
9095 Istisu-5 AZE 38.9786 48.5594 
9096 Istisu-6 AZE 38.9786 48.5594 
9098 Istisu-8 AZE 38.9786 48.5594 
9099 Istisu-9 AZE 38.9786 48.5594 
9100 Lag1-2 GEO 41.8296 46.2831 
9102 Lag1-4 GEO 41.8296 46.2831 
9103 Lag1-5 GEO 41.8296 46.2831 
9104 Lag1-6 GEO 41.8296 46.2831 
9105 Lag1-7 GEO 41.8296 46.2831 
9106 Lag1-8 GEO 41.8296 46.2831 
9111 Lag2-4 GEO 41.8296 46.2831 
9113 Lag2-6 GEO 41.8296 46.2831 
9114 Lag2-7 GEO 41.8296 46.2831 
9115 Lag2-10 GEO 41.8296 46.2831 
9119 Bak-3 GEO 41.7942 43.4767 
9120 Bak-4 GEO 41.7942 43.4767 
9121 Bak-5 GEO 41.7942 43.4767 
9124 Bak-9 GEO 41.7942 43.4767 
9125 Geg-14 ARM 40.1408 44.8203 
9128 Yeg-2 ARM 39.8692 45.3622 
9130 Yeg-4 ARM 39.8692 45.3622 
9131 Yeg-5 ARM 39.8692 45.3622 
9133 Yeg-7 ARM 39.8692 45.3622 
9134 Yeg-8 ARM 39.8692 45.3622 
9298 Edinburgh-1 UK 55.9681 -3.21833 
9312 Ullapool-8 UK 57.9 -5.1525 
9314 Gol-2 UK 57.9672 -3.96722 
9321 Ådal 1 SWE 62.8622 18.336 
9323 Ådal 3 SWE 62.8622 18.336 
9332 Bar 1 SWE 62.8698 18.381 
9336 Bön 1 SWE 62.8794 18.4473 
9339 Böt 1 SWE 57.7133 15.0689 
9343 Dja 1 SWE 57.3089 18.1512 
Ecotype ID Name Country Latitude Longitude 
9352 Död 2 SWE 57.2608 16.3675 
9353 Död 3 SWE 57.2608 16.3675 
9356 Eden 17 SWE 62.8762 18.1746 
9363 EdJ 2 SWE 62.9147 18.4045 
9369 EkS 2 SWE 57.6781 14.9986 
9370 EkS 3 SWE 57.6781 14.9986 
9371 FäL 1 SWE 63.016 18.3175 
9380 FlyA 3 SWE 55.7488 13.3742 
9381 Fri 1 SWE 55.8106 14.2091 
9382 Fri 2 SWE 55.8106 14.2091 
9383 Fri 3 SWE 55.8106 14.2091 
9386 Grön 12 SWE 62.806 18.1896 
9388 Grön 14 SWE 62.806 18.1896 
9390 Had-1 SWE 57.3263 15.8979 
9391 Had-2 SWE 57.3263 15.8979 
9392 Had-3 SWE 57.3263 15.8979 
9394 Hag-2 SWE 56.5804 16.4063 
9395 Hal-1 SWE 57.5089 15.0105 
9399 Ham-1 SWE 55.4234 13.9905 
9402 Hel-3 SWE 57.8765 14.8549 
9404 HolA-1 1 SWE 55.7491 13.399 
9405 HolA-1 2 SWE 55.7491 13.399 
9407 HolA-2 2 SWE 55.7491 13.399 
9408 Kal 1 SWE 56.047 13.9519 
9409 Kia 1 SWE 56.0573 14.302 
9412 Kor 3 SWE 57.2746 16.1494 
9413 Kor 4 SWE 57.2746 16.1494 
9416 Kru-3 SWE 57.7215 18.3837 
9418 Kva 2 SWE 57.2164 18.154 
9421 Lan 1 SWE 55.9745 14.3997 
9427 Näs 2 SWE 62.8815 18.4055 
9433 Nyl 13 SWE 62.9513 18.2763 
9434 Öde 2 SWE 62.8959 18.3659 
9436 Puk-1 SWE 56.1633 14.6806 
9437 Puk-2 SWE 56.1633 14.6806 
9442 Sim-1 SWE 55.5678 14.3398 
9450 Spro 1 SWE 57.2545 18.2109 
9451 Spro 2 SWE 57.2545 18.2109 
9452 Spro 3 SWE 57.2545 18.2109 
9453 Ste 2 SWE 57.8009 18.5162 
9454 Ste 3 SWE 57.8009 18.5162 
9455 Ste 4 SWE 57.8009 18.5162 
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9470 Tur-4 SWE 57.6511 14.8043 
9471 Ull-A-1 SWE 56.0648 13.9707 
9476 VårA 1 SWE 55.5796 14.3336 
9481 Yst-1 SWE 55.4242 13.8484 
9503 11C1 UK 55.8877 -3.21072 
9506 IP-Alo-0 POR 40.11 -7.47 
9507 IP-Coa-0 POR 38.45 -7.5 
9508 IP-Mos-1 POR 40.04 -7.11 
9509 IP-Reg-0 POR 39.29 -7.4 
9510 IP-Rei-0 POR 38.75 -7.59 
9511 IP-Vav-0 POR 38.53 -8.02 
9512 IP-Vid-1 POR 38.22 -7.84 
9513 IP-Adc-5 ESP 38.77 -4.07 
9514 IP-Adm-0 ESP 39.15 -4.54 
9515 IP-Ala-0 ESP 39.72 -6.89 
9516 IP-Ali-1 ESP 39.9 -5.09 
9517 IP-All-0 ESP 42.19 -7.8 
9518 IP-Alm-0 ESP 39.88 -0.36 
9519 IP-Ang-0 ESP 41.94 2.64 
9520 IP-Ara-4 ESP 41.7 -3.68 
9521 IP-Bar-1 ESP 41.43 2.13 
9522 IP-Bea-0 ESP 36.52 -5.27 
9523 IP-Ben-0 ESP 38.37 -2.66 
9524 IP-Ber-0 ESP 42.52 -0.56 
9525 IP-Bis-0 ESP 42.49 0.54 
9526 IP-Cab-3 ESP 41.54 2.39 
9527 IP-Cad-0 ESP 40.37 -5.74 
9528 IP-Cal-0 ESP 40.94 -1.37 
9529 IP-Cap-1 ESP 36.97 -3.36 
9530 IP-Car-1 ESP 38.25 -4.32 
9531 IP-Cdc-3 ESP 41.21 -4.54 
9532 IP-Cdo-0 ESP 42.23 -4.64 
9533 IP-Cem-0 ESP 41.15 -4.32 
9534 IP-Cmo-3 ESP 40.05 -4.65 
9535 IP-Coc-1 ESP 42.31 3.19 
9536 IP-Cor-0 ESP 40.83 -2 
9537 IP-Cum-1 ESP 38.07 -6.66 
9538 IP-Cur-4 ESP 43.12 -8.09 
9539 IP-Deh-1 ESP 40.29 -6.67 
9540 IP-Elb-0 ESP 41.81 2.34 
9541 IP-Fue-2 ESP 38.26 -5.42 
9542 IP-Fun-0 ESP 40.79 -4.05 
Ecotype ID Name Country Latitude Longitude 
9543 IP-Gra-0 ESP 36.77 -5.39 
9544 IP-Gua-1 ESP 39.4 -5.33 
9545 IP-Her-12 ESP 39.4 -5.78 
9546 IP-Hom-4 ESP 40.82 -1.68 
9547 IP-Hor-0 ESP 41.67 2.62 
9548 IP-Hoy-0 ESP 40.4 -5 
9549 IP-Hum-2 ESP 42.23 -3.69 
9550 IP-Iso-4 ESP 43.05 -5.37 
9551 IP-Jim-1 ESP 42.28 -5.92 
9552 IP-Lab-7 ESP 40.87 -4.5 
9553 IP-Ldd-0 ESP 41.58 -4.71 
9554 IP-Lso-0 ESP 38.86 -3.16 
9555 IP-Mar-1 ESP 39.58 -3.93 
9556 IP-Men-2 ESP 39.66 -4.34 
9557 IP-Moa-0 ESP 42.46 0.7 
9558 IP-Moc-11 ESP 41.57 -5.64 
9559 IP-Mon-5 ESP 38.06 -4.38 
9560 IP-Mot-0 ESP 38.19 -6.24 
9561 IP-Mun-0 ESP 40.71 -5.04 
9562 IP-Mur-0 ESP 41.67 2 
9563 IP-Nav-0 ESP 40.42 -4.65 
9564 IP-Nog-17 ESP 40.45 -1.6 
9565 IP-Orb-10 ESP 42.97 -1.23 
9566 IP-Oso-0 ESP 42.44 -4.36 
9567 IP-Pal-0 ESP 42.34 1.3 
9568 IP-Pan-0 ESP 42.76 -0.23 
9569 IP-Pds-1 ESP 42.87 -6.45 
9570 IP-Pob-0 ESP 41.35 1.03 
9571 IP-Pro-0 ESP 43.28 -6.01 
9572 IP-Pue-0 ESP 42.75 -3.05 
9573 IP-Rds-0 ESP 41.86 2.99 
9574 IP-Rel-0 ESP 38.6 -2.7 
9575 IP-Ren-6 ESP 42.77 -4.21 
9576 IP-Rev-0 ESP 40.86 -4.11 
9577 IP-Ria-0 ESP 42.34 2.17 
9578 IP-Sac-0 ESP 42.13 -6.7 
9579 IP-San-10 ESP 38.33 -3.51 
9580 IP-Scm-0 ESP 38.68 -3.57 
9581 IP-Sdv-3 ESP 42.84 -5.12 
9582 IP-Ses-0 ESP 41.48 -1.63 
9583 IP-Sne-0 ESP 37.09 -3.38 
9584 IP-Stp-0 ESP 41.19 -3.58 
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9585 IP-Svi-0 ESP 43.4 -7.39 
9586 IP-Tam-0 ESP 41.03 -3.27 
9587 IP-Tdc-0 ESP 41.5 -1.88 
9588 IP-Tol-7 ESP 42.11 0.6 
9589 IP-Tor-1 ESP 41.6 -2.83 
9590 IP-Trs-0 ESP 43.37 -5.49 
9591 IP-Vad-0 ESP 42.86 -3.59 
9592 IP-Vae-2 ESP 42.1 -5.44 
9593 IP-Vaz-0 ESP 42.26 -2.99 
9594 IP-Vdm-0 ESP 42.04 1.01 
9595 IP-Vdt-0 ESP 40.89 -5.5 
9596 IP-Ver-5 ESP 41.95 -7.45 
9597 IP-Vig-1 ESP 42.31 -2.53 
9598 IP-Vim-0 ESP 41.88 -6.51 
9599 IP-Vin-0 ESP 42.8 -5.77 
9600 IP-Vis-0 ESP 39.85 -6.04 
9601 IP-Voz-0 ESP 41.85 -1.88 
9602 IP-Vpa-1 ESP 40.5 -3.96 
9603 IP-Vpe-3 ESP 42.83 -4.72 
9604 IP-Yan-1 ESP 42.1 -2.35 
9605 IP-Zar-0 ESP 40.55 -4.19 
9606 Aitba-1 MAR 31.48 -7.45 
9607 Panik-1 RUS 53.05 52.15 
9608 Karag-2 RUS 51.37 59.44 
9609 Adam-1 RUS 51.41 59.98 
9610 Lesno-4 RUS 53.04 51.96 
9611 Lesno-1 RUS 53.04 51.9 
9612 Lesno-2 RUS 53.04 51.94 
9613 Balan-1 RUS 55.36 61.41 
9614 Kurga-3 RUS 55.53 65.33 
9615 Parti-1 RUS 52.99 52.16 
9616 Krazo-1 RUS 53.06 51.96 
9617 Karag-1 RUS 51.37 59.44 
9618 Kurga-2 RUS 55.61 65.08 
9619 Basta-1 RUS 51.84 79.48 
9620 Basta-2 RUS 51.82 79.48 
9621 Basta-3 RUS 51.84 79.46 
9622 Bijisk-4 RUS 52.52 85.27 
9623 Chaba-1 RUS 53.6 79.39 
9624 Chaba-2 RUS 53.6 79.37 
9625 Kolyv-2 RUS 51.31 82.59 
9626 Kolyv-3 RUS 51.36 82.59 
Ecotype ID Name Country Latitude Longitude 
9627 Kolyv-5 RUS 51.32 82.55 
9628 Kolyv-6 RUS 51.33 82.54 
9629 K-oze-1 RUS 51.35 82.18 
9630 K-oze-3 RUS 51.34 82.16 
9631 Lebja-1 RUS 51.65 80.79 
9632 Lebja-2 RUS 51.67 80.82 
9633 Lebja-4 RUS 51.63 80.83 
9634 Masl-1 RUS 54.13 81.31 
9635 Nosov-1 RUS 51.87 80.6 
9636 Noveg-1 RUS 51.75 80.82 
9637 Noveg-2 RUS 51.77 80.85 
9638 Noveg-3 RUS 51.73 80.86 
9639 Panke-1 RUS 53.82 80.31 
9640 Rakit-1 RUS 51.87 80.06 
9641 Rakit-2 RUS 51.9 80.06 
9642 Rakit-3 RUS 51.84 80.06 
9643 Sever-1 RUS 52.1 79.31 
9644 Zupan-1 CRO 45.07 18.72 
9645 Gradi-1 CRO 45.17 18.7 
9646 Aiell-1  #N/A #N/A 
9647 Basen-1 ITA 40.37 16.77 
9648 Bisig-1 ITA 39.48 16.28 
9649 Bivio-1 ITA 39.13 16.17 
9650 Corig-1 ITA 39.6 16.51 
9651 Filet-1 ITA 40.68 14.87 
9652 Fondi-1 ITA 41.36 13.4 
9653 Giffo-1 ITA 38.44 16.13 
9654 Liri-1 ITA 41.41 13.77 
9655 Marce-1 ITA 38.92 16.47 
9656 Marti-1 ITA 40.64 17.31 
9657 Melic-1 ITA 38.45 16.04 
9658 Nicas-1 ITA 38.97 16.34 
9659 Pigna-1 ITA 41.18 14.18 
9660 Sarno-1 ITA 40.84 14.57 
9661 Cimin-1 ITA 39.58 16.21 
9662 Stilo-1 ITA 38.47 16.47 
9663 Teano-1 ITA 41.33 14.09 
9664 Mitterberg-1-179 ITA 46.36 11.28 
9665 Mitterberg-1-180 ITA 46.36 11.28 
9666 Mitterberg-1-182 ITA 46.36 11.28 
9667 Mitterberg-1-183 ITA 46.36 11.28 
9668 Mitterberg-2-184 ITA 46.37 11.28 
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9669 Mitterberg-2-185 ITA 46.37 11.28 
9670 Mitterberg-2-186 ITA 46.37 11.28 
9671 Mitterberg-3-187 ITA 46.37 11.28 
9672 Mitterberg-3-188 ITA 46.37 11.28 
9673 Mitterberg-3-189 ITA 46.37 11.28 
9674 Mitterberg-4-190 ITA 46.37 11.29 
9675 Mitterberg-4-191 ITA 46.37 11.29 
9676 Mitterberg-4-192 ITA 46.37 11.29 
9677 Mitterberg-4-193 ITA 46.37 11.29 
9678 Mitterberg-4-194 ITA 46.37 11.29 
9679 Castelfed-1-195 ITA 46.34 11.29 
9680 Castelfed-1-196 ITA 46.34 11.29 
9681 Castelfed-1-197 ITA 46.34 11.29 
9682 Castelfed-1-198 ITA 46.34 11.29 
9683 Castelfed-1-199 ITA 46.34 11.29 
9684 Castelfed-2-200 ITA 46.34 11.29 
9685 Castelfed-2-201 ITA 46.34 11.29 
9686 Castelfed-2-202 ITA 46.34 11.29 
9687 Castelfed-2-203 ITA 46.34 11.29 
9688 Castelfed-2-204 ITA 46.34 11.29 
9689 Castelfed-3-205 ITA 46.34 11.29 
9690 Castelfed-3-206 ITA 46.34 11.29 
9691 Castelfed-3-207 ITA 46.34 11.29 
9692 Castelfed-3-208 ITA 46.34 11.29 
9693 Castelfed-3-209 ITA 46.34 11.29 
9694 Castelfed-4-210 ITA 46.34 11.29 
9695 Castelfed-4-211 ITA 46.34 11.29 
9696 Castelfed-4-214 ITA 46.34 11.29 
9697 Dolen-1 BUL 41.62 23.94 
9698 Goced-1 BUL 41.57 23.85 
9699 Kolar-1 BUL 41.37 23.14 
9700 Dolna-1 BUL 42.32 23.1 
9701 Ivano-1 BUL 43.7 25.91 
9702 Kolar-2 BUL 41.38 23.14 
9703 Melni-1 BUL 41.53 23.39 
9704 Melni-2 BUL 41.53 23.39 
9705 Choto-1 BUL 41.5 23.33 
9706 Dospa-1 BUL 41.64 24.18 
9707 Podvi-1 BUL 41.57 24.84 
9708 Kardz-1 BUL 41.62 25.35 
9709 Zerev-1 BUL 41.85 23.13 
9710 Zerev-1 BUL 41.85 23.13 
Ecotype ID Name Country Latitude Longitude 
9711 Dolna-1 BUL 42.32 23.1 
9712 Dolna-1 BUL 42.32 23.1 
9713 Stara-1 BUL 42.49 25.61 
9714 Grivo-1 BUL 41.84 25.75 
9715 Krepo-1 BUL 41.99 25.57 
9716 Leska-1 BUL 41.54 24.98 
9717 Kardz-2 BUL 41.66 25.47 
9718 Smolj-1 BUL 41.55 24.75 
9719 Koren-1 BUL 41.83 25.69 
9720 Malak-1 BUL 41.77 25.68 
9721 Schip-1 BUL 42.72 25.33 
9722 Groch-1 BUL 41.71 24.41 
9723 Slavi-2 BUL 41.42 23.67 
9724 Leska-1 BUL 41.54 24.98 
9725 Epidauros-1 GRC 37.6 23.08 
9726 Faneronemi-3 GRC 37.07 22.04 
9727 Olympia-2 GRC 37.63 21.62 
9728 Stiav-1 SVK 48.46 18.9 
9729 Stiav-2 SVK 48.46 18.9 
9730 Bela-1 SVK 48.47 18.94 
9731 Stiav-3 SVK 48.46 18.9 
9732 Halca-1 SVK 48.47 18.96 
9733 Bela-2 SVK 48.47 18.94 
9734 Bela-3 SVK 48.47 18.94 
9735 Bela-4 SVK 48.47 18.94 
9736 Teiu-2 ROU 44.69 25.17 
9737 Ulies-1 ROU 45.95 22.62 
9738 Bran-1 ROU 45.57 25.42 
9739 Toc-1 ROU 46.01 22.33 
9740 Mandr-1 ROU 46.16 21.43 
9741 Orast-1 ROU 45.84 23.16 
9742 Teiu-1 ROU 44.68 25.17 
9743 Furni-1 ROU 45.14 25 
9744 Iasi-1 ROU 47.16 27.59 
9745 Sij 1/96 UZB 41.45 70.05 
9746 Malii-1 SRB 43.71 22.3 
9747 Zabar-1 SRB 44.38 21.22 
9748 Zagub-1 SRB 44.23 21.71 
9749 Knjas-1 SRB 43.54 22.29 
9750 Sukov-1 SRB 43 22.65 
9751 Ruma-1-25 SRB 44.91 19.99 
9752 Brest-1 SRB 44 22.07 
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9753 Ruma-1-27 SRB 44.91 19.99 
9754 Sredn-1 SRB 44.66 21.37 
9755 Vajug-1 SRB 44.56 22.56 
9756 Staro-2 SRB 44.3 21.08 
9757 Staro-1 SRB 44.3 21.08 
9758 Altai-5 CHN 47.75 88.4 
9759 Anz-0 IRN 37.47 49.47 
9760 Baz-0 FRA 48.81 1.66 
9761 Bik-1 LBN 33.92 35.7 
9762 Etna-2 ITA 37.69 14.98 
9764 Qar-8a LBN 34.1 35.84 
9766 Westkar-4 KGZ 42.26 74.16 
9767 Had-1b LBN 34.25 35.92 
9768 Rü4-16 GER 48.57 9.16 
9769 HE-1 GER 48.55 8.99 
9770 KBG2-13 GER 48.53 9.01 
9771 Pfn-N2.2-6 GER 48.56 9.11 
9772 Höf-1 GER 48.41 8.85 
9773 Obn-1 GER 48.52 8.92 
9774 Alt-1 GER 48.59 9.22 
9775 Berg-1 GER 48.41 8.79 
9776 Fell3-7 GER 48.43 8.79 
9777 Gn-1 GER 48.57 9.17 
9778 Bach-7 GER 48.41 8.84 
9779 Bai-10 GER 48.5 8.78 
9780 Fell2-4 GER 48.43 8.79 
9781 Kus2-2 GER 48.52 9.11 
9782 Lu3-30 GER 48.53 9.09 
9783 Tü-PK-7 GER 48.52 9.05 
9784 Erg2-6 GER 48.5 8.8 
9785 Ha-HBT1-2 GER 48.54 9.02 
9786 Ha-P-13 GER 48.54 9.01 
9787 HI-4 GER 48.5 9 
9788 KBG1-14 GER 48.53 9.01 
9789 Obh-13 GER 48.39 8.96 
9790 Gn2-3 GER 48.58 9.18 
9791 Haes-1 GER 48.6 9.2 
9792 Lu4-2 GER 48.54 9.09 
9793 Rü-N2 GER 48.57 9.16 
9794 Tü-B1-2 GER 48.52 9.08 
9795 Wank-2 GER 48.5 9.11 
9796 Bach2-1 GER 48.41 8.84 
Ecotype ID Name Country Latitude Longitude 
9797 Ha-HBT2-10 GER 48.54 9.02 
9798 Ha-P2-1 GER 48.54 9.01 
9799 Hart-2 GER 48.39 8.85 
9800 Ha-S-B GER 48.54 9.01 
9801 Ha-SP-2 GER 48.54 9.01 
9802 Kus3-1 GER 48.51 9.11 
9803 Müh-2 GER 48.42 8.76 
9804 Obe1-15 GER 48.45 8.87 
9805 Pfn-10 GER 48.54 9.09 
9806 Rü-2 GER 48.56 9.16 
9807 Schl-7 GER 48.6 9.22 
9808 Tü-B2-3 GER 48.52 9.08 
9809 Tü-KB-6 GER 48.52 9.05 
9810 Tü-KS-7 GER 48.53 9.07 
9811 Tü-NK-12 GER 48.52 9.05 
9812 Tü-W1 GER 48.52 9.03 
9813 BI-4 GER 48.4 8.77 
9814 Fell1-10 GER 48.42 8.79 
9815 Ha-HBT3-11 GER 48.54 9.02 
9816 Tü-WH GER 48.55 9.06 
9817 Ace-0 ESP 39.84 -6.6 
9818 Aln-30 ESP 41.14 -0.25 
9819 Amu-0 ESP 42.35 -3.03 
9820 Are-0 ESP 41 -4.71 
9821 Aru-0 ESP 41.81 2.49 
9822 Aul-0 ESP 40.52 -4.02 
9823 Bae-0 ESP 43.34 -5.84 
9824 Bes-5 ESP 42.91 -4.91 
9825 Boa-0 ESP 40.4 -3.88 
9826 Bor-0 ESP 42.49 -6.71 
9827 Bos-0 ESP 42.78 0.69 
9828 Bra-0 ESP 42.5 -6.15 
9829 Bur-0 ESP 40.43 -4.75 
9830 Bus-0 ESP 36.97 -3.28 
9831 Cas-0 ESP 38.54 -3.39 
9832 Cat-0 ESP 40.54 -3.69 
9833 Cha-0 ESP 40.38 -4.21 
9834 Cho-0 ESP 40.51 -3.9 
9835 Cir-0 ESP 40.61 -6.57 
9836 Cod-0 ESP 41.25 -1.32 
9837 Con-0 ESP 37.94 -5.6 
9838 Cot-0 ESP 41.83 -5.38 
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9839 Coy-0 ESP 40.44 -4.27 
9840 Dar-0 ESP 41.13 -1.43 
9841 Ees-0 ESP 40.59 -4.15 
9842 Ele-0 ESP 39.31 -3.89 
9843 Elp-0 ESP 40.53 -3.92 
9844 Esn-2 ESP 42.27 0.19 
9845 Evs-0 ESP 40.48 -3.96 
9846 Ezc-2 ESP 42.31 -3.02 
9847 Fel-2 ESP 43.31 -5.7 
9848 Glo-1 ESP 40.11 -5.77 
9849 Gud-3 ESP 40.65 -4.11 
9850 Hec-0 ESP 42.86 -0.7 
9851 Hue-3 ESP 42.96 -6.1 
9852 Ini-0 ESP 40.46 -3.75 
9853 Lac-0 ESP 43.33 -5.91 
9854 Laf-1 ESP 43.36 -5.88 
9855 Lam-0 ESP 40.57 -3.89 
9856 Lch-0 ESP 40.51 -4 
9857 Leg-0 ESP 40.33 -3.8 
9858 Loz-0 ESP 40.98 -3.8 
9859 Lro-0 ESP 40.5 -3.88 
9860 Lum-0 ESP 42.24 -2.62 
9861 Mac-0 ESP 40.72 -3.21 
9862 Mad-0 ESP 40.45 -3.67 
9863 Man-0 ESP 43.33 -5.87 
9864 Mat-0 ESP 41.76 2.69 
9865 Mdc-0 ESP 38.88 -3.53 
9866 Mdd-0 ESP 41.89 -2.79 
9867 Mie-1 ESP 40.94 -3.22 
9868 Moe-0 ESP 41.78 2.37 
9869 Moj-0 ESP 36.76 -5.28 
9870 Moz-0 ESP 41.91 0.17 
9871 Nac-0 ESP 40.75 -3.99 
9872 Nag-0 ESP 40.49 -4.11 
9873 Ndc-0 ESP 37.94 -5.45 
9874 Oja-0 ESP 42.34 -3 
9875 Ovi-1 ESP 43.38 -5.87 
9876 Pad-0 ESP 41.34 0.99 
9877 Pdl-0 ESP 43.02 -5.6 
9878 Pee-0 ESP 40.78 -3.62 
9879 Per-0 ESP 37.6 -1.12 
9880 Pib-1 ESP 42.72 -3.44 
Ecotype ID Name Country Latitude Longitude 
9881 Pie-0 ESP 40.46 -5.32 
9882 Pil-0 ESP 40.46 -4.26 
9883 Piq-0 ESP 42.1 -2.56 
9884 Pos-1 ESP 42.25 -3.04 
9885 Prd-0 ESP 41.14 -3.68 
9886 Pru-0 ESP 42.38 1.73 
9887 Pun-0 ESP 40.4 -4.77 
9888 Pva-1 ESP 40.93 -3.31 
9889 Ras-0 ESP 40.86 -3.87 
9890 Rib-1 ESP 43.16 -5.07 
9891 Sal-0 ESP 41.93 2.92 
9892 Sam-0 ESP 42.68 -6.96 
9893 Sca-0 ESP 37.96 -5.37 
9894 Sen-0 ESP 42.59 0.76 
9895 Sfb-6 ESP 41.78 2.57 
9896 Slc-3 ESP 38.47 -3.74 
9897 Smt-1 ESP 40.95 -5.63 
9898 Som-0 ESP 41.14 -3.58 
9899 Tau-0 ESP 42.54 0.84 
9900 Tri-0 ESP 37.38 -6.01 
9901 Urd-1 ESP 42.27 -2.98 
9902 Usa-0 ESP 40.71 -3.24 
9903 Val-0 ESP 42.31 -3.1 
9904 Vas-0 ESP 40.95 -3.31 
9905 Ven-0 ESP 40.76 -4.01 
9906 Mah-6 ESP 40 4.25 
9907 ENC-2-1 FRA 50.86 3.6 
9908 ESP-1-11 FRA 50.72 3.47 
9909 GEN-8 FRA 50.59 3.3 
9910 BRI-2 FRA 50.68 3.52 
9911 ARGE-1-15 FRA 47.16 4.28 
9912 CIRY-13 FRA 46.67 4.55 
9913 CON-7 FRA 47.24 4.43 
9914 IST-29 FRA 47.58 5.33 
9915 MAR-4-16 FRA 47.45 3.94 
9916 MOL-1 FRA 47.1 4.22 
9917 RAD-21 FRA 46.69 4.34 
9918 SAUL-24 FRA 47.43 5.21 
9919 BRE-14 FRA 48.85 4.45 
9920 DIR-9 FRA 48.54 4.32 
9921 FOR-23 FRA 48.57 4.41 
9922 MIL-2 FRA 48.52 4.7 
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9923 PLO-1 FRA 48.58 4.46 
9924 PLY-20 FRA 48.59 4.24 
9925 RUM-20 FRA 48.91 4.52 
9926 TRE-1 FRA 48.86 4.1 
9927 ARR-17 FRA 44.05 3.69 
9928 BEZ-9 FRA 44.12 3.77 
9929 ISS-20 FRA 43.92 3.71 
9930 LEC-25 FRA 43.91 4.14 
9931 MOU2-25 FRA 43.98 4.31 
9932 NOZ-6 FRA 44.12 4.33 
9933 VED-10 FRA 43.74 3.89 
9934 QUI-8 FRA 44.07 4.08 
9935 BAU-15 FRA 50.6 2.93 
9936 LCL-16 FRA 50.47 3.46 
9937 CATS-6 FRA 50.79 2.69 
9938 WAV-8 FRA 50.65 2.99 
9939 Aitba-2 MAR 31.48 -7.45 
9940 Toufl-1 MAR 31.47 -7.42 
9941 Fei-0 POR 40.92 -8.54 
9942 Agu-1 ESP 41.32 -1.34 
9943 Cdm-0 ESP 39.73 -5.74 
9944 Don-0 ESP 36.83 -6.36 
9945 Leo-1 ESP 41.8 -3.11 
9946 Mer-6 ESP 38.92 -6.34 
9947 Ped-0 ESP 40.74 -3.9 
9948 Pra-6 ESP 41.05 -3.54 
9949 Qui-0 ESP 42.69 -6.93 
9950 Vie-0 ESP 42.63 0.76 
9951 Kly-1 RUS 51.34 82.57 
9952 Kly-4 RUS 51.32 82.55 
9953 Koz-2 RUS 51.33 82.19 
9954 Leb-3 RUS 51.65 80.82 
9955 Stepn-2 RUS 54.09 60.46 
9956 Stepn-1 RUS 54.06 60.48 
9957 Borsk-2 RUS 53.04 51.75 
9958 Shigu-1 RUS 53.33 49.48 
9959 Shigu-2 RUS 53.33 49.48 
9960 Kidr-1 RUS 51.31 57.56 
9961 Krazo-2 RUS 53.09 52 
9962 Galdo-1 ITA 40.57 15.32 
9963 Lago-1 ITA 39.18 16.26 
9964 Mammo-1 ITA 38.36 16.23 
Ecotype ID Name Country Latitude Longitude 
9965 Mammo-2 ITA 38.38 16.22 
9966 Monte-1 ITA 40.28 15.65 
9967 Moran-1 ITA 39.83 16.17 
9968 Timpo-1 ITA 39.27 16.27 
9969 Valsi-1 ITA 40.18 16.45 
9970 Altenb-2 ITA 46.37 11.24 
9971 Bozen-1.1 ITA 46.51 11.33 
9972 Bozen-1.2 ITA 46.51 11.33 
9973 Mitterberg-1-181 ITA 46.36 11.28 
9974 Castelfed-4-212 ITA 46.34 11.29 
9975 Castelfed-4-213 ITA 46.34 11.29 
9976 Rovero-1 ITA 46.25 11.17 
9977 Vezzano-2.1 ITA 46.63 10.82 
9978 Vezzano-2.2 ITA 46.63 10.82 
9979 Voeran-1 ITA 46.36 11.23 
9980 Angel-1 ITA 38.62 16.17 
9981 Angit-1 ITA 38.76 16.24 
9982 Apost-1 ITA 39.01 16.47 
9983 Ciste-1 ITA 41.62 12.87 
9984 Ciste-2 ITA 41.62 12.87 
9985 Slavi-1 BUL 41.43 23.65 
9986 Jablo-1 BUL 41.59 25.2 
9987 Lecho-1 BUL 41.43 23.5 
9988 Bak-2 GEO 41.79 43.48 
9989 Bak-7 GEO 41.79 43.48 
9990 Lag2.2 GEO 41.83 46.28 
9991 Vash-1 GEO 41.24 46.37 
9992 Dog-4 TUR 38.3 42.22 
9993 Nemrut-1 TUR 38.64 42.24 
9994 Ey15-2 GER 48.43 8.77 
9995 HKT2.4 GER 48.14 9.4 
9996 Nie1-2 GER 48.52 8.8 
9997 Rue3.1-31 GER 48.56 9.16 
9998 Star-8 GER 48.43 8.82 
9999 TueSB30-3 GER 48.53 9.06 
10000 Tuescha-9 GER 48.53 9.05 
10001 TueV-13 GER 48.52 9.05 
10002 TueWal-2 GER 48.53 9.04 
10003 WalHaesB4 GER 48.6 9.19 
10004 Bolin-1 ROM 44.46 25.74 
10005 Copac-1 ROM 46.11 21.95 
10006 Kastel-1 UKR 44.64 34.38 
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10007 Koch-1 UKR 50.36 29.32 
10008 Sij-1 UZB 41.45 70.05 
10009 Sij-2 UZB 41.45 70.05 
10010 Sij-4 UZB 41.45 70.05 
10011 Yeg-1 ARM 39.87 45.36 
10012 Istisu-1 AZE 38.98 48.56 
10013 Lerik1-3 AZE 38.74 48.61 
10014 Xan-1 AZE 38.65 48.8 
10015 Sha AFG 37.29 71.3 
10016 Del-10 SRV 44.94 21.18 
10017 Petro-1 SRV 44.34 21.46 
10018 Dobra-1 SRB 44.84 20.16 
10019 KZ10 KAZ 48.67 54.93 
10020 Jl-2 CZE 49.17 16.5 
10021 Hl-0 GER 52.14 9.38 
10022 Uk-3 GER 48.03 7.77 
10023 Strand-1    
10024 Tnz-1 TZA   
10025 Bsch-2 GER 50.01 8.67 
10026 Bg-5 USA 47.62 -122.35 
100000 Wil-1 LTU 54.6833 25.3167 
CS28163 Co-2 POR   
CS28072 Bs-5 SUI   
CS78198 Bch-3 GER   
CS78200 Bch-4 GER   
CS2806 Be-1 GER   
Ecotype ID Name Country Latitude Longitude 
CS28068 Bg-1 USA   
CS28075 Bg-9 USA   
CS22344 Bg-4 USA   
CS28073 Bg-6 USA   
CS28074 Bg-7 USA   
CS78195 Bla-11 ESP   
CS28087 Bla-12 ESP   
CS28088 Bla-14 ESP   
CS28080 Bla-2 ESP   
CS28081 Bla-3 ESP   
CS28083 Bla-5 ESP   
CS28090 Bla-9 ESP   
CS78410 Blh-1 CZE   
CS28097 Bs-2 SUI   
CS28110 Bu-11 GER   
CS28111 Bu-13 GER   
CS78209 Chi-1 RUS   
CS28146 CIBC10 UK   
CS28163 Co-2 POR   
CS78212 Co-3 POR   
CS28165 Co-4 POR   
CS28214 Dra-2 CZE   
CS78224 Ei-4 GER   
CS28225 Ei-5 GER   
CS28226 Ei-6 GER   
CS28274 Ga-2 GER   
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CTCTCCCTTTCTTCGGCTTT AT1G14385 G-15043 F amplifying gene fragments/5.8 Kb chunk (1) for 
sanger sequencing 
AGCCTTTCAAAGCATTTCCA AT1G14385 G-11927 F amplifying gene fragments/4.7 Kb chunk (2) for 
sanger sequencing 
TGGTCCGGTTCTCTTTTCTT BORDER AT1G14385-
AT1G14390 
G-23251 F for sequencing the ACD6 gene fragments 
ATGTGGCTACCTGCTTTGCT BORDER AT1G14385-
AT1G14390 
G-23250 F for sequencing the ACD6 gene fragments 
GTGACCTGACCACCACTCCT BORDER AT1G14385-
AT1G14390 
G-12560 F for sequencing the ACD6 gene fragments 
GCACATGTTGCTTTGGTGAC AT1G14390 G-12674 F for sequencing the ACD6 gene fragments 
ACGGGAATTTCCTCCTCAAG AT1G14390 G-11929 F for sequencing the ACD6 gene fragments 
GATGTGGACGGGAATACACC AT1G14390 G-12091 F for sequencing the ACD6 gene fragments 
GAGTTTGTAGCCTATTCAAAGG BORDER AT1gG14390-
AT1G14400 
G-14062 F amplifying gene fragments/6.5 Kb chunk (3) for 
sanger sequencing 
TGTTGCATCCGACATCATTT BORDER AT1gG14390-
AT1G14400 
G-14341 F for sequencing the ACD6 gene fragments 
TCCTGGAGGATCAACGTAGC AT1G14400 G-14412 F for sequencing the ACD6 gene fragments 
CAAAACCGTTTCTTAGGATGGA AT1G14400 G-14413 R amplifying gene fragments/5.8 Kb or 4.7 Kb chunks 
(1) (2) for sanger sequencing 
ATCACTGCAATTGCCCATGT AT1G14400 G-16287 F amplifying gene fragments/3.6 Kb chunk (4) (5) for 
sanger sequencing 
CGGTTTAGTGGATACCAGTTTACT AT1G14400 G-12549 R amplifying gene fragments/6.5 Kb chunk (3) for 
sanger sequencing 
GTGCACTTTGGAAATCAAGC AT1G14400 G-13166 F for sequencing the ACD6 gene fragments 
CTTAAACCCCGCCTCAACTT AT1G14400 G-14342 R for sequencing the ACD6 gene fragments 
CTTAAACCCCGCCTCAACTT AT1G14400 G-12241 F for sequencing the ACD6 gene fragments 
CAAACAGGGTCACGTTGTCA AT1G14400 G-13168 F for sequencing the ACD6 gene fragments 
CGGGTCATCTTTTAATCTCTGG AT1G14400 G-12070 F for sequencing the ACD6 gene fragments 
TGTGTGTGGTGGATTGCTTT AT1G14400 G-12069 R for sequencing the ACD6 gene fragments 
AGACAAGAACGACCTTTGGC AT1G14400 G-13167 R for sequencing the ACD6 gene fragments 
ATGACTCGAGACATTAACGACTTT AT1G14400 G-12548 F for sequencing the ACD6 gene fragments 
GGTTTGCGATGGACAGTTCT AT1G14400 G-12243 F for sequencing the ACD6 gene fragments 
TCATAGGGTGGCCACAAATT AT1G14400 G-13169 R for sequencing the ACD6 gene fragments 
CACCTATGCAAAACCAACCA AT1G14400 G-12072 F for sequencing the ACD6 gene fragments 
AGGAAAAACTATTCTACTTGATTCTTG AT1G14400 G-12071 R for sequencing the ACD6 gene fragments 
AACATGTCTCACAATATAACTTGTCC AT1G14400 G-12501 F for sequencing the ACD6 gene fragments 
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TGGCTCTGAACGATTGTCTAAA AT1G14400 G-12017 F for sequencing the ACD6 gene fragments 
TTTTTATGGCTCTGAACGATTG AT1G14400 G-12244 R for sequencing the ACD6 gene fragments 
AAATCTTTTAATTGTAAAGTTGTTTGG AT1G14400 G-12073 F for sequencing the ACD6 gene fragments 
TTTAACAAAACGCGCAAGTG AT1G14400 G-12016 R for sequencing the ACD6 gene fragments 
AATTAGATAAAGATATTTATGATTT AT1G14400 G-19971 R for sequencing the ACD6 gene fragments 
TTTGACCCTGGTAACAAATTGTTTTACCAG AT1G14400 G-16353 R for sequencing the ACD6 gene fragments 
ATTTCTCTCACAGCGGAGGA AT1G14400 G-12245 F for sequencing the ACD6 gene fragments 
AGATGTCGAGATGACTCCGG AT1G14400 G-13171 R for sequencing the ACD6 gene fragments 
CCAATGGAACGTGTCAAGAG AT1G14400 G-12075 F for sequencing the ACD6 gene fragments 
GCTAAATGGGGTCATCTGGA AT1G14400 G-12074 R for sequencing the ACD6 gene fragments 
GCTACCTGTCTGGTGAACGC AT1G14400 G-13300 R for sequencing the ACD6 gene fragments 
AGCCGTAGACGCTGGAAATA AT1G14400 G-12247 F for sequencing the ACD6 gene fragments 
GTAAAACCAGCTTGGGACGA AT1G14400 G-12246 R for sequencing the ACD6 gene fragments 
TCATACGGAGCATCCATTGGG AT1G14400 G-12688 R for sequencing the ACD6 gene fragments 
CCGATCAACAAAGGGTGTTT AT1G14401 G-12077 F for sequencing the ACD6 gene fragments 
TCTTTTCCAATTCATTCGGC AT1G14402 G-12076 R for sequencing the ACD6 gene fragments 
AAAACGTTGTCCAGCTTCAAA AT1G14403 G-12335 F for sequencing the ACD6 gene fragments 
GATGTGGACGGGAATACACC AT1G14404 G-12019 F for sequencing the ACD6 gene fragments 
CGAAACAAAAGCGGCTTAAG AT1G14405 G-12248 R for sequencing the ACD6 gene fragments 
ACGTTTGCTGCAGGCTTTAC AT1G14406 G-12581 F for sequencing the ACD6 gene fragments 
TGGGTATATCAGCGATAGCAAAAA AT1G14407 G-13176 F for sequencing the ACD6 gene fragments 
TTTGGCCACTAACCCAACTC AT1G14408 G-12018 R for sequencing the ACD6 gene fragments 
TGGCCACTAACCCAACTCTC AT1G14409 G-12249 F for sequencing the ACD6 gene fragments 
CTCTTATTTGGGCGCAGTTA AT1G14410 G-12079 F for sequencing the ACD6 gene fragments 
CAACACCGTAGAGCACACCA AT1G14411 G-13177 R for sequencing the ACD6 gene fragments 
AGCCGTAGACGCTGGAAATA AT1G14400 G-12247 F for sequencing the ACD6 gene fragments 
AGAAGAAACATATCCTTTGAA AT1G14400 G-18613 R for sequencing the ACD6 gene fragments 
GTTTGCTTTTGCCTTTGGAG AT1G14412 G-12023 F amplifying gene fragments/ 4.4 Kb chunk for 
sanger sequencing 
AACTCAAGACCTCCCGCTTA AT1G14413 G-12254 R amplifying gene fragments/3.6 Kb chunk for 
sanger sequencing 
ATACAGAATTGGGGTGGCAA AT1G14414 G-12022 R amplifying gene fragments/4.3 Kb chunk for 
sanger sequencing 
ACTGCACCCGTTTCTCATTC AT1G14415 G-12026 R amplifying gene fragments/4.4 Kb chunk for 
sanger sequencing 
GATAAATGTTCGTCGTATCGCCCTCTCTCTTTTGTATTCC AT1G58602.2 G-33594 F for constructing amiRNA- I miR-s 
GAGGGCGATACGACGAACATTTATCAAAGAGAATCAATGA AT1G58602.2 G-33610 R for constructing amiRNA- II miR-a 
GAGGACGATACGACGTACATTTTTCACAGGTCGTGATATG AT1G58602.2 G-33647 F for constructing amiRNA- III miR*s  
GAAAAATGTACGTCGTATCGTCCTCTACATATATATTCCT AT1G58602.2 G-33676 R for constructing amiRNA- IV miR*a  
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GATCATAAATCTGGGTAGTTCATTCTCTCTTTTGTATTCC AT1G58410.1 G-33653 F for constructing amiRNA- I miR-s 
GAATGAACTACCCAGATTTATGATCAAAGAGAATCAATGA AT1G58410.1 G-33663 R for constructing amiRNA- II miR-a 
GAATAAACTACCCAGTTTTATGTTCACAGGTCGTGATATG AT1G58410.1 G-33674 F for constructing amiRNA- III miR*s  
GAACATAAAACTGGGTAGTTTATTCTACATATATATTCCT AT1G58410.1 G-33606 R for constructing amiRNA- IV miR*a  
GATAATTCTTAGAGCAAAACCGGTCTCTCTTTTGTATTCC AT1G62630.1, 
AT1G63350.1, 
AT1G63360.1 
G-38124 F for constructing amiRNA- I miR-s 
GACCGGTTTTGCTCTAAGAATTATCAAAGAGAATCAATGA AT1G62630.1, 
AT1G63350.1, 
AT1G63360.1 
G-38125 R for constructing amiRNA- II miR-a 
GACCAGTTTTGCTCTTAGAATTTTCACAGGTCGTGATATG AT1G62630.1, 
AT1G63350.1 
,AT1G63360.1 
G-38126 F for constructing amiRNA- III miR*s  
GAAAATTCTAAGAGCAAAACTGGTCTACATATATATTCCT AT1G62630.1, 
AT1G63350.1, 
AT1G63360.1 
G-38127 R for constructing amiRNA- IV miR*a  
GATACGTTTACAAAGTTCAGCTCTCTCTCTTTTGTATTCC AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38140 F for constructing amiRNA- I miR-s 
GAGAGCTGAACTTTGTAAACGTATCAAAGAGAATCAATGA AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38141 R for constructing amiRNA- II miR-a 
GAGAACTGAACTTTGAAAACGTTTCACAGGTCGTGATATG AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38142 F for constructing amiRNA- III miR*s  
GAAACGTTTTCAAAGTTCAGTTCTCTACATATATATTCCT AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38143 R for constructing amiRNA- IV miR*a  
GATACGTTTACAAAGTTGGGCTGTCTCTCTTTTGTATTCC AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38132 F for constructing amiRNA- I miR-s 
GACAGCCCAACTTTGTAAACGTATCAAAGAGAATCAATGA AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38133 R for constructing amiRNA- II miR-a 
GACAACCCAACTTTGAAAACGTTTCACAGGTCGTGATATG AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38134 F for constructing amiRNA- III miR*s  
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GAAACGTTTTCAAAGTTGGGTTGTCTACATATATATTCCT AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38135 R for constructing amiRNA- IV miR*a  
GATTTAAGCACTCGAACTAGCTTTCTCTCTTTTGTATTCC AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38136 F for constructing amiRNA- I miR-s 
GAAAGCTAGTTCGAGTGCTTAAATCAAAGAGAATCAATGA AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38137 R for constructing amiRNA- II miR-a 
GAAAACTAGTTCGAGAGCTTAATTCACAGGTCGTGATATG AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38138 F for constructing amiRNA- III miR*s  
GAATTAAGCTCTCGAACTAGTTTTCTACATATATATTCCT AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38139 R for constructing amiRNA- IV miR*a  
GATTAGTTTGTTCGAAACGTCTCTCTCTCTTTTGTATTCC AT5G58120.1 G-38154 F for constructing amiRNA- I miR-s 
GAGAGACGTTTCGAACAAACTAATCAAAGAGAATCAATGA AT5G58120.1 G-38155 R for constructing amiRNA- II miR-a 
GAGAAACGTTTCGAAGAAACTATTCACAGGTCGTGATATG AT5G58120.1 G-38156 F for constructing amiRNA- III miR*s  
GAATAGTTTCTTCGAAACGTTTCTCTACATATATATTCCT AT5G58120.1 G-38157 R for constructing amiRNA- IV miR*a  
GATTTAGATAATAGCCGGAGCGATCTCTCTTTTGTATTCC AT5G58120.1 G-38148 F for constructing amiRNA- I miR-s 
GATCGCTCCGGCTATTATCTAAATCAAAGAGAATCAATGA AT5G58120.1 G-38149 R for constructing amiRNA- II miR-a 
GATCACTCCGGCTATAATCTAATTCACAGGTCGTGATATG AT5G58120.1 G-38150 F for constructing amiRNA- III miR*s  
GAATTAGATTATAGCCGGAGTGATCTACATATATATTCCT AT5G58120.1 G-38151 R for constructing amiRNA- IV miR*a  
GATCTACGCAATATACCTTCCGATCTCTCTTTTGTATTCC AT5G58120.1 G-38144 F for constructing amiRNA- I miR-s 
GATCGGAAGGTATATTGCGTAGATCAAAGAGAATCAATGA AT5G58120.1 G-38145 R for constructing amiRNA- II miR-a 
GATCAGAAGGTATATAGCGTAGTTCACAGGTCGTGATATG AT5G58120.1 G-38146 F for constructing amiRNA- III miR*s  
GAACTACGCTATATACCTTCTGATCTACATATATATTCCT AT5G58120.1 G-38147 R for constructing amiRNA- IV miR*a  
GATAGATGACAAGTTGACGTCGATCTCTCTTTTGTATTCC At4g16860, At4g16890, 
At4g16900, At4g16920, 
At4g16940, At4g16950, 
At4g16960 
G-34325 F for constructing amiRNA- I miR-s 
GATCGACGTCAACTTGTCATCTATCAAAGAGAATCAATGA At4g16860, At4g16890, 
At4g16900, At4g16920, 
At4g16940, At4g16950, 
At4g16960 
G-34326 R for constructing amiRNA- II miR-a 
GATCAACGTCAACTTCTCATCTTTCACAGGTCGTGATATG At4g16860, At4g16890, 
At4g16900, At4g16920, 
At4g16940, At4g16950, 
At4g16960 
G-34327 F for constructing amiRNA- III miR*s  
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GAAAGATGAGAAGTTGACGTTGATCTACATATATATTCCT AT4G16860, 
AT4G16890, 
AT4G16900, 
AT4G16920, 
AT4G16940, 
AT4G16950, 
AT4G16960 
G-34328 R for constructing amiRNA- IV miR*a  
GATTATTTAACCTATCGTCGCAGTCTCTCTTTTGTATTCC AT4G16860, 
AT4G16920 
G-34333 F for constructing amiRNA- I miR-s 
GACTGCGACGATAGGTTAAATAATCAAAGAGAATCAATGA AT4G16860, 
AT4G16920 
G-34334 R for constructing amiRNA- II miR-a 
GACTACGACGATAGGATAAATATTCACAGGTCGTGATATG AT4G16860, 
AT4G16920 
G-34335 F for constructing amiRNA- III miR*s  
GAATATTTATCCTATCGTCGTAGTCTACATATATATTCCT AT4G16860, 
AT4G16920 
G-34336 R for constructing amiRNA- IV miR*a  
GATATCTATTAATAGCCCCCCCGTCTCTCTTTTGTATTCC AT4G16860, 
AT4G16920 
G-34337 F for constructing amiRNA- I miR-s 
GACGGGGGGGCTATTAATAGATATCAAAGAGAATCAATGA AT4G16860, 
AT4G16920 
G-34338 R for constructing amiRNA- II miR-a 
GACGAGGGGGCTATTTATAGATTTCACAGGTCGTGATATG AT4G16860, 
AT4G16920 
G-34339 F for constructing amiRNA- III miR*s  
GAAATCTATAAATAGCCCCCTCGTCTACATATATATTCCT AT4G16860, 
AT4G16920 
G-34340 R for constructing amiRNA- IV miR*a  
GATGTCCGCTACAATTCGGCCGTTCTCTCTTTTGTATTCC AT4G16860, 
AT4G16920 
G-34341 F for constructing amiRNA- I miR-s 
GAACGGCCGAATTGTAGCGGACATCAAAGAGAATCAATGA AT4G16860, 
AT4G16920 
G-34342 R for constructing amiRNA- II miR-a 
GAACAGCCGAATTGTTGCGGACTTCACAGGTCGTGATATG AT4G16860, 
AT4G16920 
G-34343 F for constructing amiRNA- III miR*s  
GAAGTCCGCAACAATTCGGCTGTTCTACATATATATTCCT AT4G16860, 
AT4G16920 
G-34344 R for constructing amiRNA- IV miR*a  
GATGAATGGCAAACGTATTGCACTCTCTCTTTTGTATTCC AT4G16860, 
AT4G16920 
G-34345 F for constructing amiRNA- I miR-s 
GAGTGCAATACGTTTGCCATTCATCAAAGAGAATCAATGA AT4G16860, 
AT4G16920 
G-34346 R for constructing amiRNA- II miR-a 
GAGTACAATACGTTTCCCATTCTTCACAGGTCGTGATATG AT4G16860, 
AT4G16920 
G-34347 F for constructing amiRNA- III miR*s  
GAAGAATGGGAAACGTATTGTACTCTACATATATATTCCT AT4G16860, 
AT4G16920 
G-34348 R for constructing amiRNA- IV miR*a  
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GATACGTTTACAAAGTTGGGCTGTCTCTCTTTTGTATTCC AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38132 F for constructing amiRNA- I miR-s 
GACAGCCCAACTTTGTAAACGTATCAAAGAGAATCAATGA AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38133 R for constructing amiRNA- II miR-a 
GACAACCCAACTTTGAAAACGTTTCACAGGTCGTGATATG AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38134 F for constructing amiRNA- III miR*s  
GAAACGTTTTCAAAGTTGGGTTGTCTACATATATATTCCT AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38135 R for constructing amiRNA- IV miR*a  
GATTTAAGCACTCGAACTAGCTTTCTCTCTTTTGTATTCC AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38136 F for constructing amiRNA- I miR-s 
GAAAGCTAGTTCGAGTGCTTAAATCAAAGAGAATCAATGA AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38137 R for constructing amiRNA- II miR-a 
GAAAACTAGTTCGAGAGCTTAATTCACAGGTCGTGATATG AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38138 F for constructing amiRNA- III miR*s  
GAATTAAGCTCTCGAACTAGTTTTCTACATATATATTCCT AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38139 R for constructing amiRNA- IV miR*a  
GATACGTTTACAAAGTTCAGCTCTCTCTCTTTTGTATTCC AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38140 F for constructing amiRNA- I miR-s 
GAGAGCTGAACTTTGTAAACGTATCAAAGAGAATCAATGA AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38141 R for constructing amiRNA- II miR-a 
GAGAACTGAACTTTGAAAACGTTTCACAGGTCGTGATATG AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38142 F for constructing amiRNA- III miR*s  
GAAACGTTTTCAAAGTTCAGTTCTCTACATATATATTCCT AT3G46530.1, 
AT3G46710.1, 
AT3G46730.1 
G-38143 R for constructing amiRNA- IV miR*a  
GATCTACGCAATATACCTTCCGATCTCTCTTTTGTATTCC AT5G58120.1 G-38144 F for constructing amiRNA- I miR-s 
GATCGGAAGGTATATTGCGTAGATCAAAGAGAATCAATGA AT5G58120.1 G-38145 R for constructing amiRNA- II miR-a 
GATCAGAAGGTATATAGCGTAGTTCACAGGTCGTGATATG AT5G58120.1 G-38146 F for constructing amiRNA- III miR*s  
Continued on next page 
		 174 
Appendix Table 2. Continued from previous page… 
Sequence Target gene/region Primer name Orientation Primer purpose 
GAACTACGCTATATACCTTCTGATCTACATATATATTCCT AT5G58120.1 G-38147 R for constructing amiRNA- IV miR*a  
GATTTAGATAATAGCCGGAGCGATCTCTCTTTTGTATTCC AT5G58120.1 G-38148 F for constructing amiRNA- I miR-s 
GATCGCTCCGGCTATTATCTAAATCAAAGAGAATCAATGA AT5G58120.1 G-38149 R for constructing amiRNA- II miR-a 
GATCACTCCGGCTATAATCTAATTCACAGGTCGTGATATG AT5G58120.1 G-38150 F for constructing amiRNA- III miR*s  
GAATTAGATTATAGCCGGAGTGATCTACATATATATTCCT AT5G58120.1 G-38151 R for constructing amiRNA- IV miR*a  
GATTAGTTTGTTCGAAACGTCTCTCTCTCTTTTGTATTCC AT5G58120.1 G-38154 F for constructing amiRNA- I miR-s 
GAGAGACGTTTCGAACAAACTAATCAAAGAGAATCAATGA AT5G58120.1 G-38155 R for constructing amiRNA- II miR-a 
GAGAAACGTTTCGAAGAAACTATTCACAGGTCGTGATATG AT5G58120.1 G-38156 F for constructing amiRNA- III miR*s  
GAATAGTTTCTTCGAAACGTTTCTCTACATATATATTCCT AT5G58120.1 G-38157 R for constructing amiRNA- IV miR*a  
GATGTTGGCACATAAACTCGGAGTCTCTCTTTTGTATTCC RPP1 G-18131 F for constructing amiRNA- I miR-s 
GACTCCGAGTTTATGTGCCAACATCAAAGAGAATCAATGA RPP1 G-18132 R for constructing amiRNA- II miR-a 
GACTACGAGTTTATGAGCCAACTTCACAGGTCGTGATATG RPP1 G-18133 F for constructing amiRNA- III miR*s  
GAAGTTGGCTCATAAACTCGTAGTCTACATATATATTCCT RPP1 G-18134 R for constructing amiRNA- IV miR*a  
GATTCTTACCGATCCCAGGCGGTTCTCTCTTTTGTATTCC RPP1 G-19483 F for constructing amiRNA- I miR-s 
GAACCGCCTGGGATCGGTAAGAATCAAAGAGAATCAATGA RPP1 G-19484 R for constructing amiRNA- II miR-a 
GAACAGCCTGGGATCCGTAAGATTCACAGGTCGTGATATG RPP1 G-19485 F for constructing amiRNA- III miR*s  
GAATCTTACGGATCCCAGGCTGTTCTACATATATATTCCT RPP1 G-19486 R for constructing amiRNA- IV miR*a  
GATATATCCGTAATGATTGCGGCTCTCTCTTTTGTATTCC RPP1 G-19491 F for constructing amiRNA- I miR-s 
GAGCCGCAATCATTACGGATATATCAAAGAGAATCAATGA RPP1 G-19492 R for constructing amiRNA- II miR-a 
GAGCAGCAATCATTAGGGATATTTCACAGGTCGTGATATG RPP1 G-19493 F for constructing amiRNA- III miR*s  
GAAATATCCCTAATGATTGCTGCTCTACATATATATTCCT RPP1 G-19494 R for constructing amiRNA- IV miR*a  
GATTCAAGGAAACACGTGAGACGTCTCTCTTTTGTATTCC RPW8 G-13382 F for constructing amiRNA- I miR-s 
GACGTCTCACGTGTTTCCTTGAATCAAAGAGAATCAATGA RPW8 G-13383 R for constructing amiRNA- II miR-a 
GACGCCTCACGTGTTACCTTGATTCACAGGTCGTGATATG RPW8 G-13384 F for constructing amiRNA- III miR*s  
GAATCAAGGTAACACGTGAGGCGTCTACATATATATTCCT RPW8 G-13385 R for constructing amiRNA- IV miR*a  
GATGATACTAATGATTGTAGCGCTCTCTCTTTTGTATTCC RPW8 G-37702 F for constructing amiRNA- I miR-s 
GAGCGCTACAATCATTAGTATCATCAAAGAGAATCAATGA RPW8 G-37703 R for constructing amiRNA- II miR-a 
GAGCACTACAATCATAAGTATCTTCACAGGTCGTGATATG RPW8 G-37704 F for constructing amiRNA- III miR*s  
GAAGATACTTATGATTGTAGTGCTCTACATATATATTCCT RPW8 G-37705 R for constructing amiRNA- IV miR*a  
GATTATACGAACCTGTACTTCCTTCTCTCTTTTGTATTCC RPW8 G-37706 F for constructing amiRNA- I miR-s 
GAAGGAAGTACAGGTTCGTATAATCAAAGAGAATCAATGA RPW8 G-37707 R for constructing amiRNA- II miR-a 
GAAGAAAGTACAGGTACGTATATTCACAGGTCGTGATATG RPW8 G-37708 F for constructing amiRNA- III miR*s  
GAATATACGTACCTGTACTTTCTTCTACATATATATTCCT RPW8 G-37709 R for constructing amiRNA- IV miR*a  
GATCAGAACGTAAATCGGATCGCTCTCTCTTTTGTATTCC RPW8 G-37710 F for constructing amiRNA- I miR-s 
GAGCGATCCGATTTACGTTCTGATCAAAGAGAATCAATGA RPW8 G-37711 R for constructing amiRNA- II miR-a 
GAGCAATCCGATTTAGGTTCTGTTCACAGGTCGTGATATG RPW8 G-37712 F for constructing amiRNA- III miR*s  
GAACAGAACCTAAATCGGATTGCTCTACATATATATTCCT RPW8 G-37713 R for constructing amiRNA- IV miR*a  
ATCTTCGCTTGGAGCTTCTC FRK1 G-38244 F qRT-PCR 
TGCAGCGCAAGGACTAGAG FRK1 G-38245 R qRT-PCR 
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CTCCATACCCAAGGAGTTATTACAG WRKY29 G-38252 F qRT-PCR 
CGGGTTGGTAGTTCATGATTG  WRKY29 G-38253 R qRT-PCR 
CGTGCATCTGTAATATGCTCTAGG WRKY46 G-38254 F qRT-PCR 
GATGATGGTCACTGCTGGAG WRKY46 G-38255 R qRT-PCR 
ACACGTGCAATGGAGTTTGTGG PR1 G-38258 F qRT-PCR 
TTGGCACATCCGAGTCTCACTG PR1 G-38259 R qRT-PCR 
CATGCCATGGCCAAGGAATTAGCAGAG SGT1B G-38260 F qRT-PCR 
GAAGGCCTATACTCCCACTTCTTGAGCTC  SGT1B G-38261 R qRT-PCR 
CGGGATCCATGAATAATCAAAATGAAGACAC NDR1 G-38262 F qRT-PCR 
GAAGGCCTACGAATAGCAAAGAATACGAG NDR1 G-38263 R qRT-PCR 
GGCGATGAAGCTCAATCCAAACG ACTIN G-38266 F qRT-PCR 
GGTCACGACCAGCAAGATCAAGACG  ACTIN G-38267 R qRT-PCR 
TCCTGAGGAATGTCCTGTGA EDS1 G-13178 F qRT-PCR 
GAACCGTGTTCAGTTTCCTTG EDS1 G-13179 R qRT-PCR 
GGCGGTATCGATGATTCAGT PAD4 G-13180 F qRT-PCR 
GGTTGAATGGCCGGTTATC PAD4 G-13181 R qRT-PCR 
CGTTTCTCAGCAGTGTCGTC NPR1 G-13184 F qRT-PCR 
CCGTCTCACTGGTACGAAGA NPR1 G-13185 R qRT-PCR 
ATCACTGCAATTGCCCATGT ACD6 G-16287 F qRT-PCR 
ACACGCCACACAACCAAAA ACD6 G-16288 R qRT-PCR 
CGAAGGCGGTTTAATGGATACTGC SAG12 G-12167 F qRT-PCR 
TTAACCGGGACATCCTCATAACCTG SAG12 G-12168 R qRT-PCR 
GAGCCTTACAACGCTACTCTGTCTGTC TUB N-0078 F qRT-PCR 
ACACCAGACATAGTAGCAGAAATCAAG TUB N-0079 R qRT-PCR 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC
GACGCTCTTCCGATCT 
Not applicable G-26787 - Universal PCR Primer 1 (Used for RAD-seq) 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Not applicable G-26788 - Universal PCR Primer 2(Used for RAD-seq) 
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 Appendix Table 3. Genomic and artificial microRNA constructs used in this study 
Plasmid 
Name Purpose Alias Vector backbone 
MZ30 Genomic construct ACD6-Pro-0 pACD6-Pro-0:ACD6-Pro-0:BASTA pBLuescript SK + 
MZ32 Genomic construct ACD6-Pro-0  pACD6-Pro-0:ACD6-Pro-0:BASTA pGreenIIS_Basta 
MZ33 Est-1 :: Pro-0 ACD6 chimera pACD6-Est-1:ACD6-Pro-0:BASTA pBLuescript SK + 
MZ34 Pro-0 :: Est-1 ACD6 chimera pACD6-Pro-0:ACD6-Est-1:BASTA pBLuescript SK + 
MZ35 Est-1 :: Pro-0 ACD6 chimera pACD6-Est-1:ACD6-Pro-0:BASTA pGreenIIS_Basta 
MZ36 Pro-0 :: Est-1 ACD6 chimera pACD6-Pro-0:ACD6-Est-1:BASTA pGreenIIS_Basta 
MZ51 Genomic construct ACD6-Rmx-A180 pACD6-Rmx-A180:ACD6-Rmx-180:BASTA pBLuescript SK + 
MZ52 Genomic construct ACD6-Rmx-A180 pACD6-Rmx-A180:ACD6-Rmx-180:BASTA pGreenIIS_Basta 
MZ74 artificial miRNA construct for targeted gene approach amiR-NB-ARC (AT1G58602) pJLblue_rev 
MZ76 artificial miRNA construct for targeted gene approach amiR-NB-ARC (AT1G58602) pGreenIIS_Basta 
MZ77 artificial miRNA construct for targeted gene approach amiR-NB-LRR (AT1G58410) pJLblue_rev 
MZ79 artificial miRNA construct for targeted gene approach amiR-NB-LRR (AT1G58410) pGreenIIS_Basta 
MZ108 artificial miRNA construct for targeted gene approach amiR-RPW8 pJLblue_rev 
MZ110 artificial miRNA construct for targeted gene approach amiR-RPW8 pGreenIIS_Basta 
MZ145 artificial miRNA construct for targeted gene approach amiR-CC-NBS-LRR (AT1G62630, AT1G62650, AT1G62660) pJLblue_rev 
MZ163 artificial miRNA construct for targeted gene approach amiR-CC-NBS-LRR  (AT1G62630, AT1G62650, AT1G62660) pGreenIIS_Basta 
MZ146 artificial miRNA construct for targeted gene approach amiR-RPP13 (AT3G46530.1, AT3G46710.1, AT3G46730.1) pJLblue_rev 
MZ164 artificial miRNA construct for targeted gene approach amiR-RPP13 (AT3G46530.1, AT3G46710.1, AT3G46730.1) pGreenIIS_Basta 
MZ148 artificial miRNA construct for targeted gene approach amiR-RPP13 (AT3G46530.1, AT3G46710.1, AT3G46730.1) pJLblue_rev 
MZ165 artificial miRNA construct for targeted gene approach amiR-RPP13 (AT3G46530.1, AT3G46710.1, AT3G46730.1) pGreenIIS_Basta 
MZ149 artificial miRNA construct for targeted gene approach amiR-RPP13 (AT3G46530.1, AT3G46710.1, AT3G46730.1) pJLblue_rev 
MZ166 artificial miRNA construct for targeted gene approach amiR-RPP13 (AT3G46530.1, AT3G46710.1, AT3G46730.1) pGreenIIS_Basta 
MZ150 artificial miRNA construct for targeted gene approach amiR-ADR2 (AT5G58120.1) pJLblue_rev 
MZ167 artificial miRNA construct for targeted gene approach amiR-ADR2 (AT5G58120.1) pGreenIIS_Basta 
MZ151 artificial miRNA construct for targeted gene approach amiR-ADR2 (AT5G58120.1) pJLblue_rev 
MZ168 artificial miRNA construct for targeted gene approach amiR-ADR2 (AT5G58120.1) pGreenIIS_Basta 
EK19 A artificial miRNA construct for targeted gene approach amiR-RPP7 pGreenIIS_Basta 
EK20 A artificial miRNA construct for targeted gene approach amiR-RPP7 pGreenIIS_Basta 
EK21 A artificial miRNA construct for targeted gene approach amiR-RPP7 pGreenIIS_Basta 
EK22 A artificial miRNA construct for targeted gene approach amiR-RPP7 pGreenIIS_Basta 
EK26 A artificial miRNA construct for targeted gene approach amiR-RPP7 pGreenIIS_Basta 
EK27 A artificial miRNA construct for targeted gene approach amiR-RPP7 pGreenIIS_Basta 
EC290 A artificial miRNA construct for targeted gene approach amiR-RPP4/5 pGreenIIS_Basta 
EC292 A artificial miRNA construct for targeted gene approach amiR-RPP4/5 pGreenIIS_Basta 
EC293 A artificial miRNA construct for targeted gene approach amiR-RPP4/5 pGreenIIS_Basta 
EC294 A artificial miRNA construct for targeted gene approach amiR-RPP4/5 pGreenIIS_Basta 
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EC295 A artificial miRNA construct for targeted gene approach amiR-RPP4/5 pGreenIIS_Basta 
KB209 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
KB210 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
KB211 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
KB212 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
KB217 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
KB226 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
KB228 B artificial miRNA construct for targeted gene approach amiR-RPP1 pGreenIIS_Basta 
MT79 C artificial miRNA construct for targeted gene approach amiR-ACD6 pGreenIIS_Basta 
 A amiRNA constructs made by Dr. Eunyoung Chae; B amiRNA constructs made by Dr. Kirsten Bomblies; amiRNA construct made by Dr. Marco Todesco 
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Appendix Table 4. Adaptors used for multiplexing individuals for RAD-
Seq  
No. Index Restriction Site (PstI) 
1 CAGATA TGCAG 
2 GAAGTG TGCAG 
3 TAGCGGAT TGCAG 
4 TATTCGCAT TGCAG 
5 ATAGAT TGCAG 
6 CCGAACA TGCAG 
7 GGAAGACAT TGCAG 
8 AACGCACATT TGCAG 
9 GAGCGACAT TGCAG 
10 CCTTGCCATT TGCAG 
11 GGTATA TGCAG 
12 TCTTGG TGCAG 
13 GGTGT TGCAG 
14 GGATA TGCAG 
15 CTAAGCA TGCAG 
16 ATTAT TGCAG 
17 GCGCTCA TGCAG 
18 ACTGCGAT TGCAG 
19 TTCGTT TGCAG 
20 ATATAA TGCAG 
21 TGGCAACAGA TGCAG 
22 CTCGTCG TGCAG 
23 GCCTACCT TGCAG 
24 CACCA TGCAG 
25 AATTAG TGCAG 
26 GGAACGA TGCAG 
27 ACTGCT TGCAG 
28 TGCTT TGCAG 
29 GCAAGCCAT TGCAG 
30 CGCACCAATT TGCAG 
31 CTCGCGG TGCAG 
32 AACTGG TGCAG 
33 ATGAGCAA TGCAG 
34 CTTGA TGCAG 
35 GCGTCCT TGCAG 
36 ACCAGGA TGCAG 
37 CCACTCA TGCAG 
38 TCACGGAAG TGCAG 
39 TATCA TGCAG 
No. Index Restriction Site (PstI) 
40 TAGCCAA TGCAG 
41 ATATCGCCA TGCAG 
42 CTCTA TGCAG 
43 GGTGCACATT TGCAG 
44 CTCTCGCAT TGCAG 
45 CAGAGGT TGCAG 
46 GCGTACAAT TGCAG 
47 ACGCGCG TGCAG 
48 GTCGCCT TGCAG 
49 AATAACCAA TGCAG 
50 AATGAACGA TGCAG 
51 ATGGCAA TGCAG 
52 GAAGCA TGCAG 
53 AACGTGCCT TGCAG 
54 CCTCG TGCAG 
55 CTCAT TGCAG 
56 ACGGTACT TGCAG 
57 GCGCCG TGCAG 
58 CAAGT TGCAG 
59 GGAGTCAAG TGCAG 
60 TGAAT TGCAG 
61 CATAT TGCAG 
62 GTGACACAT TGCAG 
63 TATGT TGCAG 
64 TGCAGA TGCAG 
65 CATCTGCCG TGCAG 
66 GGACAG TGCAG 
67 ATCTGT TGCAG 
68 AAGACGCT TGCAG 
69 GAATGCAATA TGCAG 
70 TAGCAG TGCAG 
71 CTTAG TGCAG 
72 TTATTACAT TGCAG 
73 GCCAACAAGA TGCAG 
74 TGCCGCAT TGCAG 
75 CGTGTCA TGCAG 
76 CAACCACACA TGCAG 
77 GCTCCGA TGCAG 
78 CGTTCA TGCAG 
79 CATCACAAG TGCAG 
80 TCCAG TGCAG 
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81 AACTGAAG TGCAG 
82 GATTCA TGCAG 
83 CAAGCCAATT TGCAG 
84 TTGCGCT TGCAG 
85 CGCAGACACT TGCAG 
86 TGTGGA TGCAG 
87 TGGATA TGCAG 
88 ATAGCGT TGCAG 
89 CCATAGA TGCAG 
90 GGCACGCAT TGCAG 
91 ATTAACAATT TGCAG 
92 CAATA TGCAG 
93 TAGTCCAT TGCAG 
94 CGTGACCT TGCAG 
95 CTTCAGA TGCAG 
96 ATCTGCAACA TGCAG 
97 AAGGA TGCAG 
98 TTACT TGCAG 
99 TTATCCAT TGCAG 
100 GGATTG TGCAG 
101 GACGTGA TGCAG 
102 GACGGCA TGCAG 
103 CGTCTG TGCAG 
104 TCTGA TGCAG 
105 AACTT TGCAG 
106 GAGTCACAAT TGCAG 
107 CGGTTGCAT TGCAG 
108 GTCCTGCCA TGCAG 
109 GTTACA TGCAG 
110 GCGGA TGCAG 
111 ATGATACG TGCAG 
112 CTGTTG TGCAG 
113 TCAGTAAT TGCAG 
114 TCACA TGCAG 
115 GTCGT TGCAG 
116 ACGCTAA TGCAG 
117 ATAGG TGCAG 
118 CCTGCCA TGCAG 
119 TAAGACA TGCAG 
120 TGAGA TGCAG 
121 AATGCAG TGCAG 
No. Index Restriction Site (PstI) 
122 CCGTGA TGCAG 
123 GCCAGACATT TGCAG 
124 GTGCG TGCAG 
125 TTACACA TGCAG 
126 CCGTCACAGT TGCAG 
127 CTGTGT TGCAG 
128 CGCGCCG TGCAG 
129 CTAACA TGCAG 
130 GGCCTG TGCAG 
131 TGACGT TGCAG 
132 ACTGAG TGCAG 
133 GCGCACT TGCAG 
134 GGTAAGCA TGCAG 
135 AATCGGAGG TGCAG 
136 TGGAGCCT TGCAG 
137 GATGGCCAT TGCAG 
138 TGCAA TGCAG 
139 GAGACG TGCAG 
140 CCGTACCACT TGCAG 
141 GTAACG TGCAG 
142 TCCTCACAT TGCAG 
143 TCGTA TGCAG 
144 GTATTGACT TGCAG 
145 GCTCA TGCAG 
146 CAGTAA TGCAG 
147 GGAGAGCAT TGCAG 
148 CCATG TGCAG 
149 CGCTCACACA TGCAG 
150 TGTTACG TGCAG 
151 GATTGGAAGA TGCAG 
152 AATAAGAGT TGCAG 
153 TACAAG TGCAG 
154 TTCAGCCAGT TGCAG 
155 TGAAGCAACT TGCAG 
156 ACAACGCAT TGCAG 
157 GGCGGACGA TGCAG 
158 AATGTA TGCAG 
159 GTACGGACG TGCAG 
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